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ABSTRACT 
 
MAMMOGRAPHY UTILIZATION IN AFRICAN AMERICAN WOMEN  
 
 
 
 
By 
April D. Kidd 
December 2017 
 
Dissertation supervised by Alison M. Colbert, PhD, PHCNS-BC 
Purpose: Breast cancer presents differently among women causing breast cancer health 
disparities with women of color disproportionally shouldering later-stage screening, 
incidence, and treatment, and greater mortality. This study assessed 10 predictors and 
rates of recent and long-term mammography utilization for women 43-79 years of age to 
better understand differences among age strata and races.  This was the first study to use 
both the calculated Gail Risk scores (calculates absolute breast cancer risk over time 
intervals) from the 2010 National Health Interview Survey (NHIS) and a temporary 
homelessness variable in predicting mammography utilization using national-level data. 
Theoretical Framework:  A modified Behavioral Model for Vulnerable Populations 
guided this study and provided a unique and well-established framework in evaluating 
vulnerable population domains and ethnicities.   
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Methods: Secondary data analysis of 2010 NHIS data was completed, that included a 
Cancer Control Module (cancer control questions), which is incorporated into the NHIS 
every five years. Using logistic regression, N= 6,334; n=1,141 for African American 
(AA) was used to examine mammography utilization differences between and among age 
strata and races (AA, Non-Hispanic White, and Hispanic), with focus on younger AA 
women in their 40s.  Wald F test statistics with two-sided p-values <.05 and odds and 
adjusted ratios were used to determine statistical significance. 
Results:  AA had the highest (79.3%) of lowest risk Gail Risk scores, while Whites had 
the highest (30.7%) of highest risk Gail Risk scores. There was no statistically significant 
difference in Gail Risk scores by race on recent, Wald F(2, 299)=1.76, p=0.18, and long-
term Wald F(2, 299)-0.58, p=0.56. Women in the 50-64 age strata had greater odds of 
both recent, Wald F(2, 299)=7.52, p<0.01 and long-term,Wald F(2, 299)=38.04, p<0.01. 
Whites had 0.62 adjusted odds ratio (AOR) (95% CI, 0.46-0.83) to have recent, and 0.76 
AOR (95% CI, 0.59-0.99) to have long-term. Homelessness and transportation delays 
were not predictors in the adjusted recent model, while only transportation delay was not 
a predictor for long-term. AA long-term mammography utilization were consistent with 
long-term mammography utilization for all three races together with the older two age 
strata with higher odds (50-64 strata: 1.80 odds ratio (OR) (95% CI, 1.24-2.62) and 65-79 
strata: 1.75 OR (95% CI, 1.18-2.59)). 
Significance to Nursing: Risk assessment and mammography are vital prevention 
modalities in mitigating breast cancer health disparities. It is important for women to 
know their risk and for continued testing of predictor interactions to improve 
mammography knowledge and practice.  
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CHAPTER 1 
INTRODUCTION 
1.1 Background 
 Breast cancer is second only to lung and bronchus cancer as the leading cause of 
cancer death among women in the United States (American Cancer Society, 2017; 
Oeffinger et al., 2015). Mammography is one facet of secondary cancer prevention that, 
if routinely utilized, may decrease breast cancer mortality in some women (American 
Cancer Society, 2016, 2017; Andersson & Janzon, 1997; Duffy et al., 2010; Mahon, 
2007; Tabar et al., 1995). Understanding mammography behaviors in those for whom it is 
clinically, theoretically, and/or practically appropriate can provide an opportunity for 
improving breast health, as well as potentially mitigating breast cancer health disparity 
that plague women of color.   
Although there has been more research over the last several years surrounding 
factors associated with breast health practices in older women, little is known about the 
mammography behaviors of African American women, and far less is known about 
mammography behaviors of younger African American women in their 40s and their 
associated individual breast cancer risk (Conway-Phillips & Millon-Underwood, 2009; 
Kidd, Colbert, & Jatoi, 2015).  This scarcity of information specifically for younger 
women is due in part to the controversy surrounding mammography’s questionable 
benefit in this population (Buist, Porter, Lehman, Taplin, & White, 2004; Jatoi & Baum, 
1993; Tabar et al., 2011). Regardless of the debate surrounding its utilization and benefit 
in this younger population, mammography is used and has benefit to some (Ooi, 
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Martinez, & Li, 2011; Siu, Bibbins-Domingo, Grossman, LeFevre, & Force, 2016; van 
Ravesteyn et al., 2012).  Therefore, it is important to understand these behaviors that may 
promote better breast health in this younger African American population.  
 Screening mammography has been used in the United States as a mass population 
screening intervention since the 1960s to detect the presence of breast cancer, facilitating 
early treatment and cure (Shapiro, 1977, 1997; Shapiro, Strax, & Venet, 1966). The 
controversy surrounding mammography has centered on its benefit versus harm, 
particularly in women in their 40s (Kerlikowske, 2012; Passmore, Williams-Parry, 
Casper, & Thomas, 2017; van Ravesteyn et al., 2012). Other issues surrounding 
mammography include concerns due to false positives, unnecessary testing and biopsies, 
low-dose radiation exposure, over diagnosis, and increased lead time (Beemsterboer, 
Warmerdam, Boer, & de Koning, 1998; Bleyer & Welch, 2012; Jatoi & Anderson, 
2010a; Loberg, Lousdal, Bretthauer, & Kalager, 2015). 
1.1.1 Breast Cancer Health Disparity   
Despite advances in care and treatment, health disparities persist in breast cancer, 
most notably in relation to race (Desantis, Ma, Bryan, & Jemal, 2013; DeSantis, 
Naishadham, & Jemal, 2013).  Women of color, and specifically African American 
women, disproportionately shoulder later-stage diagnosis and breast cancer mortality 
(American Cancer Society, 2016; Amirikia, Mills, Bush, & Newman, 2011; Sassi, Luft, 
& Guadagnoli, 2006; Vona-Davis & Rose, 2009).  Research suggests that this health 
disparity can be attributed to multiple causes, to include socioeconomic (Rahman, 
Dignan, & Shelton, 2003; Vona-Davis & Rose, 2009), structural, cultural, biological 
(Jerome-D'Emilia & Suplee, 2015; Sturtz, Melley, Mamula, Shriver, & Ellsworth, 2014), 
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intrapersonal, and interpersonal factors (American Cancer Society, 2016; Mishra, 
DeForge, Barnet, Ntiri, & Grant, 2012; Watson-Johnson et al., 2011).  Screening 
mammography is an important intervention in mitigating this breast cancer health 
inequity (Conway-Phillips & Millon-Underwood, 2009; Freedman, Petitti, & Robins, 
2004; Oeffinger et al., 2015; Siu et al., 2016; Smith, 2014) . 
 Breast cancer is the leading site of new cancer cases and the second leading cause 
of cancer death for African American women (American Cancer Society, 2016, 2017; 
Oeffinger et al., 2015; Smith, Brooks, Cokkinides, Saslow, & Brawley, 2013).  Although 
White women generally have a higher incidence of breast cancer, African American and 
other women of color shoulder a disproportionate disease burden, with higher mortality 
from the disease (American Cancer Society, 2015; Amirikia et al., 2011; Surveillance, 
2017).  An aggressive form of breast cancer (referred to as triple-negative), has poorer 
prognosis, and is almost twice as common in African Americans than in other races 
(American Cancer Society, 2015; Amirikia et al., 2011; Carey et al., 2006).   
The higher breast cancer mortality seen in younger African American women (in their 
40s and younger) is due in large part to this aggressive tumor morphology and higher 
rates of interval cancers (Buist et al., 2004; Carey et al., 2006; Ooi et al., 2011), while 
other causes of higher cancer mortality in racial and ethnic women of color can be 
attributed to obstacles in cancer prevention and detection (American Cancer Society, 
2016; Bjurstam et al., 2003; Conway-Phillips & Millon-Underwood, 2009; Smith et al., 
2013). 
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1.2 Purpose of the Study 
The purpose of this study is to explore associations and predictors of 
mammography utilization for women 43-79 years of age to better understand differences 
among and between the age groups and races (African American, Non-Hispanic White, 
and Hispanic) that may contribute to the breast cancer health disparity, using variables 
borne from the literature and identified in a modified Behavioral Model for Vulnerable 
Populations. The Behavioral Model for Vulnerable Populations provided an explorative 
perspective unique within vulnerable populations that explained the many factors 
impacting health behaviors and outcomes (Aday & Andersen, 1974; Andersen, 1995; 
Gelberg, Andersen, & Leake, 2000).  Special attention and focus in the study was on the 
in younger African American women and women in their 40s. 
This study also compared the relative impact of a woman’s individual breast 
cancer risk, the Gail risk score, on mammography utilization. This study evaluated recent 
mammography utilization (having had a mammogram in the past 1-2 years) (Clark, 
Rakowski, & Bonacore, 2003), and long-term mammography utilization (having an on-
schedule mammography over a prolonged period of time) (Rakowski et al., 2006; Vernon 
et al., 2008).  Assessing recent mammography utilization, though important, evaluating 
mammography over extended periods of time provides a considerable enhanced gauge in 
measuring health improvement (Breen & Meissner, 2005a; Clark et al., 2003; Kindig & 
Stoddart, 2003; Kindig, 2007; O'Neill et al., 2008). 
1.3 Study Data: The National Health Interview Survey 
 Secondary data analysis of 2010 National Health Interview Survey (NHIS) data 
was used for this study.  The NHIS allowed cross-sectional analysis of the data and 
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generalizability. The NHIS is a nationwide multi-purpose health survey of civilian non-
institutionalized households of the United States, conducted by the US Census Bureau 
(Ackermann & Cheal, 1994; Center for Disease Control and, 2011b, 2011c, 2012). The 
2010 NHIS included a Cancer Control Supplement, which asked questions on cancer 
control, and is administered every five years (Center for Disease Control and, 2011b).  
The 2010 NHIS data was used because, at the time of the study, 2015 NHIS data had not 
been released and Gail risk were not calculated for the 2015 data. 
1.4 Research Questions 
 Question 1.  Are there differences in recent and long-term mammography 
utilization for African American women by age strata: 43-49, 50-64, and 65-79?  
Question 2.  Are the predisposing (age, race, marital status, Gail risk score, and 
homelessness), enabling (regular source of care, income, transportation, and health 
insurance) and need (perceived health status) variables associated with recent and long-
term mammography utilization?  
Question 3.  Do the model variables associated with recent and long-term 
mammography utilization differ by race for women in the same age strata?   
Question 4.  Does Gail risk score on recent and long-term mammography 
utilization differ by race? 
1.5 Dissertation Organization and Progression 
 The researcher completed the manuscript dissertation option, wherein each 
chapter is its own stand-alone document.  The chapters delineate the progressive growth, 
development, and evolution of the study.  From the initial approved study proposal, to the 
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results manuscript, changes were made that refined study analysis using the complex data 
of the NHIS.    
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2.1 Abstract 
The mammography controversy has presented both opportunities and challenges 
for achieving optimal breast health in younger African American women, and in battling 
health inequities that place them at greater risk of mortality.  In spite of the controversy, 
there remains a need to understand the complex issues related to mammography 
knowledge, attitudes and behaviors of young minority women, while empowering them 
to take an active role in their breast healthcare. The purpose of this article is to describe 
the complicated issues related to screening in younger African American women (in their 
40s), within the context of the uncertainty about the evidence surrounding screening 
practices.  Literature was reviewed to garner a comprehensive update of the 
mammography controversy, and its impact on mammography practices.  Implication for 
Practice:  Nurses should be aware of the mammography controversy and breast cancer 
risk assessment and how they affect younger women’s participation in mammography 
screening.  Mammography screening should be shared decision making between patient 
and health provider.  Better understanding of breast health and its effect and impact on 
younger minority women is needed.  Nurses have a prominent role to advocate for, 
empower, and educate patients as they face the task of deciding whether to begin and/or 
continue mammography in their 40s. 
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2.2 Introduction 
 Mammography screening for women in their forties has been contentious since its 
early beginnings (Christie, 1977; Hale & deValpine, 2014; Shapiro, Venet, Strax, Venet, 
& Roeser, 1985).  Recommendations are vehemently debated, and consensus has not 
been reached about best practice guidelines for women, most notably the optimal age to 
initiate, optimal interval (annually versus biennially), and the age screening should stop 
(Jatoi & Baum, 1993; Quanstrum & Hayward, 2010). There is also theoretical concern 
that low dose radiation from screening mammography may potentially induce breast 
cancers in women who harbor mutations in the BRCA 1 or BRCA 2 genes (these genes 
are responsible for DNA repair, and mutations in these genes may reduce the ability to 
repair damage from low-dose radiation)(Foulkes, 2008; Frankenberg-Schwager & 
Gregus, 2012; Swift, Morrell, Massey, & Chase, 1991; Taylor, 1992).  Moreover, 
mammography screening is associated with false-positives, which may result in 
unnecessary biopsies and anxiety, has been associated with a significant rate of  breast 
cancer overdiagnosis (finding lesions that would never progress and are not life 
threatening), and lead time (the time mammography detected cancers remain in the 
preclinical phase) (Bleyer & Welch, 2012; Bleyer & Welch, 2012; Christie, 1977; Hale & 
deValpine, 2014; Jatoi & Baum, 1993).  Although opinions are polarized, there is 
agreement that women should be encouraged to participate fully in the discussions 
surrounding their breast health and the ultimate decision making. Therefore, cogent 
guidance is needed to enable women--along with their health provider-- to make the best 
breast health decision.  
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In addition to the controversy, a very real disparity in breast cancer outcomes 
exists, steeped in differences surrounding early detection and treatment.  There is a 
distinct and resolute need to provide good quality health care to all populations, but often, 
younger African American women’s breast health has been overlooked, leading to a 
breast cancer health disparity, due in part to them shouldering the burden of breast cancer 
mortality (Conway-Phillips & Millon-Underwood, 2009).  This crisis of inequity 
demands better understanding and solutions that take into consideration the unique needs 
of younger minority women. While there are many factors that contribute to this 
disparity, it is essential that the mammography controversy does not overshadow the real 
need for quality, individualized breast care, which includes a thorough understanding of 
screening risks, benefits and options.  There must be a degree of consensus reached 
concerning the optimal level of breast health education and screening required for the 
unique needs of this population.  In addition to the demand for high-quality care, this new 
landscape of seemingly constant changes and modifications to recommendations based 
on the evolving evidence, also challenges health care providers to ensure that women are 
provided the necessary information to make informed choices about their own care. 
 Nurses need to be aware of the existing health care disparity and the continuously 
evolving debate in mammography screening in order to provide comprehensive care to 
the patients. The purpose of this article is to describe the complicated issues related to 
mammography screening in younger African American women, within the context of the 
uncertainty about the evidence surrounding screening practices.   
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2.3 Breast Cancer Health Disparity 
Health disparities arise from many factors, including unequal socioeconomic 
factors, culture differences, discrimination, and health system barriers that influence 
access to cancer prevention and treatment services (American Cancer Society, 2013a; 
American Cancer Society, 2013b; American Cancer Society, 2014; Calvocoressi et al., 
2004; Finney, Tumiel-Berhalter, Fox, & Jaen, 2006).  Mitigating health disparities is a 
major concern as evidenced by its inclusion in national health benchmarks within Healthy 
People 2020 and the National Prevention Strategy, which identify ideal population health 
improvement targets (U.S. Department of Health and Human Services, 2011a; U.S. 
Department of Health and Human Services, 2011b).   
Breast cancer, a leading example of US health disparity, accounts for an estimated 
15% of US cancer deaths and is the leading site of new cancer cases in women and the 
second leading cause of cancer death for African American women (American Cancer 
Society, 2011; American Cancer Society, 2013a; American Cancer Society, 2013b; 
American Cancer Society, 2014).  A percentage of the higher breast cancer mortality seen 
in younger African American women is due to aggressive tumor morphology, while other 
gaps in cancer mortality for racial and ethnic minorities can be attributed to obstacles in 
cancer prevention and detection (American Cancer Society, 2011; American Cancer 
Society, 2013a; Andersson & Janzon, 1997; Bjurstam, Bjorneld, Duffy, Smith, Cahlin, 
Erikson et al., 1997; Conway-Phillips & Millon-Underwood, 2009).  Although African 
American women have a lower incidence of breast cancer than White women overall, 
among women under 45 years of age, African American women have a higher incidence 
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of breast cancer than Whites (American Cancer Society, 2013b; American Cancer 
Society, 2013b).   
The reasons for this disparity are not fully understood, but may partly be 
attributed to differences in knowledge, attitudes, and behavior around breast health in 
young African American women. Mammography is often recommended for women 
considered average risk beginning at age 40 or 50, but many African American women 
lack knowledge about their own risk, and consequently present in later stages of cancer 
development (Byrne, Glasgow, & DeShields, 2011; Conway-Phillips & Millon-
Underwood, 2009; Dailey, Kasl, Holford, & Jones, 2007; Feldstein et al., 2011).  This 
lack of information about screening options and less breast cancer awareness, or 
acknowledgment of risk, may, in many instances, serve as a catalyst for increased breast 
cancer mortality. In order to effectively address the reality of these health disparities, it’s 
important to understand the controversy around screening, and how the current climate 
can allow for healthy debate, without jeopardizing advancements in health equity.  
2.4 The Case for Mammography 
 The main issue that has fueled the controversy is the lack of randomized clinical 
trial (RCT) evidence supporting mammography’s benefit or lives saved if used by women 
in their forties.  Of the nine mammography RCTs conducted globally to evaluate the 
efficacy of screening, only one has been conducted in the United States, the 1960s Breast 
Cancer Screening Project of the Health Insurance Plan (HIP) of New York, and few, if 
any, included minority populations such as African American women. Only two trials 
(the Canadian National Breast Cancer Screening Study, and the UK Age Trial) have been 
conducted to specifically address mammography efficacy for women in their forties, both 
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indicating that if women begin screening in their 40s, benefit would not be seen until 12-
14 years, at which time, they would already be in their 50s, presumably with less 
screening benefit for the younger age group (Bjurstam, Bjorneld, Duffy, Smith, Cahlin, 
Eriksson et al., 1997; Bjurstam et al., 2003; Elwood, Cox, & Richardson, 1993; Hendrick, 
Smith, & Rutledge, 1997; Miller, To, Baines, & Wall, 2002; Nystrom & Larsson, 1993; 
Nystrom et al., 1993; Tabar et al., 1995; Tabar et al., 1996).  The HIP trial results were 
the impetus for the initiation of mass mammography screening in the U.S., because this 
trial demonstrated a reduction in breast cancer mortality for women who were screened, 
versus those who were not (Shapiro et al., 1985; Shapiro, 1997).  The HIP trial was 
initiated in 1963, and there have now been questions surrounding its methodology, 
power, and screening technologies, when comparing it to newer trials. For younger 
women specifically, mammography clinical trials have shown far less of a benefit for 
women in their 40s than in their 50s.  This lesser perceived benefit (lives saved), coupled 
with the theoretical risk of inducing breast cancer in younger women who already have a 
hereditary predisposition for breast cancer, cause significant concern for mass screening, 
as it may often be used without scrutiny of these individualized risks (Clark, 2004; 
Foulkes, 2008; Taylor, 1992).  
Despite this, many organizations, researchers and clinicians maintain that 
screening mammography may have benefit in the broad context of detecting breast cancer 
in its precocious stage of development in some women, allowing early cancer treatment 
and cure than would otherwise be accomplished if cancer was detected later (Hale & 
deValpine, 2014; Tabar et al., 2011; US Preventive Services Task Force, 2009). The two 
sides of this issue are complex, but recent advances in what is known about breast cancer 
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itself, as well as where it may have most benefit, could bring some consensus about 
mammography use. 
Breast cancer is not a homogenous disease, but a heterogeneous disease consisting 
of many facets, with differences based on the type of cells, location of the cancer, and 
invasiveness of the disease (Habel & Stanford, 1993; Stanford & Greenberg, 1989).  
Because of this, there is not a single screening modality that detects all types of breast 
cancers at equal levels of specificity and sensitivity (Kolb, Lichy, & Newhouse, 2002; 
Tilanus-Linthorst et al., 2002). Breast cancer morphology is also complex, with different 
presentation and characteristics among women.  Tumors are typically described by their 
level of expressed estrogen.  High- grade estrogen negative (ER-) cancers do not express 
estrogen (also referred to as triple receptor- negative when additionally negative for 
progesterone receptor and human epidermal growth factor receptor), and women with this 
type have a poorer prognosis (Habel & Stanford, 1993; Krizmanich-Conniff et al., 2012; 
Stanford & Greenberg, 1989).  Alternatively, low-grade estrogen positive (ER+) cancers 
express estrogen, and women with this type have a better prognosis (Habel & Stanford, 
1993; Stanford & Greenberg, 1989). White women have a higher incidence of ER+ breast 
cancers, which are slow growing, lending itself to better mammography detection 
(Howlader et al., 2013; Stanford & Greenberg, 1989).  Conversely, ER- cancers are fast-
growing, and are most prevalent in younger African American women (< 50 years of age) 
(Gapstur, Dupuis, Gann, Collila, & Winchester, 1996; Ooi, Martinez, & Li, 2011; 
Stanford & Greenberg, 1989).  Because of ER- tumor histological make up, and its 
aggressive growing nature, mammography does not detect ER- tumors as readily as ER+ 
tumors (Foulkes, 2008; Tilanus-Linthorst et al., 2002).   
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This is further complicated by the “collateral effects” of mammography screening 
that don’t address its effectiveness in detection, but rather harm caused by the test itself.  
Although mammography has been shown to detect cancer early and save the lives of 
some women who use it, it has also caused undue harm to many women due to false 
positives, over-diagnosis, lead-time, and low-dose radiation exposure, causing 
unnecessary further testing and biopsies, and the needless exposure to radiation 
(Beemsterboer, Warmerdam, Boer, & de Koning, 1998; Bleyer & Welch, 2012; Jatoi & 
Anderson, 2010). Clearly, it may not be most beneficial for younger minority women, 
due to elevated associated risks (Bjurstam et al., 2003; Shapiro, 1977; Shapiro, 1997).  
However, clinicians cannot afford to dismiss mammography in it’s entirely for this 
population.  Again, if it’s going to be used, researchers and health care providers must 
figure out ways to address the shortcomings of mammography, while also mitigating the 
risks surrounding its utilization in the younger at risk population.       
Recently, a risked–based or risk stratification approach to mammography 
utilization has been advocated, which would help women ascertain their individual breast 
cancer risk using prediction models by including various factors such as breast density, 
menopause status, and age (Bertrand et al., 2013; Kerlikowske et al., 2013).  There are 
easily available risk-based online tools to support and provide women guidance on if and 
when they should engage in mammography, and the most appropriate interval based on 
their risk of developing cancer (Centre for Cancer Prevention, 2014; Fletcher, 2011; 
Kerlikowske et al., 2013; National Institutes of Health, 2011). Individual risk factors 
should play a potent role in guiding screening practices (Schrager & Marko, 2013). In a 
recent comparative modeling study (median of 10,610 (N) in four models) to determine 
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the threshold relative risk for the harm-benefit ratio of screening between women in their 
40s to those 50-74 years of age, for those with a 2-fold elevated risk of breast cancer, 
their risk of starting biennial screening at 40 was comparable to average risk women 
beginning biennial screening at 50 (van Ravesteyn et al., 2012).  Mammography is 
promoted as an intervention, if practiced early and routinely within the context of 
individualized assessment, could help equalize breast cancer health disparity and 
decrease breast cancer mortality.   
It is understood mammography is one tool, often accompanied by other detection 
modalities (i.e. ultrasound, magnetic resonance imaging, clinical breast exam, etc.), that 
may be used in detecting breast cancer early (Fletcher, 2011; Kolb et al., 2002; Patterson 
& Noroozian, 2012; Taylor, 1992; Tilanus-Linthorst et al., 2002). Developments in 
knowledge about the disease suggest that mammography may be more ideal as an 
individualized tool than as a mass screening tool. Despite this, mammography may still 
have a place in the spectrum of breast cancer early detection in younger and older 
women.  The challenge is ascertaining through further research, its most appropriate 
place.  
Digital breast tomosynthesis (DBT), a fairly new technology, is providing even 
greater detection clarity of non-calcified masses by providing a 3-dimensional view of 
images, and reducing tissue superimposition (Houssami & Skaane, 2013; Houssami & 
Zackrisson, 2013; Patterson & Noroozian, 2012; Rafferty, Park, Philpotts, Poplack, 
Sumkin, Halpern, & Niklason, 2013b; Skaane et al., 2013).  In clinical trials, DBT has 
shown increased detection rates of 30%, fewer recalls, and fewer false-positives when 
combined with 2-dimensional digital mammography (Rafferty, Park, Philpotts, Poplack, 
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Sumkin, Halpern, & Niklason, 2013b; Skaane et al., 2013; Tingberg et al., 2011). DBT is 
continuing in clinical trial testing, and thus far does not provide promise in reducing 
interval breast cancers in high risk women.  Magnetic Resonance Imaging (MRI) is used 
as adjunct in high risk women, and specifically women with BRCA gene mutation, 
offering significant detection benefit without using ionizing radiation, and is more 
sensitive than mammography (Bosse et al., 2013; Kuhl et al., 2005).  Cost limits the use 
of MRI in at risk populations, further expanding the cancer disparity (Mahon, 2007; 
Patterson & Noroozian, 2012).  Additionally, MRI has not been widely implemented due 
to associated higher false-positive rates (Bosse et al., 2013; Patterson & Noroozian, 
2012). Despite these detection advances, continued improvements are needed for high 
risk women, and until such time, mammography will continue to have a place in the early 
detection portfolio. 
2.5 Screening Guidelines 
When screening is utilized, it should be conducted systematically and following 
the best practice guidelines for frequency and timing (American Cancer Society, 2011; 
American Cancer Society, 2013a; Christie, 1977; Institute of Medicine, 2003; Malmgren, 
Parikh, Atwood, & Kaplan, 2012; Quanstrum & Hayward, 2010). Breast cancer screening 
guidelines differ based on the screening commencement age and screening interval, using 
research results favored by the guideline sponsoring organization (i.e. American Cancer 
Society, U.S. Preventive Services Task Force, Center for Disease Control and Prevention, 
American College of Radiology, etc.) (American Cancer Society, 2011; American Cancer 
Society, 2013a; American Cancer Society, 2014; Mahon, 2007; US Preventive Services 
Task Force, 2009).  Unfortunately, the widely accepted practice of mass screening has led 
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to a blanket passage for women to participate in screening without adequately provided 
individualized understanding and informed consent.       
There have been significant changes recently to mammography screening 
guidelines, which has caused women to have many different screening routines 
(Calvocoressi, Sun, Kasl, Claus, & Jones, 2008; Squiers et al., 2011). All of the 
guidelines are ostensibly based on the same body of evidence, but there is still 
discrepancy. There is RCT evidence to support recommended mammography 
commencement at age 50, while an abundance of epidemiological and observational 
studies do lend credence to screening by younger women in their 40s (American Cancer 
Society, 2011; American Cancer Society, 2013a; Christie, 1977; Hendrick et al., 1997; 
Kerlikowske et al., 2013; Shapiro, 1977; Shapiro, 1997).  In 2009, The US Preventive 
Services Task Force (USPSTF) changed their recommended age from 40 to 50 (US 
Preventive Services Task Force, 2009).  The discussion and rationale surrounding this 
change has stemmed debate, as well as sparked screening behavior change in this 
younger population (Kremer et al., 2012).  In the absence of health provider guidance and 
informed consent, this behavior change that now recommends women in their 40s delay 
screening may place high risk African American women at even greater risk of 
developing later stage breast cancer (Calvocoressi et al., 2008).  Table 1 provides an 
overview of selected organizational mammography screening recommendations, which 
show the varied differences and similarities advocated among organizations. 
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Table 2.1  Overview of Selected Agency Mammography Screening Guidelines for 
Asymptomatic Women 
AGENCY INTENDED USER MAMMOGRAPHY 
RECOMMENDATION 
American Cancer Society (ACS) Patients and Physicians Annually beginning at age 40 
U.S. Preventive Services Task 
Force (USPSTF) 
Physicians, Nurses, and Allied 
Healthcare Professionals 
Biennial beginning at age 50 until 
age 74 
American College of Radiology 
(ACR) 
Physicians Annually beginning at age 40 
National Comprehensive Cancer 
Network (NCCN) 
Physicians Annually beginning at age 40 
(American Cancer Society, 2013a; American Cancer Society, 2014; Mahon, 2007; 
Mainiero et al., 2012; National Comprehensive Cancer Network, 2013; US Preventive 
Services Task Force, 2009) 
 
2.6 Informed Consent 
Practice guidelines dictate that prior to the administration of a medical procedure, 
patients are provided informed consent.  This involves providing specific details to 
patients on the purpose, benefits, risk of a medical procedure, and alternatives, and 
without it, care is considered malpractice or neglect (Jatoi & Baum, 1993; Osman, 2001; 
Ward, 1999).  Nurses have been and continue as an integral entity of the multidisciplinary 
healthcare team, involved in protecting patient rights, and ensuring they understand 
medical procedures and interventions (Judkins-Cohn, Kielwasser-Withrow, Owen, & 
Ward, 2014; Sims, 2008a; Sims, 2008b).  Therefore, in providing consent to patients, 
nurses must not only have the communication skills to function in this role, but also the 
clinical, legal and ethical knowledge to serve in a number of roles: manager (ensuring 
adequate process); witness (record patient’s understanding); patient advocate (ensure 
patient’s understanding); and information giver (recapitulate information in lay terms) 
(Judkins-Cohn et al., 2014; Susilo et al., 2013). 
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 Informed consent has been an important facet of the mammography controversy.  
Mass population screening practices are not ideal for women in their 40s in the absence 
of informed consent due to potential risk that could cause breast cancer or other 
unnecessary harm.  Informed consent is not generally practiced in mammography 
screening; more of a simple consent is routinely used. A cornerstone of health 
empowerment and education is a social justice approach to health knowledge, risks, and 
benefits related to screening mammography.  Although women may be at risk of early 
breast cancer morbidity and mortality with delayed screening, the larger risk is 
conducting an unnecessary intervention without informed consent.  Younger women have 
dual challenges of knowing and understanding both their breast cancer and screening 
risks (Jatoi & Baum, 1993; Tabar et al., 2011).   
There is a clear social justice need to have equal informed consent for women 
undergoing screening mammography, without which is both assault on patient rights, and 
medical malpractice (Jatoi & Baum, 1993; Osman, 2001; Tabar et al., 2011; Ward, 1999).  
Informed consent is not a standard of care practiced across the U.S. with mass, mobile, 
and some primary care prescribed mammography screenings (American Cancer Society, 
2011; American Cancer Society, 2014; Jatoi & Baum, 1993; Marshall, 2005).  Typically 
with mass and mobile screenings, health providers are not present at the point of care 
with patients, as mammography technicians provide the onsite screening services. 
Assuring mammography screening informed consent might be a challenge, as the current 
health infrastructure does not readily avail itself to this seldom practiced standard.  
Therefore, health service infrastructures that provide mammography screening services 
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should be retooled to accommodate the availability of informed consent prior to 
screening accessibility.   
An understanding by patients of the risks and benefits of a medical intervention or 
procedure is the foundation of patient autonomy, and serves as the standard of decision 
making in healthcare.  Patient autonomy is synonymous with liberty, privacy, and 
individual choice, forming the doctrine of informed consent (Jatoi & Baum, 1993; 
Osman, 2001).  Informed consent allows patients to accept or decline participation in a 
medical procedure (American Cancer Society, 2012).  Simple consent is not appropriate 
for a medical intervention or procedure (American Cancer Society, 2012; Osman, 2001; 
Ward, 1999).  Informed consent should serve as the standard of care for all medical 
procedures, to include screening mammography (Jatoi & Baum, 1993; Osman, 2001).  
  Women must be informed about the potential harmful effects of mammography 
(Beemsterboer et al., 1998; Jatoi & Baum, 1993; Tabar et al., 2011; Ward, 1999).  
Overdiagnosis produces anxiety in women surrounding some preclinical cancers such as 
ductal carcinoma in situ (DCIS) that can realistically be present for years without 
progressing to invasive cancer. And since there is no consensus that DCIS leads to 
clinical cancer, overdiagnosis of DCIS can also lead to unnecessary anxiety and stress in 
patients.  False positive results can also cause anxiety and stress, by leading to 
unnecessary additional tests and procedures for women who believe they have breast 
cancer when they do not (American Cancer Society, 2014; Feig, 2006; Smith, 
Cokkinides, & Eyre, 2007).  Although costs should also be considered, costs may be less 
of a problem due to the availability of mammography coverage by the vast array of 
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insurance providers, and due to the availability of free or reduced cost mammography 
(Eddy, Hasselblad, McGivney, & Hendee, 1988).   
African American women must also be informed about the preponderance of the 
evidence showing differences in cancer characteristics including its aggressiveness.  
Information should also be shared on the breast cancer disparity and potential causes, 
leading to increased mortality in this population.  Shared knowledge surrounding 
prominent aspects that have led to this cancer disparity provide avenues for changing and 
improving the breast cancer landscape.  Screening informed consent, specifically for 
African American women, should encompass the very real aspects of the problem, risk, 
and alternatives. 
2.7 Conclusion 
The mammography controversy highlights the very real concerns surrounding 
screening for women in their forties.  Issues raised present both opportunities and 
challenges for achieving optimal breast health in younger high risk women, and in 
battling the pervasive health inequities that put younger African American women at 
greater risk of mortality. Additionally, there remains a critical need to understand the 
complex issues related to the mammography knowledge, attitudes and behaviors of 
minority women, especially as we move away from population-based recommendations 
to more personalized healthcare decision making.  Paramount to this, is the real-world 
perspective of the unique mammography needs and challenges of African American 
women.  Nurses are in a unique position to educate patients and provide the necessary 
support—however, they must be adequately prepared to discuss risks and benefits that 
are constantly changing. They must also be well-versed in the implications of 
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recommended guidelines, and the disparate way those recommendations can impact 
different populations. This poses a significant challenge for nurses, and requires that they 
keep up to date on research, expert guidelines, and interpretations that evidence for 
patient care. They must also be acutely aware of existing disparity, and how advances in 
personalized healthcare can contribute to patient care and treatment plans that are tailored 
to meet the unique needs of their patients as individuals. 
 There is no longer a simple diagnosis of “breast cancer.” Scientific advances have 
provided the knowledge needed to differentiate different kinds of cancer, and with that, 
different modes of detection and treatment, yet more remains to be done. One size does 
not fit all, and that means that healthcare providers must view screening guidelines 
through the lens of personalized healthcare. Women must weigh their own individual 
health risks, along with consultation with their health provider, in deciding their breast 
health regimes (American Cancer Society, 2012; Jatoi & Baum, 1993; Osman, 2001).  
Empowering younger women to take an active and informed role in their health care 
improves health behaviors systemically.  The decision to proceed with mammography 
screening is an individual one that should be entered into with care, knowledge, 
understanding, and a deliberate effort to adhere to screening guidelines if the benefits 
outweigh the risk.  Due to the cancer disparity facing young African American women, it 
is paramount that they receive education and guidance on their cancer risk 
(socioeconomic factors that influence access to health services, and knowledge on tumor 
morphology and overall breast health), as well as their optimal screening choices.  While 
there may never be a definitive consensus on screening practices, close attention to the 
highest quality research, combined with an equal amount of attention on the preferences 
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and experiences of young African American women, has the potential to improve 
advances in the country’s breast cancer detection and treatment rates, and addressing the 
existing grave racial breast cancer health disparity that exits. 
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CHAPTER 3 
PROPOSAL 
3.1 Specific Aims 
Specific Aim 1. To describe the mammography adherence rates of African 
American women 43-79 years of age.  Are there differences in mammography adherence 
rates (short-term and long-term) for African American women by age strata 43-49, 50-64, 
and 65-79 years of age? Mammography adherence rates between age strata will be 
compared to determine if there are significant differences.  Mammography adherence will 
be operationalized using the number of on-schedule mammograms over a total six year 
period; at least two for short-term, and three or more for long-term adherence.    
Specific Aim 2.  To identify relationships between and among Behavioral Model 
population variables (predisposing, enabling, and need variables) on the mammography 
adherence health behavior variable. What are the relationships between and among 
predisposing – age, race, marital status, Gail risk score, and homelessness; enabling – 
regular source of care, income, transportation, and insurance; need – perceived health 
condition; and health behavior – mammography adherence. This aim will identify 
relationships of selected population variables on mammography adherence, and well as 
determine which variables may predict adherence. Predisposing variables are social-
demographic, genetic, and cultural and community status variables, which may describe 
one’s propensity to participate in health services (Aday & Andersen, 1974; Andersen, 
1995; Gelberg et al., 2000).  The predisposing variables age, race, marital status, 
homelessness, and Gail risk score will be used.  Enabling variables outline the individual 
and community means and resources that may facilitate accessing health services (Aday 
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& Andersen, 1974; Andersen, 1995; Gelberg et al., 2000).   The enabling variables 
regular source of care, income, transportation, and insurance will be used.  Need 
variables describe knowledge, values, and needs about an individual’s perceived or 
evaluated health (Aday & Andersen, 1974; Andersen, 1995; Gelberg et al., 2000).  
Perceived health will be evaluated in this study. Mammography adherence will be 
operationalized using the number of on-schedule mammograms over a total six year 
period; at least two for short-term, and three or more for long-term adherence.  
Specific Aim 3. To compare long-term mammography adherence rates and the 
Behavioral Model variables that differ between and among ethnicities for women in the 
same age strata.  Do long-term mammography adherence rates and the model variables 
differ between and among ethnicities for women in the same age strata - 43-49, 50-64, 
and 65-79 years of age?  This aim will provide information to better describe and 
compare both statistically significant model variable differences between and among 
women 43-79 years of age (by age strata) of different ethnicities and their long-term 
mammography adherence rates. For this study, ethnicity will be used to denote race (non-
Hispanic White, non-Hispanic African American, and Hispanic) and/ or the terms may be 
used interchangeably. 
Specific Aim 4. To identify and describe the relationship of individual breast 
cancer risk on mammography adherence.  What is the relationship of Gail risk scores on 
mammography adherence? The Gail risk score provides awareness into a woman’s five-
year and lifetime risk of developing breast cancer (National Institute of Health, 2011). 
This aim will provide insight into the applicability and consideration of an individual’s 
breast cancer risk on mammography adherence practices.  As the individual need for 
 46 
mammography continually becomes a formidable determinant of mammography 
practices, this aim, provides information retrospectively on the relationship between risk 
and adherence.  
3.2. Background and Significance 
Scientific evidence posits that cancer is caused by both external factors (mutable) 
and internal factors (immutable) (American Cancer, 2013a, 2014).  Although little can be 
done to eradicate immutable factors, there are ways to mitigate mutable cancer factors 
through awareness, knowledge, and behavior change. Some cancers can be prevented 
and/or detected early through health promoting behavior, resulting in early removal of 
precancerous growth. The five-year survival rate for all cancers improved from 50% in 
the mid to late 1970s, to 68% in the early 2000s, due in part to early detection (Mahon, 
2007; Services, 2000; Smith et al., 2003; Tabar, Duffy, Vitak, Chen, & Prevost, 1999; 
Tabar et al., 2011).  Breast cancer affects women in significant numbers all across the 
world, accounting for just over one million cases; second only to lung cancer (American 
Cancer, 2013a; World Health, 2009).  Breast cancer is the most common cancer globally 
among women, and often the most likely cause of cancer death (American Cancer, 2013a, 
2013b).   
Research has shown that early detection of breast cancer – breast self-exam 
(BSE)/ breast self-awareness, clinical breast exam (CBE), magnetic resonance imaging 
(MRI), and mammography- provide the greatest prospect for optimal treatment 
(American Cancer, 2013a, 2013b; Duffy et al., 2010; Smith et al., 2013; U. S. Preventive 
Services Task Force, 2009; World Health, 2009).  While each detection modality may 
have a place in the broad spectrum of early cancer detection, mammography (along with 
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MRI for high risk women) has the highest levels of specificity and sensitivity in detecting 
cancers early.  Although some have questioned mammography’s reliability and 
efficaciousness versus benefits and risks in women <50 years of age, screening 
mammography remains the cornerstone of improved breast cancer control – the gold 
standard screening modality (American Cancer, 2013a; Kearney & Murray, 2009; Tabar 
et al., 2011; World Health, 2009). Continued updates to the mammography screening 
guidelines, although beneficial, have led to some ambiguity for patients, particularly in 
women 40-49 years of age (American Cancer, 2013a; Conway-Phillips & Millon-
Underwood, 2009; U. S. Preventive Services Task Force, 2009). This ambiguity 
surrounding the mammography guidelines, along with lagging social capital cohesiveness 
about breast health, has caused some women to question mammography’s benefit, delay 
screening until their 50s or later, and question whether they should participate in 
mammography (Conway-Phillips & Millon-Underwood, 2009; Dean et al., 2014; Hale & 
deValpine, 2014).  
Health disparity among different populations is a growing concern in the United 
States (US), placing some communities at a disadvantage in shouldering disease burden 
(Byrne, Glasgow, & DeShields, 2011; Conway-Phillips & Millon-Underwood, 2009; 
Feldstein et al., 2011).  Despite improvements seen by lowered cancer mortality 
nationally, continued gaps exist between segments of the population, with the majority of 
cancer burden among racial and ethnic minorities. For example, African American 
women cancer mortality rates have declined more slowly in comparison to white women 
(American Cancer, 2013b, 2014). Gaps in cancer mortality for racial and ethnic 
minorities are due primarily to obstacles in cancer prevention and detection (American 
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Cancer, 2013a, 2014; O'Malley, Sheppard, Schwartz, & Mandelblatt, 2004; Rawl, 
Champion, Menon, & Foster, 2000).   
A major goal of population health is improving the overall health of a population, 
which is accomplished by assessing health behaviors over longer periods of time; what is 
considered over the life course (Kindig & Stoddart, 2003; Kindig, 2007). Population 
health is the study of health determinants or variables that impact individuals of a group 
and the distribution of health outcomes within the population. Therefore, assessing health 
behavior adherence long term provides a more tangible evaluation of overall population 
health, than health behavior evaluation of a single point in time (Andersen, 1995; Kindig 
& Stoddart, 2003; Kindig, 2007).  Identification, evaluation, and analysis of the 
determinants of health and their impact are a vital trajectory towards optimal health 
outcomes (Andersen, 1995; Evans & Stoddart, 1990; Services, 2000, 2011a). The 
multiple determinants of health are: social environment, biology, behaviors, physical 
environment, and access to health services (Evans & Stoddart, 1990; Services, 2011a).  
Conceptualization of multiple variables that may impact or predict screening 
mammography adherence is paramount to greater mammography understanding, as well 
as health improvement (Andersen, 1995; Evans & Stoddart, 1990; Kindig & Stoddart, 
2003). 
3.2.1 Mammography Adherence 
 Adherence to screening guidelines often refers to consistently following a 
guideline supported by a specific health organization.  Mammography adherence has also 
been used to describe having had a recent mammogram within the past two years, as well 
as having an initial mammogram (Clark et al., 2003; Gierisch, Reiter, Rimer, & Brewer, 
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2010; O'Neill et al., 2008). As an example, if a woman received her first mammogram at 
40, and she continued to receive them annually, she would be considered adherent to the 
American Cancer Society (ACS) mammography guidelines; she would not be considered 
adherent to the ACS guidelines if she did continue following the annual guidance in 
subsequent years (American Cancer, 2013a; Smith et al., 2013).   
Significant research concerning mammography utilization has addressed the existence of 
an initial mammogram – whether or not a women has ever had a mammogram, as well as 
recent mammogram (Clark et al., 2003; Mack, Pavao, Tabnak, Knutson, & Kimerling, 
2009; Steele-Moses et al., 2009).  Both initial and recent mammography, although 
important, provide limited information on health behaviors over time, as they only 
provide the existence of a single health behavior activity (Kindig & Stoddart, 2003; 
Kindig, 2007). It is vitally important to assess mammography adherence over a longer 
period of time aside from merely the first (initial) and second utilization, to better 
understand individual and population health patterns and trends (Breen & Meissner, 
2005a; Gierisch, Reiter, et al., 2010). 
 Much of the literature before 2000 used the term ‘adherence’ to describe a 
woman’s compliance with screening mammography recommendations as defined by 
having an initial mammogram at the recommended age. The health literature after 2000 
has used several terms to describe ‘adherence,’ many with slightly different meanings:  
mammography maintenance, sustained mammography, mammography utilization, 
regular mammogram, interval and repeat mammogram, and screening compliance 
(Marchi & Gurgel, 2010; O'Malley, Forrest, & Mandelblatt, 2002; O'Neill et al., 2008; 
Purc-Stephenson & Gorey, 2008; Rakowski et al., 2006; Smith-Bindman et al., 2006). 
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Until recently, little research has addressed mammography adherence, or what could be 
considered as successive on-schedule mammography screening over time (two years and 
greater).  Consequently, without standard terminology to describe successive on-schedule 
mammography screening over time, ambiguity and varying definitions permeate, to 
include difficulty in comparing research study methodologies and results (Clark et al., 
2003; O'Neill et al., 2008; Phillips & Wilbur, 1995; Phillips, Kerlikowske, Baker, Chang, 
& Brown, 1998).  Therefore, a standard way to label, measure, and describe consistent 
adherence to recommended breast cancer screening recommendations should exist (Breen 
& Meissner, 2005a; Clark et al., 2003; Gierisch, Earp, Brewer, & Rimer, 2010; Gierisch, 
Reiter, et al., 2010; Kearney & Murray, 2009; Phillips, Morrison, Andersen, & Aday, 
1998). 
 It is proposed that mammography adherence be thought of as short-term or long-
term adherence to recommended screening guidelines.  Short-term adherence is proposed 
as screening of at least twice consecutively on a routine schedule. Long-term adherence is 
proposed as “sticking to” screening guidelines of three or more consecutive occasions. 
For the purpose of this study, both annual and biennial screening guidelines will be used, 
gaining a better understanding of adherence regardless of the recommended guideline 
followed.  The term long-term adherence provides both an operational and conceptual 
idiom that allows evaluation and analysis of health success (Kindig & Stoddart, 2003; 
Kindig, 2007; O'Neill et al., 2008). 
Past research has provided insight as well as contradictions into generalized 
predictors and barriers to mammography screening in women 50 years of age and older, 
to include: age, race, marital status, income, level of education, health care access and 
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insurance, prior breast problems, and participation in other healthcare preventive services 
(O'Neill et al., 2008; Phillips, Kerlikowske, et al., 1998; Rakowski et al., 2006; Stoddard 
et al., 1998). Although helpful, there is a more recent need to further address and analyze 
mammography behaviors by race, age, and, individualized medical requisite (Conway-
Phillips & Millon-Underwood, 2009; Jatoi & Anderson, 2010b; Shippee et al., 2012).   
The need to analyze predictors and barriers to mammography adherence by African 
American women have been associated with many factors – cultural attitudes, health care 
access, socioeconomic status, cost, failure of health provider to recommend 
mammography, lack of insurance, cancer fear, mammography misconception, and health 
provider trust (Champion et al., 2004; Champion et al., 2008; Conway-Phillips & Millon-
Underwood, 2009; O'Malley et al., 2004; Schueler, Chu, & Smith-Bindman, 2008).  Yet, 
there is still a greater need to further explore and verify predictors in younger women in 
their 40s, particularly in African American women in efforts to help mitigate breast 
cancer disparity and improve overall breast health.  Although mammography utilization 
has remained high since 2005, the lowest utilization numbers are for women 40-49 years 
of age at 62.3%, which causes some concern and heightened need for further evaluation 
(American Cancer, 2013a; Conway-Phillips & Millon-Underwood, 2009; Duffy et al., 
2010; Gierisch et al., 2009).  
3.2.2 Breast Cancer Health Disparity 
 Breast cancer, accounts for 15% of all US cancer deaths, and is the leading site of 
new cancer cases and the second leading cause of cancer death for African American 
women (American Cancer, 2013a, 2013b; Smith et al., 2013). A percentage of the higher 
breast cancer mortality seen in younger African American women is due to aggressive 
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tumor morphology, while other gaps in cancer mortality for racial and ethnic minorities 
can be attributed to obstacles in cancer prevention and detection (American Cancer, 
2013a; Andersson & Janzon, 1997; Bjurstam et al., 1997; Conway-Phillips & Millon-
Underwood, 2009).  Although African American women have a lower incidence of breast 
cancer than White women overall, among younger women under 45 years of age, African 
American women have a higher incidence of breast cancer than Whites (American 
Cancer, 2013a).  Therefore, greater depth of understanding is needed into mammography 
behaviors of younger high risk African American women. 
 Health disparities arise from many factors, including unequal socioeconomic 
factors, culture differences, discrimination, and health system barriers that influence 
access to cancer prevention and treatment services (American Cancer, 2014; Calvocoressi 
et al., 2004; Finney, Tumiel-Berhalter, Fox, & Jaen, 2006). Mitigating health disparities 
is a major concern as evidenced by its inclusion in national health benchmarks within 
Healthy People 2020 and the National Prevention Strategy, which identify ideal 
population health improvement targets (Services, 2011a, 2011b).  Healthy People is a 
series of various 10-year health objectives used to monitor the health progress of the 
United States (US). The latest initiative, Healthy People 2020, has a goal of decreasing 
health disparity and promoting health equity among all ages (Services, 2011a).  One way 
of ascertaining  the status of health disparity and health equity, as well as goal 
progression, is by evaluating health behaviors over an extended period of time (Kindig & 
Stoddart, 2003). 
 The reasons for breast cancer health disparity are not fully understood, but may 
partly be attributed to differences in knowledge, attitudes, and behavior around breast 
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health in young African American women. Mammography is often recommended for 
women considered average risk beginning at age 40 or 50, but many African American 
women lack knowledge about their own risk, and consequently present in later stages of 
cancer development (Byrne et al., 2011; Conway-Phillips & Millon-Underwood, 2009; 
Dailey, Kasl, Holford, & Jones, 2007; Feldstein et al., 2011). This lack of information 
about screening options and less breast cancer awareness, or acknowledgment of risk, 
may, in many instances, serve as a catalyst for increased breast cancer mortality. In order 
to effectively address the reality of these health disparities, it’s important to understand 
the controversy around screening, the impact of individual cancer risks, and how the 
current climate can allow for healthy debate, without jeopardizing advancements in 
health equity. 
3.2.3 Mammography Controversy 
 The main issue that has fueled the controversy is the lack of agreed upon evidence 
surrounding randomized clinical trial (RCT) evidence supporting mammography in 
women in their 40s. Of the nine RCTs addressing mammography efficacy, only the 1960 
Breast Cancer Screening Project of the Health Insurance Plan (HIP) of New York was 
completed in the US, and of the 31,000 participants in the study group, approximately 
20% were African American (it is not clear how many African American women were 
also in the control group of 31,000) (Fink, Shapiro, & Roester, 1972; Shapiro, Strax, & 
Venet, 1971). The two trials (the Canadian National Breast Cancer Screening Study, and 
the UK Age Trial) that have been conducted to address mammography efficacy for 
women in their forties, have indicated that should women begin screening in their 40s, 
benefit may not be seen until 12-14 years.  Consequently, the Canadian and UK RCTs 
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indicate that women who begin screening in their 40s would already be in their 50s 
before any benefit may be seen (Bjurstam et al., 1997; Bjurstam et al., 2003; Elwood, 
Cox, & Richardson, 1993; Hendrick, Smith, & Rutledge, 1997; Miller, To, Baines, & 
Wall, 2002; Nystrom & Larsson, 1993; Tabar, Duffy, & Chen, 1996; Tabar et al., 1995). 
The HIP trial results were the forbearer for the initiation of mass screening in the U.S., 
because this trial demonstrated a reduction in breast cancer mortality for women 
screened, versus those who did not screen (Shapiro, 1997; Shapiro, Venet, Strax, Venet, 
& Roeser, 1985).  The datedness of the HIP trial has raised questions concerning its 
methodology, power, and screening technologies, when comparing it to more recent 
trials. For younger women specifically, mammography clinical trials have shown far less 
of a benefit for women in their 40s than in their 50s.  Nevertheless, many organizations, 
researchers, and clinicians maintain that screening mammography may have benefit in 
the broad context of detecting breast cancer in its precocious stage of development in 
some women, allowing early cancer treatment and cure than would otherwise be 
accomplished if cancer was detected later (Duffy et al., 2010; Hale & deValpine, 2014; 
Humphrey, Helfand, Chan, & Woolf, 2002; Tabar et al., 2011; U.S. Preventive Services 
Task Force, 2016).  
 Breast cancer is not a homogenous disease, but a heterogeneous disease consisting 
of many facets, with differences based on the type of cells, location of the cancer, and 
invasiveness of the disease (Habel & Stanford, 1993; Stanford & Greenberg, 1989).  
Because of this, there is not a single screening modality that detects all types of breast 
cancers at equal levels of specificity and sensitivity (Kolb, Lichy, & Newhouse, 2002; 
Tilanus-Linthorst et al., 2002). Breast cancer morphology is also complex, with different 
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presentation and characteristics among women.  Tumors are typically described by their 
level of expressed estrogen.  High- grade estrogen negative (ER-) cancers do not express 
estrogen, and alternatively, low-grade estrogen positive (ER+) cancers do express 
estrogen (Habel & Stanford, 1993; Stanford & Greenberg, 1989). White women have a 
higher incidence of ER+ breast cancers, which are slow growing, lending itself to better 
mammography detection (Howlader et al., 2013; Stanford & Greenberg, 1989).  
Conversely, ER- cancers are fast-growing, and are most prevalent in younger African 
American women (< 50 years of age) (Gapstur, Dupuis, Gann, Collila, & Winchester, 
1996; Ooi et al., 2011; Stanford & Greenberg, 1989). Therefore, because of ER- tumor 
histological make-up, and its aggressive growing nature, mammography does not detect 
ER- tumors as readily as ER+ tumors, which does create detection challenges (Foulkes, 
2008; Tilanus-Linthorst et al., 2002).   
The controversy is further complicated by the “collateral effects” of 
mammography screening that don’t address its effectiveness in detection, but rather harm 
caused by the test itself.  Although mammography has been shown to detect cancer early 
and save the lives of some women who use it, it has also caused undue harm to many 
women due to false positives, over-diagnosis, lead-time, and low-dose radiation 
exposure, causing unnecessary further testing and biopsies, and the needless exposure to 
radiation (Beemsterboer et al., 1998; Bleyer & Welch, 2012; Jatoi & Anderson, 2010b). 
These lesser perceived benefits, coupled with the theoretical risk of inducing breast 
cancer in younger women who already have a hereditary predisposition for breast cancer, 
cause significant concern, as it may be used without assessing individualized risk (Clark, 
2004; Foulkes, 2008; U.S. Preventive Services Task Force, 2016).  Mammography may 
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not be most beneficial for younger minority women, due to elevated associated risks, but, 
clinicians cannot afford to dismiss mammography in it’s entirely for this population, but 
figure out ways to address its shortcomings, while also mitigating the risks in the younger 
at-risk population (Bjurstam et al., 2003; Shapiro, 1977, 1997).       
3.2.4 Individual Cancer Risk 
Recently, a risked –based or risk stratification approach to mammography 
utilization has been advocated, which would help women ascertain their individual breast 
cancer risk using prediction models by including various factors such as breast density, 
menopause status, and age (Bertrand et al., 2013; Kerlikowske et al., 2013).  The Gail 
risk score is one such risk-based tool that can be used to determine a woman’s 5-year and 
lifetime individual risk of developing breast cancer (National Institute of Health, 2011).  
Although not routinely utilized along with mammography guidance, a risk-based 
approach to screening would provide women guidance on if and when they should 
engage in mammography, and the most appropriate interval (Fletcher, 2011; Kerlikowske 
et al., 2013). Mammography is promoted as an intervention, if practiced early and 
routinely within the context of individualized assessment, could help equalize breast 
cancer health disparity and decrease breast cancer mortality (Pace & Keating, 2014).   
It is understood mammography is one tool, often accompanied by other detection 
modalities (i.e. ultrasound, magnetic resonance imaging, clinical breast exam, etc.), that 
may be used in detecting breast cancer early (Fletcher, 2011; Kolb et al., 2002; Patterson 
& Noroozian, 2012; Taylor, 1992; Tilanus-Linthorst et al., 2002). Developments in 
knowledge about the disease suggest that mammography, along with individualized 
risked-based approach, may be more ideal as an individualized tool than as a mass 
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screening tool (Fletcher, 2011; Kerlikowske et al., 2013; Pace & Keating, 2014).  
Utilizing the knowledge gained through decades of mammography utilization, along with 
the newer knowledge on risk-based modeling, and the consideration of newer screening 
adjunct modalities, solidifies the premise that mammography may still have a place in the 
spectrum of breast cancer early detection in younger and older women.  The challenge is 
ascertaining through further research, its most appropriate place in the spectrum of both 
mass and individualized decisions. 
3.3 The Behavioral Model for Vulnerable Populations 
 The Behavioral Model for Vulnerable Populations is derived from Andersen’s 
original Behavioral Model developed in the 1960s to study access to medical care.  The 
model was later expanded by Andersen and Aday in 1974 to include an elaboration of 
health service measures, which also identified four specific characteristics that are 
derived from health policy: health delivery systems, the population at risk, consumer 
satisfaction, and utilization of health services (Aday & Andersen, 1974).  The original 
model has gone through many revisions since its development to more adequately reflect 
advances in the science, and to incorporate a portrayal of multiple influences that may 
impact health status (Andersen, 1995). The original and updated Behavioral models 
identify population characteristics variables (predisposing, enabling, and need factors) as 
predictors of personal health behavior (Aday & Andersen, 1974; Andersen, 1995; 
Gelberg et al., 2000).  
 Within the Behavioral Model, health behaviors are impacted by population 
characteristics- predisposing, enabling, and need variables. Predisposing variables are 
social-demographic, genetic, and cultural and community status variables, which may 
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describe one’s propensity to participate in health services (Aday & Andersen, 1974; 
Andersen & Urban, 1998).  Enabling variables are an individual or population’s own 
personal resources, and directly impacts their ability to access and use health services 
(Aday & Andersen, 1974; Andersen, 1995).  Need variables are an individual or 
population’s self-rated and evaluated view of their health conditions (Aday & Andersen, 
1974; Andersen & Urban, 1998; Gelberg et al., 2000).  Participation in personal health 
practices, such as adherence to self-care or safe or unsafe behaviors is influenced by 
population characteristics.  The model conceptualizes the complex interactions and 
importance of a population’s predisposing, enabling, and need characteristics on their 
health behavior practices.   
 The Behavioral Model for Vulnerable Populations provides an explorative 
perspective that encapsulate domains, although not exclusive, are unique within 
vulnerable populations, which are not oftentimes considered within the context of the 
original and subsequent Behavioral Model updates.  Therefore its utilization provides an 
optimal avenue in guiding this study on mammography adherence in African American 
women.  The Behavioral Model for Vulnerable Populations depicts that population 
characteristics predict another in a linear fashion (predisposing predicts enabling, and 
enabling predicts need), and together collectively, explain health behaviors and outcomes 
(Gelberg et al., 2000).  For this study, the model was modified to conceptualize both the 
impact that population characteristics have in a linear fashion (predisposing on enabling; 
and predisposing and enabling on need), as well as their impact individually on 
mammography adherence. In addition, the model was also modified to conceptualize the 
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collective impact Gail risk scores have as part of the collective predisposing variable, as 
well as their impact individually on mammography adherence.  
Gelberg et al. (2000) originally tested the Behavioral Model for Vulnerable 
Populations in a prospective study (N=363) who were homeless, to identify predictors of 
health service utilization and physical health outcomes. Physical health outcomes 
included conditions of immediate impact (leg/skin/foot problems and vision impairment), 
as well as more serious long-term consequence problems (tuberculosis exposure and high 
blood pressure) (Gelberg et al., 2000).  Study participants were followed longitudinally 
for up to eight months if they met one of the study conditions.  Results indicated the 
health status for the four physical health outcomes improved over time, and were 
predicted by a number of variables, and most prominently, having access to care.  In this 
homeless population, mental health, residential history, substance abuse, victimization 
history, and competing needs affected the use of health services and health outcomes. 
Notably, the homeless adults were willing to use health services if they believed it was 
important (Gelberg et al., 2000).  Additional testing of the model was recommended with 
other vulnerable populations. 
 The Behavioral Model for Vulnerable Populations has been used in various 
studies to predict health behaviors among different vulnerable populations. Bazargan, 
Farooq, and Baker (2004) used the model to examine correlates of adherence to cervical 
cancer screening among publicly housed Hispanic and African American women. They 
identified continuity of care, affordability, and recommendation from a health care 
provider as significant predictors to having an up-to-date cervical cancer screen 
(Bazargan, Bazargan, Farooq, & Baker, 2004).  Austin, Andersen, and Gelberg (2008) 
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used the model to describe ethnic differences in the correlates of mental distress between 
population characteristic (predisposing and enabling) variables among African American, 
Hispanic, and White homeless women.  The model’s utilization in vulnerable populations 
involving various ethnic groups, including African American women, has identified 
contributing factors to a health behavior or outcome, that differ among ethnic groups, 
which signify the importance of cultural competence and assessing outcomes of interest 
separately for each ethnic group (Austin et al., 2008; Bazargan et al., 2004; Fernandez & 
Morales, 2007; Gonzalez et al., 2012; Harcourt et al., 2013; Owusu et al., 2005). 
 Race and ethnicity were further explored using the model to examine cervical 
cancer screening among minority women (Hispanic American, Hispanic immigrant, and 
African American). Non-Hispanic Whites were screened more often than minority 
women.  African American women were less likely to have cervical cancer screening 
than Non-Hispanic White women, but more likely to have screening than the Hispanic 
groups (Owusu et al., 2005).  In a study by Gonzalez, Castaneda, Mills, Talavera, Elder, 
and Gallo (2012), the model was used in a self-reported cancer screening study (breast, 
cervical, and colorectal) in Mexican-American women, which showed that having a 
regular source of care was a significant predictor to screening adherence.  Additionally, 
the study showed that principle correlates for cancer screening adherence was sticking to 
other preventive services.   
Fernandez and Morales (2007) identified in their study of cervical and breast 
cancer screening utilization in Texas Mexican American women, that most differences in 
screening were due largely to socioeconomic characteristics and access barriers.  
Harcourt et al. (2013), used the model to evaluate breast and cervical cancer screening by 
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African Immigrant women living in Minnesota, which showed screening barriers to 
include duration of residence in US and ethnicity.  Utilization of the Behavioral Model 
for Vulnerable Populations has shown sound applicability for utilization across 
ethnicities, as well as in evaluating correlates and predictors of cancer screening in 
women (Fernandez & Morales, 2007; Gonzalez et al., 2012; Harcourt et al., 2013; Owusu 
et al., 2005). However, the model has not been used extensively to evaluate breast cancer 
screening in African American women, which creates an opportunity for further 
exploration. 
 Research using the model in other vulnerable populations has demonstrated a 
critical need for assessing outcomes of interest separately among ethnic groups, helping 
to inform needed culturally, competent, and appropriate care. The model provides further 
insight into characteristics that may predict or serve as barriers to sustained 
mammography adherence in African American women in their 40s.  For the proposed 
study, a modified Behavioral Model with variables from the Behavioral Model for 
Vulnerable Populations that are reflective of a vulnerable population will be utilized. The 
following selected variables will be used:  predisposing (age, race, marital status, Gail 
risk score, and homelessness variables); enabling (regular source of care, income, 
transportation, and insurance variables); and need (perceived health status variable).  
These selected variables will be tested to determine their relationship on mammography 
adherence health behavior.  The model used to guide this study is depicted in  
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Figure 3.1 Modified Behavioral Model depicted with proposed study variables. 
3.4 Identification of Study Variables 
Figure 3.1 identifies the variables that will be used in the proposed study, as 
guided by a Modified Behavioral Model of Vulnerable Populations.  The selected 
predisposing variables are age, race, marital status, and homelessness.  Enabling variables 
are regular source of care, income, transportation, and insurance.  The selected need 
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variable is perceived health status, and mammography adherence is the selected health 
behavior.  Each of the variables and their relationships to one another as postulated in the 
model, are described below. 
3.4.1 Mammography Adherence   
The Healthy People initiative has provided a health odometer for the U.S. for the 
past 30 years, with the goal of improving overall health and wellness. However, the 
mammography screening objective only evaluates recent mammography – a singular 
episode in time (Department of Health and Human Services, 2012).  This singular health 
behavior does little to evaluate health behaviors over time, which is important to 
ascertaining population health improvement.  In understanding the mammography 
screening decisions of women, adherence should not be evaluated as a singular 
dichotomous episode in isolation.  Instead, assessing health behaviors over an extended 
period of time provides a much better gauge to evaluate health improvements (Kindig & 
Stoddart, 2003; Kindig, 2007; O'Neill et al., 2008).   
Adherence to screening guidelines often refers to consistently following the 
guideline supported by a specific health organization. There is no clear and agreed upon 
way to define and conceptualize adherence to screening guidelines. A standard way to 
label, measure, and describe consistent adherence to the recommended breast cancer 
screening recommendations is necessary to create a solid foundation for both research 
and practice (Breen & Meissner, 2005a; Clark et al., 2003; Gierisch, DeFrank, et al., 
2010; Gierisch, Earp, et al., 2010; Gierisch, Reiter, et al., 2010; Phillips, Morrison, et al., 
1998).  Since the measurement of mammography adherence can vary, depending on how 
it is operationalized, it is beneficial to look at two different elements of mammography 
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adherence – short-term and long-term. It is proposed that short-term mammography 
adherence refer to at least two episodes of consecutively sticking to a recommended 
screening guideline (Blackman, Bennet, & Miller, 1999; Rakowski et al., 2004; 
Rakowski et al., 2006). It is also proposed that long-term mammography adherence refer 
to three or more episodes of consecutively sticking to a recommended screening 
guideline. In a study by Russell, Champion, and Skinner (2006), evaluating psychosocial 
factors related to repeat mammography, in one of the first times the term long-term 
screening was utilized, the term reflected mammography utilization over a 5-year period 
(Russell, Champion, & Skinner).  In their study, women’s participation in long-term 
screening was associated with greater knowledge about screening and fewer screening 
barriers (Russell, Champion, et al., 2006).  For this study, short-term adherence is 
proposed as screening of at least twice consecutively on a routine schedule. Long-term 
adherence is proposed as “sticking to” screening guidelines of three or more consecutive 
occasions.  Both annual and biennial screening guidelines will be used in this study, 
gaining a better understanding of adherence regardless of the recommended guideline 
followed. 
3.4.2 Age 
Breast cancer is the most common cancer among women, and often the most 
likely cause of cancer death (American Cancer, 2013a; Smith, Cokkinides, & Eyre, 
2007).  As women age, her lifetime probability of getting breast cancer increases, 
therefore, age, an immutable factor, was selected as a key population characteristic to 
stratify the study population, with primary focus on women in their forties (American 
Cancer, 2013a).  The odds of breast cancer increases with age, particularly over the age 
 65 
of 50, yet women younger than age 50 do get breast cancer in alarming numbers 
(American Cancer, 2013a, 2014). According to the American Cancer Society (2014), of 
the 288,130 cases of breast cancer for all aged women, 64,670 are in women under 50 
years of age (American Cancer, 2013a, 2014; Smith et al., 2007).  For younger African 
American women who present with breast cancer in their 40s or younger, it is often an 
aggressive form (American Cancer, 2013b; Conway-Phillips & Millon-Underwood, 
2009).    
There are conflicting reports surrounding whether or not age is a predictor of 
mammography utilization (Augustson, Vadaparampil, Paltoo, Kidd, & O’Malley, 2003; 
Nash, Chan, Horowitz, & Vlahov, 2007; Phillips, Kerlikowske, et al., 1998; Russell, 
Champion, et al., 2006).  In a study by Russell and colleagues (2006) evaluating 
psychosocial factors related to repeat mammography specifically in African American 
women >= 50 years of age, there were no significant differences noted by age (Russell, 
Champion, et al.).  A number of studies have indicated that women 50-74 years of age are 
more adherent to mammography screening in comparison to women in their 40s 
(Calvocoressi et al., 2004; Nash et al., 2007; Rakowski et al., 2006). On the other hand, 
other studies indicate that women in their 40s adhere to screening more often than women 
50 years of age and older (Calvocoressi et al., 2004; Calvocoressi, Sun, Kasl, Claus, & 
Jones, 2008; Rawl et al., 2000).  Despite conflicting study results, age is shown to be a 
predictor of mammography utilization (Hiatt, Klabunde, Breen, Swan, & Ballard-
Barbash, 2002; Hiatt et al., 2001; Hiatt et al., 2008; Mandelblatt et al., 1999; Nash et al., 
2007; Phillips, Kerlikowske, et al., 1998).  
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Age has also been noted as a predictor of other cancer screenings such as cervical 
cancer, while participating in other prevention screening services (Jennings-Dozier & 
Lawrence, 2000; O'Malley et al., 2002; O'Malley, Mandelblatt, Gold, Cagney, & Kerner, 
1997; Rawl et al., 2000).  Of the socio-demographic variables, age has routinely 
correlated most strongly with cancer screening and adherence, as well as serving as a 
significant predictor for mammography utilization (Evans et al., 1998; Finney et al., 
2006; Hiatt et al., 2002; Nash et al., 2007; Phillips, Kerlikowske, et al., 1998; Welch, 
Miller, & James, 2008). Additionally, mammography has been found to have significant 
utilization or adherence differences between age groups, with lower utilization in older 
women as compared to younger women, with age and race having a significant 
interaction (Finney et al., 2006; Hiatt et al., 2002; Rawl et al., 2000).   
There is a dearth of knowledge surrounding mammography adherence behaviors 
of African American women in their forties, which demands further exploration.  
Mammography ambiguity exists by younger women due in part to the mammography 
controversy, which is centered upon mammography’s benefit and efficaciousness versus 
risk, coupled with the changing and varied recommended screening guidelines that either 
recommends screening for average risk women beginning at 40 or 50 years of age.  A 
guideline change by the U.S. Preventive Services Task Force (USPSTF) in 2009 
recommended that average risk women begin screening at 50 versus 40 years of age, has 
been prompted by conflicting bodies of evidence surrounding the benefits of screening, 
and questionable lives saved and decreases in mortality (Nystrom & Larsson, 1993; 
Tabar et al., 1995; Tabar et al., 2011; U. S. Preventive Services Task Force, 2009).  
Although screening this younger population has shown benefit in smaller studies, there 
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has been lack of statistically significant benefit in the eight RCTs, showing no benefit 
until 12-14 years after initiating screening (Andersson & Janzon, 1997; Elwood et al., 
1993; Nystrom et al., 1993; Tabar et al., 2011).  Consequently, with the numerous 
conflicting results as to whether or not age is a significant predictor for mammography 
adherence, there is credence for including age as a variable needing further research. 
3.4.3 Race 
Breast cancer is not a homogeneous disease, and therefore may present differently 
in women of different ethnicities (Habel & Stanford, 1993; Stanford & Greenberg, 1989).  
Because of this, breast cancer clinical presentation, psychosocial and behavioral practices 
(screening) differences must be further explored so that clinical and public health 
strategies can ensure optimal breast health among ethnicities (Andaya et al., 2012; 
Gelberg et al., 2000; Jatoi & Baum, 1993).   In a meta-analysis by Purc-Stephenson and 
Gorey (2008) of mammography adherence articles from 1990-2006, they found evidence 
suggesting that screening differences persist among ethnic minority women (Purc-
Stephenson & Gorey). As a consequence, there are significant breast cancer health 
disparities by race in the United States (American Cancer, 2013a, 2014).  White women 
have the greatest breast cancer incidence, yet African American women have higher 
mortality from the disease, which warrants further exploration (American Cancer, 2013a, 
2014; Conway-Phillips & Millon-Underwood, 2009).   
Breast cancer incidence for other minority races (American Indian, Asian 
American/ Pacific Islander, and Hispanic/Latina) has remained lower than that of both 
Whites and African American over the past 15 years (American Cancer, 2013a).  Overall, 
minority women shoulder a disproportionate disease burden – higher rates of breast 
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cancer, disease mortality, and obstacles to prevention and detection (American Cancer 
Society, 2013a). For women in their 40s, African American women disproportionately 
shoulder the disease burden, due in part to the aggressive nature of the breast cancer as 
well as obstacles in cancer prevention and detection (American Cancer, 2013a, 2013b; 
Andersson & Janzon, 1997; Bjurstam et al., 1997; Conway-Phillips & Millon-
Underwood, 2009; Rawl et al., 2000). 
In Breen and Kessler’s study comparing  multi-year (1987 and 1990) National 
Health Interview Survey results, mammography screening rates differed by race, with 
African Americans participating in more mammography (1994).  Race has been a 
prominent mammography screening predictor variable in several studies, although this 
result conflicts with other studies where race was not a good predictor of mammography 
screening (Breen & Kessler, 1994; Breen & Meissner, 2005a; Breen, Rao, & Meissner, 
2010; Calvocoressi et al., 2004; Hiatt et al., 2002; Owusu et al., 2005; Phillips, 
Kerlikowske, et al., 1998).  In Rawkowski and colleague’s (2006) study of correlates of 
repeat mammography in women 45-75 years of age using 2003 Health Information 
National Trends Survey (HINTS) data, surprisingly, race was not statistically 
significantly associated with repeat mammography (Rakowski et al.).   Nevertheless, 
studies do agree that cancer screening behaviors differ by race (Dailey, Kasl, Holford, 
Calvocoressi, & Jones, 2007; Evans et al., 1998; Foulkes, 2008; Gapstur et al., 1996; 
Howlader et al., 2013).   
Mammography is often associated with anxiety, pain, and fatalism, which are 
mammography barriers in African American women (Champion & Springston, 1999; 
Halbert et al., 2006; Hiatt et al., 2002; Rimer et al., 1996; Watson-Johnson et al., 2011; 
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Wilson et al., 2009).  African Americans oftentimes have this fatalistic approach to 
screening, believing that if cancer is found, death is imminent (Champion & Springston, 
1999; Rimer et al., 1996; Russell, Champion, et al., 2006). Younger African American 
women, who present with breast cancer, may have an aggressive form of cancer, which 
may avert mammography detection due to its fast growth between screening schedules 
(Stanford & Greenberg, 1989). Therefore, in addition to mammography screening, 
education on individual cancer risk is needed, particularly for younger women, that could 
provide them tailored guidance on when to start screening as well as suggested interval 
between screenings (Bertrand et al., 2013; Bleyer & Welch, 2013; Kerlikowske, 2012; 
Kerlikowske et al., 2013).   
Mammography does still have a role in early screening in younger African 
American women as well as in other minority women. Although race has been shown is 
several studies not to be a statistically significant predictor of mammography utilization, 
there are differences in utilization by race due in part to a variety of factors such as 
cultural beliefs and religion (Chagpar, Polk, & McMasters, 2008; Champion et al., 2008; 
Champion & Springston, 1999; Fox et al., 2004; Gierisch et al., 2009; Meissner, Breen, 
Taubman, Vernon, & Graubard, 2007; O'Malley et al., 2002).  For this study, ethnicity 
will be used to denote race (non-Hispanic White, non-Hispanic African American, and 
Hispanic) and/ or the terms may be used interchangeable.  Further exploration into 
mammography screening behaviors by ethnicities is needed to mitigate breast cancer 
health disparities and develop strategies to improve overall breast health long-term. 
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3.4.4 Living Conditions 
Barriers to mammography adherence by African American women have been 
associated with many factors to include:  cultural attitudes, healthcare access, 
socioeconomic status, cost, failure of health provider to recommend mammography, lack 
of insurance, cancer fear, mammography misconception, and health provider trust 
(Conway-Phillips & Millon-Underwood, 2009; Hiatt et al., 2001; O'Malley et al., 2002; 
O'Malley et al., 2004; Ooi et al., 2011; Purc-Stephenson & Gorey, 2008; Schueler, Chu, 
& Smith-Bindman, 2008).  Living conditions are a component of the overall 
socioeconomic status variables, which provides insight into an individual’s social/family 
status and financial resources (Kindig & Stoddart, 2003; Kindig, 2007).  For this study, 
living conditions are operationalized using marital status and homelessness.  Since the 
selected variables of marital status and homelessness, are closely related socioeconomic 
conditions, they are discussed together.   
Living conditions and homelessness are variables that denote vulnerability 
(Gelberg et al., 2000).  However, Gelberg, Andersen, and Leake (2000) tested the 
utilization of the Behavioral Model for Vulnerable Populations in a homeless population, 
and found that one’s homeless status did not deter them from obtaining healthcare 
(Gelberg et al.).  Availability of a support system, such as spouse, or extended family in 
the home are associated with having greater health utilization of mammography (Calle, 
Flanders, Thun, & Martin, 1993; Dean et al., 2014; Katz et al., 2009; Russell, Champion, 
et al., 2006).   Lack of spouse in the home and homelessness have been shown to affect 
mammography utilization, by offering competing demands on time, resources, and 
finances (Conway-Phillips & Millon-Underwood, 2009; Phillips & Wilbur, 1995; 
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Russell, Perkins, Zollinger, & Champion, 2006; Steele-Moses et al., 2009; Strzelczyk & 
Dignan, 2002; Welch et al., 2008).   
Familiar companionship, such as that exhibited by the presence of a spouse, 
provides reciprocal concern and caring that oftentimes leads to women being reminded to 
conduct their preventive screenings.  Forgetting to make an appointment is an identified 
barrier to screening, as well as simply being too busy(Gierisch et al., 2009).  A spouse 
and/or close-knit family provides the fundamental upstream of the social determinant; the 
building  blocks of human activity(Hiatt & Breen, 2008).  Therefore, women who are 
unmarried or those with a lack of social support are less likely to undergo screening 
(Dean et al., 2014; Keating, Landrum, Guadagnoli, Winer, & Ayanian, 2006; Lopez, 
Khoury, Dailey, Hall, & Chisholm, 2009).   
Homelessness will be assessed to determine if this status over the past year has 
had an effect on mammography adherence.  Homelessness is a vulnerable population 
variable that provides insight into women’s past or current living conditions.  According 
to Barry and Breen, economically troubled or medically underserved communities 
increase the likelihood of late-stage cancer diagnosis (2005).  Because of the distressed 
nature of both the community and individual resources, women may delay screening or 
do not participate at all. 
Marital status and homelessness provide valid windows into the challenges and 
opportunities facing African American women, as they are also a vulnerable population.   
A clearer understanding of the roles that marital status and homelessness play in 
mammography adherence of minority women, and specifically younger African 
American women is needed to determine their individual and synergistic effect.  
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3.4.5 Economic Resources 
The economic resource variables that will be evaluated in this study are income 
and insurance. Both variables have been shown in numerous studies to impact 
mammography utilization (Hiatt et al., 2001; O'Malley et al., 2002; Schueler et al., 2008).  
Financial barriers can be protuberant, causing healthcare to become secondary to 
ensuring basic needs are met. Adams, Becker, and Colbert (2001) found that cost was one 
of the most important reasons African American women did not have mammograms.  As 
an available resource, health insurance aids in mitigating the cost barrier, in an attempt at 
making mammography affordable, as is seen with mammography vans and other 
affordability program (Adams et al., 2001; Sung, Alema-Mensah, & Blumenthal, 2002).  
Having insurance was the strongest predictor of low mammography use in a study 
evaluating cancer screening in California underserved women (Hiatt et al., 2001). 
Although the Affordable Care Act should help mitigate many health insurance barriers, it 
does not provide universal health care coverage to all in the US, and therefore some may 
still be affected by inadequate or no health coverage for mammography. 
Having insurance is a key factor that directly impacts one’s ability to pay for and 
access medical services, as well as follow up interventions, and has been significantly 
related to utilization of medical services (Mandelblatt et al., 1999; Sung et al., 2002).   
Leong-Wu and Fernandez (2006) looked at correlates of mammography in low-income 
Asian American women, and determined that health insurance was positively associated 
with adherence.  Sung, Alema-Mensah, and Blumenthal (2002) looked specifically at 
inner-city African American women to determine associated factors for their failure to 
follow through with mammography after an education intervention, and lack of adequate 
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insurance was the associated barrier.  In a study by Rakowski, Meissner, Vernon, Breen, 
Rimer, and Clark (2006) in identifying correlates of repeat mammography using 2003 
HINTS data, having insurance was one of the strongest socio-demographic associations.  
Earlier using the 2000 National Health Interview Survey (NHIS) data, Rakowski and 
colleagues (2004) also identified not having insurance as a correlate for lowered 
mammography adherence in women 55-79 years of age. 
Having an income equal to or greater than $35,000 is a significant predictor of 
annual breast screening (Dailey, Kasl, Holford, Calvocoressi, et al., 2007; Nash et al., 
2007; Welch et al., 2008).  Higher income associates very closely with the ability to 
afford health insurance, thereby mitigating the cost barrier. In a study to evaluate factors 
that affect adherence to screening in Latino women, lack of affordability was one of the 
most cited barriers (Mack et al., 2009). In a study to evaluate socio-ecological variables 
that impact screening, women living in areas with a higher percentage of poverty, were 
less likely to use mammography (Mobley, Kuo, Clayton, & Evans, 2009).  
Socioeconomic status along with age, are the socio-demographic variables that correlate 
most strongly with screening utilization (Hiatt et al., 2002; Welch et al., 2008). 
Therefore, income and whether a woman has health insurance to cover preventive health 
care are significant variables to consider.  
In a study by Phillips and colleagues (1998), examining 1992 NHIS data for 
factors associated with women’s adherence to mammography, they found that higher 
income, having fewer than three household members, participation in the decision to 
screen, and living in an area with no shortage of primary care providers were significant 
adherent factors. Additionally, in a study by Nash and colleagues (2007) that looked at 
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barriers to both cervical and breast cancer screening in New York City women 50 years 
of age and older, income, and employment status were statistically significantly 
associated with a likelihood of screening.  In a study that evaluated factors associated 
with repeat screening, working for pay was significantly associated with repeat screening 
(Halabi et al., 2000).  As income is a direct correlation to one’s socioeconomic status, 
lower socioeconomic status is associated with delayed or absent utilization of primary or 
preventive healthcare overall, and is more pronounced in the African American 
community (Champion & Springston, 1999; Conway-Phillips & Millon-Underwood, 
2009; Dailey, Kasl, Holford, Calvocoressi, et al., 2007; Greene, Torio, & Klassen, 2005). 
Despite the strong correlation of higher income to mammography utilization and 
adherence, Fox and colleagues (2004) in their study of mammography adherence 
predictors, income was not a statistically significant predictor.  In their study, they 
surveyed multiethnic low income women 50 years of age and older to evaluate their 
screening experiences.  Because of conflicting study results, as well as the need to learn 
more about the breast health behaviors of minority women, more research is needed in 
this area.  
3.4.6 Regular Source of Care and Transportation   
Access to healthcare services has been studied extensively over the past 50 years.  
Andersen and Aday’s earlier Behavioral Model and the many studies that have tested the 
model, point to the fundamental need for access to healthcare to increase health 
utilization (Aday & Andersen, 1974; Andersen, 1995; Breen & Meissner, 2005b; Gelberg 
et al., 2000). Access to healthcare, as represented by the extensive research work of 
Andersen and Aday, point to the physical access of transportation that provides 
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fundamental entry to available healthcare services (Aday & Andersen, 1974; Andersen & 
Urban, 1998; Andersen, 1995).  
In Russell, Champion, and Skinner’s (2006) study of African American women to 
investigate their health beliefs associated with repeat mammography, as with other 
studies, having prior mammography, access to healthcare (a source of care and 
transportation), and greater knowledge of mammography, were associated with fewer 
perceived barriers to screening (Calvocoressi et al., 2004; Calvocoressi, Stolar, Kasl, 
Claus, & Jones, 2005; Halabi et al., 2000; Russell, Champion, et al.). A regular source of 
care and having a provider recommendation are primary predictors of mammography 
utilization (Adams et al., 2001; Breen & Kessler, 1994; Breen & Meissner, 2005b; Hiatt 
et al., 2002).  Consensus in previous studies is that a regular source of care is a 
statistically significant predictor of mammography adherence (Gierisch et al., 2009; 
Rahman et al., 2003; Rakowski et al., 2004; Rakowski et al., 2006).  Mandelblatt and 
colleagues (1999) evaluated breast and cervical cancer screening in multiethnic women 
ages 18-74, and determined that having a regular source of care significantly predicted 
screening utilization or recent mammography.  A regular source of care provides entry 
into the healthcare system that allows ready monitoring of health care needs through 
continuity of care by a usual provider or provider group.  A regular source of care is a 
significant predictor that increases utilization of cancer screening (Breen & Kessler, 
1994; May, Kiefe, Funkhouser, & Fouad, 1999; Nash et al., 2007; O'Malley et al., 1997; 
Phillips, Kerlikowske, et al., 1998; Rakowski et al., 2004; Rakowski et al., 2006; Smith-
Bindman et al., 2006).   
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Women need and require the dialogue with their health care provider to aid in 
their decision to commence and continue with screening (American Cancer, 2013a, 2014; 
Jatoi & Anderson, 2010b; Jatoi & Baum, 1993; Marshall, 2005).  Conversely, with the 
changing screening recommendation and no consensus as to the need for women in their 
40s to screen, women require the guidance and informed decision-making assistance 
from their health provider to better determine their level of risk, benefit, and need for 
mammography (Jatoi & Anderson, 2010a; Jatoi & Baum, 1993). Transportation is an 
important qualifier in mitigating access barriers.  If women have transportation to 
healthcare services along with a regular source of health care, and insurance, they are 
more likely to follow through with obtaining mammography services. 
3.4.7 Perceived Health Status   
It is important to evaluate perceived health status, as it has a direct bearing on 
one’s intention and eventual actualization of a health behavior.  Several studies indicate 
that younger women often do not present for health services if they are healthy, but will 
show up if they perceive an ailment (Halabi et al., 2000; Hiatt et al., 2001; Mandelblatt et 
al., 1999; Mandelblatt & Yabroff, 2000).  Conversely, other studies indicate that fear of 
finding breast cancer has deterred African American women from engaging in 
mammography (Champion & Springston, 1999; Russell, Champion, et al., 2006; Russell, 
Perkins, et al., 2006). Those engaging in preventive or health promotion screenings, or 
those who have a good perception of their health, are more likely to engage and continue 
with preventive screenings (Evans et al., 1998; Fox et al., 2004; Gierisch, Earp, et al., 
2010; Gierisch et al., 2009).  Alternatively, other studies have shown that women with a 
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high cancer risk also have a higher screening adherence (Gierisch et al., 2009; Halabi et 
al., 2000; Zapka, Stoddard, Maul, & Costanza, 1991).   
  Perceived health status also provides information on a population’s vulnerability 
status (Gelberg et al., 2000).  African American women may have cancer fatalism (the 
belief that once cancer is detected and diagnosed, death is inevitable), which may give 
them a false sense of having a better perceived health than their actual health status 
(Breen & Meissner, 2005a; Champion et al., 2006; Fair, Monahan, Russell, Zhao, & 
Champion, 2012).  In a study by Fair and colleagues (2012), they tested the interaction of 
African American women’s perceived risk of breast cancer and perceived benefits of 
mammography (Fair et al.).  Those who had a high perceived risk and low perceived 
mammography benefit were reluctant to engage in mammography utilization and 
adherence (Fair et al., 2012).  Additionally, studies that have evaluated other ethnicities, 
also point out that women who perceive their cancer risk as high, oftentimes do not 
adhere to mammography, due to fear of the results (Champion et al., 2008; Champion & 
Springston, 1999; Davis, Stewart, & Bloom, 2004). Therefore, it is paramount to 
determine the impact of perceived health status on mammography adherence.   
The literature has provided both conflicting and agreeable support of variables 
that correlate, predict, and/or impact mammography screening. Select variables identified 
in the literature that will be tested in this study are:  age, race, marital status, regular 
source of care, income, transportation, insurance, and perceived health status.  The 
preponderance of this support in the literature is for women 50 years of age and older 
with a dearth of research on younger women in their 40s, and even less on younger 
minority women. The Behavioral Model has provided a broad and well utilized model for 
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testing healthcare access and health behavior utilization, including mammography 
adherence.  The Behavioral Model for Vulnerable Populations has been used in exploring 
mammography, albeit less, it allows the inclusion of newer variables that are germane to 
vulnerable populations, allowing the model’s expansion and exploration into challenges 
faced by vulnerable populations, like minorities. For this study, a modified Behavioral 
Model will be used, with the inclusion of a vulnerable specific variable, homelessness, 
from the Behavioral Model of Vulnerable Populations.  As the path is laid for greater 
individualized healthcare screenings, of paramount exploration, is determining if a 
women’s Gail risk score, might also impact mammography. Variables will be tested to 
determine their impact on mammography adherence in African American women in their 
40s compared to women of other ethnicities and ages. 
3.4.8 Gail Risk Score 
 The Gail risk score is an individualized breast cancer risk assessment tool that 
uses a women’s personal and family medical and reproductive history to provide a 5-year 
and lifetime risk of developing breast cancer (Gail et al., 1989; Millstine, David, & 
Pruthi, 2014; National Institutes of Health, 2011).  When used along with the advice of 
their healthcare provider, this tool can provide women insight as to when, how often, and 
if they should begin breast cancer screening. It is a free online tool that is readily 
available anytime.  The tool assess the following areas:  1) medical history of  breast 
cancer; 2) known breast cancer gene (BRCA1 or BRCA2); 3) age; 4) age at first 
menstrual cycle; 5) age of first live birth; 6) first-degree relatives who have or had breast 
cancer; 7) having had a breast biopsy;  and 8) race (National Institutes of Health, 2011). 
Utilizing the Gail risk score in this study will provide valuable information as to its 
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impact on mammography adherence.  The tool has been tested in large populations of 
both White and African American women, although further testing is needed to validate 
its findings in Hispanic women (National Institutes of Health, 2011). Knowledge gained 
through use of the Gail risk score may provide additional insight on whether risk tools 
such as the Gail risk score, should be promoted to better inform women of their breast 
cancer risk, and improve overall breast health.  For this study, pre-calculated 2010 NHIS 
Gail risk scores will be used, with a target increased cancer risk of >=20% lifetime risk.  
The 20% risk was selected, as women with a >=20% elevated lifetime risk are considered 
high risk and advised to have both mammography and MRI screening modalities (Bosse 
et al., 2013; Kuhl et al., 2005; Patterson & Noroozian, 2012).  
3.5 Research Design and Methods of Parent Data 
3.5.1 The National Health Interview Survey 
 The NHIS is a continuous, multi-purpose nationwide survey of civilian non-
institutionalized households of the United States (US) (Center for Disease & Prevention, 
2011, 2012). The survey is conducted by the National Center for Health Statistics 
(NCHS), Centers for Disease Control and Prevention (CDC), and population interviews 
are administered by the US Census Bureau. The survey was developed after the National 
Health Survey Act of 1956 provided for ongoing surveys and studies to obtain current 
statistical data on the health, illness, and health access status of the US population (Center 
for Disease & Prevention, 2010, 2011; Center for Disease Control and, 2012). The NHIS 
has been conducted since 1957, with approximately 35,000 – 40,000 households (75,000 
– 100,000 individuals) annually (Botman, Moore, Moriarity, & Parsons, 2000; Center for 
Disease & Prevention, 2012). The size of the dataset helps to ensure optimal power.  Data 
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from the NHIS has been a major source of data used to track national health objectives 
related to health status, health care access, and health disparities (Services, 2000, 2011a).  
 The NHIS permits the sampling of households and non-institutional quarters for 
the four main geographic regions as well as certain metropolitan and nonmetropolitan 
locations in all 50 states and the District of Columbia.  Designed to generate a 
representative household sample, the NHIS is a stratified multistage area probability 
sample with the initial stage being the selection of 428 primary sampling units (PSUs) 
from the almost 1,900 geographically designed PSU in the US. The sample of PSUs is 
segregated into four panels so geographic regions can be compared.  A PSU is a county, 
group of neighboring counties, or metropolitan statistical area. The second stage involves 
the selection of area segments, geographically defined with at least eight addresses, and 
permit area segments, which are made up of about four post-1990 addresses.  
 Since 1987, the NHIS has required that African American and Hispanic 
populations be oversampled in order to better estimate health, disease, and disability 
(Center for Disease & Prevention, 2012).  The Asian population is now also oversampled 
(Center for Disease & Prevention, 2012). Each person in the sampled population has a 
selection probability greater than zero, and their weights are later adjusted based on age, 
sex, race/ ethnicity totals from the Census. All sampled addresses within the chosen 
segment are selected to be interviewed and all those aged 17 and over in the household, 
who are at home at the time, are asked to respond for themselves and/or any children or 
absent adults.  A subsample of adults is selected to answer additional items on Sample 
Adult questionnaire.  Information is gathered on socio- demographics, general health, 
mobility, and function, health behaviors, health insurance, and health care utilization.  
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Participants provide informed consent to participate in the survey.  Participant rights are 
protected throughout the survey, as non-identified data is used. 
 NHIS data is released annually as public use data files, and is used by 
policymakers, academia, researchers, and the general public (Center for Disease Control 
and Prevention, 2011a). Additional restricted data files not released via public use files 
(i.e. finer geographic details, etc.), may be obtained through proposal submittal to the 
NCHS Research Data Center (RDCs) (Center for Disease Control and Prevention, 
2011c). The RDC’s goal is to protect the confidentiality of study subjects, while 
discriminately providing sensitive data to researchers specific to their research questions 
posed.  The NHIS data represents a statistically representative sample of the US 
population, which has allowed greater generalization of research study results that use its 
data (Center for Disease Control and Prevention, 2010; Centers for Disease Control and 
Prevention (CDC), 2012).  The survey consists of a core set of questions that remain 
routinely unchanged each year, although periodic review and revisions do occur. The 
core questions are comprised of basic health and demographic items (Botman et al., 
2000; Center for Disease Control and Prevention, 2011d).  In addition, various 
supplemental questions are added from year to year, ascertaining current specialized 
health data on a variety of health topics – cancer screening, tobacco usage, diet and 
nutrition, food security, fitness center use, etc. (Center for Disease Control and 
Prevention, 2011d; Centers for Disease Control and Prevention (CDC), 2012; National 
Institute of Health, 2011). 
NHIS 2010 year survey data will be used for this study. Questions from the 
following NHIS survey sections will be used:  a) Household  – to assess race; b) Family 
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File – to assess health insurance status, marital status, income, perceived health status; c) 
Sample Adult– to assess gender, age, regular source of care, and homelessness, 
transportation, and cancer status; and d) Cancer Control Supplement – to assess 
mammography behavior.  The literature has guided this author’s proposed questions 
selected from the NHIS. The 2010 year survey data incorporated the Cancer Control 
Supplement (CCS) into its survey questions, which provides a mechanism to assess 
mammography adherence over time (Services, 2000; Wilson, 2007). The CCS was first 
fielded in the NHIS in 1987, 1990, and 1992 (Swan, Breen, Coates, Rimer, & Lee, 2003; 
Wilson, 2007).  Since 2000, the CCS is administered with the NHIS every five years, 
with the latest administered in the NHIS 2010 year survey (Center for Disease Control 
and, 2011c). The CCS is designed to monitor trends and patterns of cancer behaviors and 
cancer screening. The CCS is randomly administered to selected adults 18 years of age 
and older, while mammography questions are administered to women 30 years of age and 
older (Center for Disease Control and, 2011c). 
3.5.2 Survey Design & Sample 
 NHIS sampling and interviewing are uninterrupted throughout each year, 
following a multistage area probability design that permits representative sampling of 
households. The sampling plan used for the 2010 data was introduced in 2006, and is 
redesigned every 10 years. The 2010 sampling plan consists of 428 primary sampling 
units (PSU's) drawn from 1,900 geographically defined PSU's that cover the 50 States 
and the District of Columbia. A PSU may consist of a county, adjoining counties, or a 
metropolitan statistical area (Center for Disease Control and Prevention, 2011d). For the 
PSU, there are two types of second-stage units used - area and permit segments.  
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Geographically defined area segments contain addresses, while permit segments cover 
housing units built after the 2000 census.  
Oversampling of Blacks, Hispanics, and Asians was done.  Although samples are 
taken from each state and the District of Columbia, the NHIS sample is too small to 
provide State level data with acceptable precision. The total NHIS sample is divided into 
four separate panels, so that each panel is a representative sample of the population, 
lending itself to greater sample size flexibility (Center for Disease & Prevention, 2011). 
The sample of the 2010 sample selected for interview is a representative sample of the 
directed population (Center for Disease & Prevention, 2011; Center for Disease Control 
and, 2012).  For the 2010 survey, there were 34,329 households interviewed (89,976 
persons in 35,177 families), and the annual response rate was 90% (Center for Disease 
Control and, 2011c).  
3.5.3 Data Collection 
 The NHIS is an annual cross-sectional survey conducted using computer-assisted 
personal interview by rigorously trained interviewers from the US Census Bureau.  The 
NHIS is principally charged with recording, examining and analyzing a large portion of 
the spectrum of the population’s health.  The core questions are comprised of basic health 
and demographic items. In addition, various supplemental questions are added from year 
to year, ascertaining current specialized health data on a variety of health topics – such as 
cancer screening, tobacco use, etc. The 2010 year survey data incorporated the Cancer 
Control Supplement (CCS) into its survey questions, which provided a mechanism to 
assess mammography adherence over time. The CCS is administered with the NHIS 
every five years, with the latest administration in the 2010 NHIS (Center for Disease & 
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Prevention, 2012; Center for Disease Control and, 2011c, 2012). The CCS is randomly 
administered to selected adults 18 years of age and older, while mammography questions 
are administered to women 30 years of age and older.  For items that contain the same 
questions from year to year, multi-year data can be pooled to increase the sample size if 
needed. The large sample size of the NHIS, lends itself well to analysis used in studies 
with many predictor variables.  Participation in the survey is voluntary, and 
confidentiality of participants is maintained. For each family sampled, one adult and one 
sample child were randomly selected and information collected on each. The survey 
consists of a core set of questions that remain routinely unchanged each year, although 
periodic review and revisions do occur (Center for Disease & Prevention, 2011).  
3.6 Research Design and Methods 
3.6.1 Innovation 
 The proposed study will explore relationships between and among multiple 
variables in determining which variable(s) predict mammography adherence in younger 
African American women in their 40s as compared to women of other ethnicities and 
ages. The mammography behaviors of women in their 40s are often overshadowed by the 
controversy surrounding the risks versus benefits of its utilization in this population. The 
dilemma encircling the mammography controversy has too often taken center stage, 
blinding an equally paramount need of studying breast health behaviors.  Using a 
modified Behavioral Model, this study will test the applicability of the Behavioral Model 
of Vulnerable Populations variable– homelessness – on mammography adherence, while 
also further exploring the impact of Gail risk scores on screening. Utilization of the Gail 
risk score retrospectively in this study offers a unique perspective in determining the 
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impact of individual cancer risk on mammography adherence.  In an effort to standardize 
mammography adherence lexicon, conceptual terminology is proposed – short-term and 
long-term mammography adherence.  This research will provide needed insight into the 
breast health behaviors of this oftentimes disparate population as compared to other 
ethnicities and age strata, determining predictors of mammography adherence.   Using 
secondary data analysis of existing national level data could provide a statistically 
significant model of mammography adherence. Results of this study will validate 
adherence results, provide guidance to increasing mammography adherence, and 
mitigating breast cancer health disparity, and promote women’s breast health promotion 
and disease prevention in younger African American women.  
3.6.2 Approach 
The researcher will complete a retrospective correlational secondary analysis 
study of 2010 NHIS data. Women 43-79 years of age will be included in this study. 
Women 40-42 years of age will not be included in the study, as non-adherence data may 
confound or skew results using either annual or biennial guidelines.  For women in the 
40-42 age range, it is more likely that recent mammography data would be available as 
opposed to mammography adherence data, due to the shortened timeframe. As an 
example, a 40 year old may not have initiated mammography as of yet, and a 42 year old 
may have only had one mammogram on a biennial schedule.  
The NHIS is a continuous, multi-purpose nationwide survey of civilian non-
institutionalized households of the US (Center for Disease & Prevention, 2011; Center 
for Disease Control and, 2011a, 2012). The sample is a public use dataset that is publicly 
available.  The large sample size of the data lends itself well to having an ample sample 
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size that will ensure a high power.  Descriptive statistics and logistic regression will be 
used to analyze the data.  
 The purpose of this study is to explore associations and predictors of 
mammography adherence in younger African American women in their 40s as compared 
to older women and ethnicities using a modified Behavioral Model. Variables of the 
model will be tested for their relatedness to the dependent variable, mammography 
adherence.  Mammography adherence rates will also be compared among races. 
3.6.3 Data Collection 
 After IRB approval, the data will be accessed from the public domain site and 
saved on a designated and secure MacBook designated only for this research.  All data 
will be saved in the public domain location as de-personalized data.  The research 
MacBook will be password protected to protect the integrity of the research data.  The 
Center for Disease Control and Prevention’s Research Data Center will be contacted for 
any additional data needed that is not available on the public domain site. 
3.6.4 Research Questions 
The following four research questions will guide this study: 
1. Are there differences in adherence rates (short-term and long-term) for African 
American women by age strata 43-49, 50-64, and 65-79?   
Ho: There is no difference in adherence rates (short-term and long-term) for 
African American women by age strata.  
2.  What are the relationships between and among predisposing - age, race, marital status, 
Gail risk score, and homelessness; enabling - regular source of care, income, 
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transportation, and insurance; and need – perceived health status variables on 
mammography adherence health behavior? 
 Ho:  There are no statistically significant relationships between and among 
identified predisposing, enabling, and need variables on mammography adherence. 
3.  Do long-term mammography adherence rates and the model variables differ between 
and among ethnicities for women in the same age strata? 
 Ho:  Long-term mammography adherence rates and model variables do not differ 
between and among ethnicities for women in the same age strata. 
4.  What is the relationship of Gail risk scores on mammography adherence? 
 Ho:  There is no relationship between Gail risk scores and mammography 
adherence. 
3.6.5 Sample 
 The 2010 NHIS is large with 89,976 persons (women, men, and children) 
included in the data set. Therefore, from this sample, women meeting the inclusion 
criteria will be included as part of the study sample.  Study inclusion criteria are:  African 
American, White, and Hispanic women 43-79 years of age.  The sample will consist of 
women who have used both the 12 month (annual) interval, as well as those who have 
used the 24 month (biennial) interval.  Women with a present or past history of breast 
cancer will be excluded from the sample. 
3.6.6 Variables  
 Answers to select survey questions will be analyzed that address each study 
variable.  The literature was used to guide question selection. The predisposing, enabling, 
and need variables are the independent variables in the study.  The dependent variable is 
 88 
mammography adherence.  Missing data and responses of ‘don’t know’ and ‘refused to 
answer the question’ will be excluded from data analysis, except in the case of income, 
where imputed income files will be used.  Table 1.0 outlines the variable, questions, and 
coding that will be used during analysis. The 2014 American Cancer Society 
mammography guideline will be used to guide annual screening. The 2009 U.S. 
Preventive Services Taskforce mammography guideline will be used to guide biennial 
screening. Utilizing a 12- and 24- month screening algorithm developed by Rakowski 
and colleagues, mammography questions identifying mammogram month and year, as 
well as the time period since last mammogram, will inform the interval schedule used for 
women in the study (Rakowski et al., 2004).  The location of care will be used as a 
descriptive statistic and comparison variable.  
Table 3.1                                  VARIABLE TABLE – 2010 NHIS 
    
 
 
 
DESCRIPTIVE 
VARIABLE NAME 
 
 
 
VARIABLE 
QUESTION/DEFINITION 
LEVEL OF 
MEASUREMENT 
& DATASET 
VARIABLE 
NAME 
 
 
 
CODING/ 
RECODING  
 
Gender 
 
Question:  Are you Male or Female?  
Provides information on adult 
respondent gender. 1=male, 2=female 
 
Dichotomous       
(SEX) 
 
Only Use #2 as 
inclusion 
criteria 
Race 
 
 
 
 
 
 
 
Question: What race or races do you 
consider yourself to be? Respondents 
are asked about their race and can 
choose one or more out of the 16 race 
choices. 1=White, 2=Black/African 
American, 3=Indian (American), 
4=Alaska Native, 5=Native Hawaiian, 
6=Guamanian, 7=Samoan, 8=Other 
Pacific Islander, 9=Asian Indian, 
10=Chinese, 11=Filipino, 
12=Japanese, 13=Korean, 
14=Vietnamese, 15=Other Asian, 
16=Some other race.  
 
 
Nominal     
(RACE) 
Include those 
who select 1 & 
2; Exclude 3-16 
 89 
 
 
 
DESCRIPTIVE 
VARIABLE NAME 
 
 
 
VARIABLE 
QUESTION/DEFINITION 
LEVEL OF 
MEASUREMENT 
& DATASET 
VARIABLE 
NAME 
 
 
 
CODING/ 
RECODING  
Race Question:  Do you consider yourself 
Hispanic / Latino?  1=Yes, 2=No 
Dichotomous       
(NATOR) 
Include 1 only 
as inclusion 
criteria 
Race Question:  Which one of these groups 
would you say best represents your 
race.  Respondents are asked this 
question if they selected more than one 
race for variable RACE. 1 =White, 2 
=Black/African American, 3 =Indian 
(American), 4 =Alaska Native, 
5= Native Hawaiian, 6= Guamanian, 7 
=Samoan, 8= Other Pacific Islander, 
9= Asian Indian,10 =Chinese, 11= 
Filipino, 
12= Japanese, 13 =Korean, 14 
=Vietnamese,15 =Other Asian,16= 
Other Race 
Nominal      
(MLTRAC) 
Include those 
who select 1 & 
2; Exclude 3-16 
Age Question:  What is your age?/How old 
are you? Provides an age for the adult 
respondent 
Ratio                           
(AGEDOB_1) 
Recode to 
nominal level; 
group ages 43-
49 =#1; 50-64 
=#2; 65-79 = 
#3. 
Marital Status Are you now married, widowed, 
divorced, separated, never married, or 
living with a partner?  1. Married; 2. 
Widowed; 3. Divorced; 4. Separated; 
5. Never Married 6. Living with 
partner; 7. Refused; 9 Don't know 
Nominal      
(MARITAL) 
Married = 1 & 
6; Not married 
= 2,3,4,5 
Income Use calculated Poverty Index Ratio 
(Income and family size) Compared 
against the 2009  Poverty Threshold.                                    
Ratio                         
(RAT_CAT3) 
 
Income Use imputed income data Ratio        
(FIN250) 
 
Need - Perceived 
Health 
Would you say [fill: your/ALIAS's] 
health in general is excellent, very 
good, good, fair, or poor?  1 Excellent; 
2 Very good; 3 Good;  4 Fair; 5 Poor; 
7 Refused;  9 Don't know 
Ordinal   
(PHSTAT) 
Recode to 
nominal; 1,2,3 
= 
Excellent/Good; 
4&5 = 
Fair/Poor 
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DESCRIPTIVE 
VARIABLE NAME 
 
 
 
VARIABLE 
QUESTION/DEFINITION 
LEVEL OF 
MEASUREMENT 
& DATASET 
VARIABLE 
NAME 
 
 
 
CODING/ 
RECODING  
GAIL risk score Calculated score from various NHIS 
questions. 
Ratio              
(Calculated Value 
from outside 
source) 
Five year and/or 
Lifetime breast 
cancer risk >= 
20% 
Regular Source of Care Is there a place that you usually go to 
when you are sick or need advice 
about your health? 1=Yes, 2=There is 
NO place, 3=There is More Than One 
place. 
Nominal     
(AUSUALPL) 
Recode to 
dichotomous; 1 
& 3= Yes;     2= 
NO 
Location of Care What kind of place is it - a clinic, 
doctor's office, emergency room, or 
some other place?  What kind of place 
do you go to most often  1=Clinic or 
health center, 2=Doctor's Office or 
HMO, 3=Hospital emergency room, 
4=Hospital outpatient department, 
5=Some other place, 6=Doesn't go to 
one place most often 
Nominal  
(APLKIND) 
Interested in #3 
as potential 
comparison 
    Homelessness Question:  Have you ever spent more 
than 24 hours living on the streets, in a 
shelter, or in a jail or prison? 1= Yes, 
2= No. 
Dichotomous  
(HOMELESS) 
1=Yes 
Transportation Question:  There are many reasons 
people delay getting medical care. 
Have you delayed getting care for any 
of the following reasons in the PAST 
12 MONTHS? You didn't have 
transportation.  1=Yes, 2= No. 
Dichotomous  
(AHCDLY_5) 
1 = Yes 
Insurance Question: (Include health insurance 
obtained through employment or 
purchased directly as well as 
government programs like Medicare 
and Medicaid that provide Medical 
care or help pay medical bills.) Are 
you/ Is anyone in the family covered 
by any kind of health insurance or 
some other kind of health care plan? 
1=Yes, 2=No 
 Dichotomous  
(FHICOV) 
1 = Yes 
Initial Mammogram  Question:  Have you EVER HAD a 
mammogram? 1-Yes, 2=No. 
Dichotomous  
(MAMHAD)  
 
 
 
1=Yes; 2= No 
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DESCRIPTIVE 
VARIABLE NAME 
 
 
 
VARIABLE 
QUESTION/DEFINITION 
LEVEL OF 
MEASUREMENT 
& DATASET 
VARIABLE 
NAME 
 
 
 
CODING/ 
RECODING  
 
 
Recent Mammogram 
Schedule 
 
 
Question:  Was (your last 
mammogram):  1 =A year ago or less, 
2=More than 1 year but not more than 
2 years,3= More than 2 years but not 
more than 3 years, 4= More than 3 
years but not more than 5 years, 5= 
Over 5 years ago. 
 
 
Nominal  
(RMAM2) 
 
 
Variable used to 
help determine 
which 
mammography 
schedule used 
and existence of 
recent 
mammogram: 1 
& 2 = annual; 
3=biennial; 4 & 
5 = Not on 
schedule 
 
Short and Long- Term 
Mammography 
Adherence 
 
 
 
 
 
 
 
 
Question:  How many mammograms 
have you had in the LAST 6 YEARS?  
This question asked of women who 
have ever had a mammogram. 
 
Ratio    
(MAM6YR) 
 
Recode into 
dichotomous 
variables 
(Adherent = 
Yes/No).  
Short-term = at 
least two on 
annual or 
biennial 
schedule; Long-
term = three or 
more on annual 
or biennial 
schedule 
 
12- or 24- month 
Mammogram Interval 
Algorithm 
 
*Most recent mammogram month and 
year:   When did you have your most 
recent mammogram (mth); Enter year 
of last mammogram 
 
 
Nominal  
(RMAM1_MT) 
(RMAM1_YR)  
 
Variables used 
to calculate 
most recent 
mammogram 
and screening 
schedule. 
 
Cancer  
 
Have you ever been told by a doctor or 
other health professional that you had 
cancer or a malignancy or any kind? 
1=Yes; 2=No 
 
Dichotomous  
(CANEV) 
 
1 = Yes.  Used 
as exclusion 
criteria 
 
 
Breast Cancer 
 
 
If they have had cancer.  What kind of 
cancer was it?  05=Breast 
 
 
CANKIND_1; 
CANKIND_2; 
CANKIND_3; 
CANKIND_4 
 
 
Only include 05 
- Breast Cancer 
type; used as 
exclusion 
criteria 
  Note. Proposed study variables. 
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Data will be analyzed for both short and long-term mammography adherence.  
Independent variables will consist of the following:  age, race, marital status, income, 
poverty index ratio, income, perceived health status, Gail risk score, regular source of 
care, homelessness, transportation, and insurance.  The gender variable will be used to 
exclude male participants from the sample. Ethnicity will be used to denote race (non-
Hispanic White, non-Hispanic African American, and Hispanic) and/ or the terms may be 
used interchangeably. 
 A copulation of 2-3 questions will be used to determine mammography adherence 
– how many mammograms a woman has had over a six year period, along with questions 
to help determine the interval of their most recent mammogram. Women who have ever 
had a mammogram will be included in the study sample. The study sample will only 
include NHIS participants who meet the inclusion criteria. Adherence will be defined as a 
number, then later recoded to a categorical variable to reflect adherence as ‘yes’ or ‘no.’  
The adherence variable will be calculated using the following formulas: 
 a) Short-term:  At least two consecutive mammograms on an annual or biennial 
mammography guideline schedule.   
 b) Long-term:  At least three or more consecutive mammograms on an annual or 
biennial mammography guideline schedule. 
The continuous mammography adherence variable will be recoded as a dichotomous 
variable.  Both the 12- and 24-month timeframes will be used to determine significant 
differences. The interval algorithm established by Rakowski and colleagues (2004) will 
be used to determine if participants used a 12 or 24 month interval. The following 
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questions will be used to help determine the mammography schedule practiced by 
participants: 
 a) Recent mammogram schedule.  If they had their last mammogram one year ago 
or less, or more than one year, but not more than two years, they will be coded as using 
the annual mammography schedule.  If their last mammogram was more than two years 
ago, but less than three years, they will be coded as using biennial mammography 
schedule. The most recent mammogram month and year data, will be used to further 
delineate participant’s mammography interval schedule practiced (most recent one), 
along with the recent mammogram schedule. 
 b) Formula:  (recent mammography) 1 year ago or less or >1 year but < 2 years = 
Annual (adherent – Yes);  (recent mammography) > 2 years, but < 3 years = Biennial 
(adherent – Yes). Women who obtained a mammogram > 3 years, but < 5 years and > 5 
years are not adherent to mammography screening guidelines (adherent – No).  The 
month and year of their last mammography will provide greater depth and verification of 
their most recent mammogram, if provided.  
 The pre-calculated Gail risk scores were computed from risk factor questions 
within the 2010 NHIS on age, age of first live birth, age at menarche, number of first-
degree relatives with breast cancer, and the number of breast biopsies. The calculations 
were made using the National Cancer Institute’s Breast Cancer Risk Assessment Tool, 
which was specifically modified to produce risk estimates for non-Hispanic African 
American (National Institute of Health, 2011). 
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3.6.7 Data Analysis Plan 
 The data will be cleaned and recoded to ensure that data is coded properly and 
that no missing data is used. The data will be analyzed using the latest version of SPSS or 
SAS.  Although a priori sample size determination will be conducted, threats to power 
and effect size will be avoided due in part to the large sample size. Variable data will be 
recoded as needed to support appropriate level of measurement for the statistical tests 
used, as outlined in Table 1.0.   The following analysis will be conducted for each 
specific aim after ensuring the sample is normally distributed: 
Specific aim 1. To describe the mammography adherence rates of African 
American women 43-79 years of age.  A three-group independent-samples chi-square 
(x2) test will be used to test group differences in proportions.  Both the dependent 
variable (mammography adherence) and the independent variable (age) are nominal 
variables, and meet the level of measurement for this test.  Short and long-term 
mammography adherence will be evaluated for African American women in each age 
strata. Phi coefficient will be used to provide information on the magnitude of any 
significant differences as well as the effect size. An alpha of 0.05 will be used to define 
the significance. 
Specific aim 2. To identify relationships between and among Behavioral 
Model population variables (predisposing, enabling, and need variables) on the 
mammography adherence health behavior variable.  Logistic regression will be used 
to analyze the relationship between and among the Behavioral Model variables 
(independent variables) on mammography adherence (dependent variable). Logistic 
regression will also determine which variables may predict adherence. Four separate 
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models will be created and tested:  1) short-term/ biennial; 2) short-term/annual; 3) long-
term/biennial; and 4) long-term/annual. Adherence will be recoded as yes/no.  Logistic 
regression will allow modeling the probability of each of the variables on mammography 
adherence. Variables included in the logistic regression test will be verified, ensuring that 
they meet the level of measurement assumptions for logistic regression:  the dependent 
variable is dichotomous, and the independent variables are nominal or ratio.  
Assumptions of the test will be verified to ensure that they are met:  normal distribution 
validated, sample independently measured.  Using bivariate correlation analysis, the 
multicollinearity assumption will be checked among the independent predictor variables 
to ensure they are not too closely correlated.  The tolerance threshold will be >.85.  
Standard residuals will be checked for outliers.  An evaluation of outliers will be 
conducted by examining standardized residuals for each case.  Any outliers with a 
standardized residual threshold cutoff of >=3.0 will be removed from the analysis. The 
data will be checked to ensure that a linear relationship exists between independent 
variables and the log odds of the dependent variable. An alpha of 0.05 will be used to 
define the significance. Variables will be entered into the logistics regression model 
simultaneously, to achieve a parsimonious model with strong predictive power. The Wald 
statistic will be used to evaluate the significance of individual predictors at alpha of .05. 
The odds ratio (Exp(B) will be reported for each predictor. The Chi-square goodness of 
fit will be used to test the overall model. Nagelkerle R2 will be used to estimate the effect 
size.  The Wald statistic or other statistic will be used to evaluate the significance of 
individual predictors.  The odds ratio, standard error, and beta weights will be reported 
 96 
for each predictor. The classification table results will be used to determine the success of 
the overall model, compared to the model with no predictors.  
Specific aim 3. To compare long-term mammography adherence rates and 
the Behavioral Model variables that differ between and among ethnicities for 
women in the same age strata.  Logistic regression will be used to compare long-term 
mammography adherence rates and the relationship with Behavioral Model variables 
(independent variables) on mammography adherence (dependent variable). Two separate 
models will be created and tested:  1) long-term/biennial; and 2) long-term/annual. Long-
term adherence will be recoded as adherent (yes or no).  Logistic regression will allow 
modeling the probability of each of the Behavioral Model variables on long-term 
mammography adherence by ethnicity (African American, White, and Hispanic). Logistic 
regression statistical technique as described with Specific Aim 2 will be followed.  The 
coefficient for the variable would indicate an up or down likelihood of long term 
adherence within the strata ethnicity.    
Specific aim 4.  To identify and describe the relationship of individual breast 
cancer risk on mammography adherence.  Independent group t-tests will be used to 
analyze the relationship between Gail risk score and mammography adherence; determine 
if the Gail risk scores are significantly related to mammography adherence.  Independent 
group t-tests will be used to calculate the mean Gail risk score for each of the four 
groups:  1) short-term/ biennial; 2) short-term/annual; 3) long-term/biennial; and 4) long-
term/annual. Adherence will be recoded as yes/no.  A t statistic, degrees of freedom, and 
confidence intervals will be calculated. Assumptions of the test will be verified to ensure 
that they are met:  normal distribution validated, sample independently measured, and 
 97 
homoscedasticity.  Levene’s test for equality of variances will be conducted to generate 
the F statistic to determine if sample variances are equal.  An alpha of 0.05 will be used 
to define the significance.  
Descriptive statistics will be used to describe the sample distribution (i.e. sample 
size, central tendencies, and mean), compare, and characterize the sample. The mean and 
range will be used to describe the ratio variables. Tables will include all variables with a 
description of the sample.  Although the large size of the sample will help minimize a 
Type II error and adequately enhance the study’s power, an online power calculator will 
be used to calculate the study’s power. The effect size will also be calculated using 
Cohen’s guidelines for a moderate effect.   
3.6.8 Study Limitations 
 The large sample size of the data does provide some advantage to the study.  
Despite this, the study does have potential limitations.  The retrospective secondary data 
design of the study, and the self-reporting of the data in the parent study, all present study 
limitations.   Self-reporting relies on the study participant’s recall of events, medical tests, 
etc., which present recall and accuracy challenges.  Despite this, the validity of self-
reporting is continuously noted as an effective and efficient method to obtain reliable 
information (Caplan, Mandelson, Anderson, & Health Maintenance, 2003; Caplan, 
McQueen, et al., 2003; Cronin et al., 2009).  Results of a study by Caplan and colleagues 
to validate women’s self-report of cancer screening using a national survey tool, was 
highly sensitive for assessing adequate rates (Caplan, McQueen, et al., 2003).  In that 
study, they compared Behavioral Risk Factor Surveillance System (BRFSS) self-report 
responses and medical record information, which agreed 95% of the time. In another 
 98 
study by Caplan, Mandelson, and Anderson (2003), self-report rates exceeded medical 
record verification rates, which also indicated that self-report could also overestimate 
mammography utilization within a certain time frame. Other limitations may be identified 
during actual analysis of the data.  
 Use of the Gail risk score present study limitations surrounding its validity and 
accuracy in other ethnicities aside from White, Asian, and Pacific Islander women.  
Although the tool has been tested and performs well in African American women, it may 
underestimate their risk if they have had previous biopsies (Gail et al., 2007; National 
Institute of Health, 2011).  Since the model has not been validated for Hispanic women 
and other ethnicities, it does not provide a good estimate of breast cancer risk in these 
populations, which could impact current study results (National Institute of Health, 
2011).  The tool is also not the most appropriate to use for women who have breast 
cancer-producing mutations or hereditary conditions that increase a woman’s risk for 
breast cancer, as it can underestimate their risk (Euhus, Leitch, Huth, & Peters, 2002; 
National Institute of Health, 2011). The Gail risk score also present challenges of 
adequate genetic risk estimation, as it does not consider family history of ovarian cancer, 
second-degree relatives affected by cancer, nor paternal family history of cancer 
(American Cancer, 2013a; Gail et al., 1989; Millstine et al., 2014; National Institute of 
Health, 2011). 
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3.7 Human Protections and Planned Actions 
 This secondary data analysis study is exempt from full review by the Institutional 
Review Board. After going to the IRB, and the proposal is defended in Mar 2015, the 
following actions are planned: 
 Access public-use data and clean and recode the data set;   
 Program and Run the analysis using a statistical software package; 
 Analyze the data and synthesize the findings; and 
 Write up the study findings and results manuscript. 
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CHAPTER 4 
RESULTS MANUSCRIPT 
4.1 Introduction to Manuscript 
 This chapter is presented as a results manuscript that will eventually be submitted 
for publication.  The abstract has been formatted for journal submission. The remainder 
of this chapter has not been formatted for journal submission; therefore, it is longer than 
what would be provided for publication.  
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4.2 Abstract 
Introduction:  This study assessed predictors and rates of recent and long-term 
mammography utilization for women 43-79 years of age to better understand differences 
among age strata and races.  This was the first study to use Gail Risk scores from the 
2010 National Health Interview Survey (NHIS) and the homelessness variable in 
predicting mammography using national-level data.   
 
Methods:  A cross-sectional analysis of NHIS data. Using logistic regression, N= 6,334 
was used to examine mammography differences (African American (AA), Non-Hispanic 
White, and Hispanic), with focus on younger AA. Wald F test statistics with two-sided p-
values <.05 and odds and adjusted ratios used. 
 
Results:  AA had highest (79.3%) of lowest risk Gail Risk scores, while Whites had 
highest (30.7%) of highest risk Gail Risk scores. Women in the 50-64 strata had greater 
odds of both recent, Wald F(2, 299)=7.52, p<0.01 and long-term,Wald F(2, 299)=38.04, 
p<0.01. Whites had 0.62 adjusted odds ratio (AOR) (95% CI, 0.46-0.83) for recent, and 
0.76 AOR (95% CI, 0.59-0.99) for long-term. Homelessness and transportation were not 
predictors for adjusted recent model, while only transportation was not a predictor for 
long-term. AA long-term utilization were consistent with long-term utilization for all 
three races together with older two age strata with higher odds (50-64 strata: 1.80 odds 
ratio (OR) (95% CI, 1.24-2.62) and 65-79 strata: 1.75 OR (95% CI, 1.18-2.59)). 
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Conclusion: Risk assessment and mammography are vital prevention modalities. It is 
important for women to know their risk and for continued evaluation of predictor 
interactions to improve mammography knowledge and practice.  
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4.3 Introduction 
Despite advances in care and treatment, health disparities persist in breast cancer, 
most notably in relation to race (Desantis, Ma, Bryan, & Jemal, 2013; DeSantis, 
Naishadham, & Jemal, 2013).  Women of color, and specifically African American 
women, disproportionately shoulder later-stage diagnosis and breast cancer mortality 
(American Cancer Society, 2016b; Amirikia, Mills, Bush, & Newman, 2011; Sassi, Luft, 
& Guadagnoli, 2006; Vona-Davis & Rose, 2009).  Research suggests that this health 
disparity can be attributed to multiple causes, to include socioeconomic, structural, 
cultural, biological, intrapersonal, and interpersonal factors (American Cancer Society, 
2016b; Jerome-D'Emilia, 2015; Mishra, DeForge, Barnet, Ntiri, & Grant, 2012; Sturtz, 
Melley, Mamula, Shriver, & Ellsworth, 2014; Vona-Davis & Rose, 2009; Watson-
Johnson et al., 2011).  Screening mammography, although controversial, is an important 
intervention in mitigating this breast cancer health inequity (Conway-Phillips & Millon-
Underwood, 2009; D. A. Freedman, Petitti, & Robins, 2004; Oeffinger et al., 2015; Siu, 
Bibbins-Domingo, Grossman, LeFevre, & Force, 2016; Smith, 2014) .  
 Overall, breast cancer remains the second leading cause of cancer death among 
women in the United States (American Cancer Society, 2015, 2016a, 2017).  
Mammography is one facet of secondary cancer prevention that if routinely utilized, may 
decrease breast cancer mortality in some women (American Cancer Society, 2015; D. A. 
Freedman et al., 2004; Hale & deValpine, 2014; Oeffinger et al., 2015; U.S. Preventive 
Services Task Force, 2016).  Mammography screening for women in their 40s has 
undergone extensive scrutiny lately, as to its effectiveness and commencement age; 
recent consensus from the American Cancer Society (ACS) and the U.S. Preventive 
Services Task Force (USPSTF) is to begin screening for women in their 40s should be 
 133 
based on their individual risk factors (Ford et al., 2015; Hellquist et al., 2011; Siu et al., 
2016; U.S. Preventive Services Task Force, 2016). These differences in mammography 
screening guidelines have caused ambiguity for women in their 40s (Calvocoressi, Sun, 
Kasl, Claus, & Jones, 2008; Gierisch et al., 2009; Passmore, Williams-Parry, Casper, & 
Thomas, 2017).   Irrespective of the guideline followed, there is clear evidence 
mammography remains a vital component of early breast cancer detection (Coldman et 
al., 2014; Duffy et al., 2010; Ford et al., 2015; Shapiro, 1977; Smith, 2014; Weedon-
Fekjaer, Romundstad, & Vatten, 2014).     
Although women 50 and older have a higher probability of getting the disease 
(Bjurstam et al., 2003; Moss et al., 2006; Siu et al., 2016), women in their 40s get breast 
cancer in alarming numbers (23% diagnosed), and an estimated 13% die from the cancer 
(American Cancer Society, 2015; Bjurstam et al., 2003; Moss et al., 2006; Ooi, Martinez, 
& Li, 2011; Siu et al., 2016; van Ravesteyn et al., 2012).  African American women in 
their 40s in particular, shoulder a significant burden of the disease mortality (4% of 
African American vs. 2% for Non-Hispanic White women), and it is acknowledged that 
more research is needed that will allow greater understanding of breast cancer disparities 
and mammography practices (American Cancer Society, 2015; Carey et al., 2006; 
Foulkes, 2008; Jatoi & Anderson, 2010b; Pal et al., 2015; Rawl, Champion, Menon, & 
Foster, 2000; Surveillance, 2017).  Specifically, research in understanding mammography 
utilization decisions, behaviors, and key predictors in women in their 40s, with special 
attention to women of color , is essential to advancing breast health (Breen & Meissner, 
2005; Kidd, Colbert, & Jatoi, 2015; Kindig & Stoddart, 2003; Ray, Joe, Freimanis, 
Sickles, & Hendrick, 2017). The purpose of this study was to examine recent and long-
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term mammography utilization in women 43-79 years of age, guided by a unique model 
using vulnerable population domains, with specific emphasis on African American 
women in their 40s using nationally representative 2010 National Health Interview 
Survey (NHIS) data. 
4.4 Background 
Breast cancer is the leading site of new cancer cases and the second leading cause 
of cancer death for African American women (American Cancer Society, 2016b, 2017; 
Oeffinger et al., 2015; Smith, Brooks, Cokkinides, Saslow, & Brawley, 2013).  Although 
White women generally have a higher incidence of breast cancer, African American and 
other women of color shoulder a disproportionate disease burden, with higher mortality 
from the disease (American Cancer Society, 2015; Amirikia et al., 2011; Surveillance, 
2017).  Of the four main molecular subtypes of breast cancer, 12% are referred to as 
triple-negative (ER-, PR-, and HER2-), an aggressive form of cancer with poorer 
prognosis, which is almost twice as common in African Americans than in other races 
(American Cancer Society, 2015; Amirikia et al., 2011; Carey et al., 2006).  Carey et al. 
(2006) in their analysis of the Carolina Breast Cancer Study found that these basal-like 
cancers were more prevalent among premenopausal African American women (39%), 
compared to postmenopausal African American women (14%) and non-African 
American women (16%). Higher breast cancer mortality seen in younger African 
American women (in their 40s and younger) is due in large part to aggressive tumor 
morphology, while other causes for higher cancer mortality in racial and ethnic women of 
color can be attributed to obstacles in cancer prevention and detection (American Cancer 
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Society, 2016b; Bjurstam et al., 2003; Carey et al., 2006; Conway-Phillips & Millon-
Underwood, 2009; Smith et al., 2013).   
Screening mammography has been used in the United States as a mass population 
screening intervention since the 1960s to detect the presence of breast cancer, facilitating 
early treatment and cure (Shapiro, 1977, 1997; Shapiro, Strax, & Venet, 1966). The 
controversy surrounding mammography has centered on its benefit versus harm, 
particularly in women in their 40s (Kerlikowske, 2012; Passmore et al., 2017; van 
Ravesteyn et al., 2012). The preponderance of randomized clinical trial evidence purports 
that women who might begin screening in their 40s would not see benefit until 12-14 
years later (Bjurstam et al., 1997; Elwood, Cox, & Richardson, 1993; Miller, To, Baines, 
& Wall, 2002; Nystrom et al., 1993; Tabar et al., 1995; Tabar et al., 1996).  Other issues 
surrounding mammography include concerns due to false positives, unnecessary testing 
and biopsies, low-dose radiation exposure, over diagnosis, and increased lead time 
(Beemsterboer, Warmerdam, Boer, & de Koning, 1998; Bleyer & Welch, 2012; Jatoi & 
Anderson, 2010a; Loberg, Lousdal, Bretthauer, & Kalager, 2015). 
Breast cancer is a heterogeneous disease with a complex morphology, and does 
present different among women causing breast cancer disparities due to screening, 
incidence, mortality, and treatment (American Cancer Society, 2015; Carey et al., 2006; 
Jatoi & Anderson, 2010b; Kidd et al., 2015; Rao, Breen, & Graubard, 2016; White et al., 
2017). Reasons for this breast cancer disparity are not fully identified, but research 
suggests it may partly be attributed to modifiable risk factors—differences in breast 
cancer knowledge about risk, attitudes, and mammography behavior (Champion et al., 
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2004; Conway-Phillips & Millon-Underwood, 2009; Samson, Porter, Hurley, Adams, & 
Eberth, 2016; Schueler, Chu, & Smith-Bindman, 2008; Watson-Johnson et al., 2011).   
Current guidelines suggest different mammography commencement ages and 
intervals (e.g. ACS, USPSTF), with constant re-evaluation surrounding its net benefit 
versus harms for women 40-49 years of age (Ray et al., 2017; Siu et al., 2016; Siu & 
Force, 2016; Smith et al., 2013).  Updated screening guidelines now advocate women 
understanding their individual breast cancer risk, informing screening commencement 
and continued adherence (Siu et al., 2016; U.S. Preventive Services Task Force, 2016; 
van Ravesteyn et al., 2012; Wu, Grabaud, & Gail, 2012). 
4.4.1 Mammography Utilization 
Recent mammography utilization refers to having had a mammogram in the past 
1-2 years (Clark, Rakowski, & Bonacore, 2003). Once women begin screening, and have 
a recent screening mammogram, they have greater odds of continuing with screening 
(Breen & Meissner, 2005; Gonzalez et al., 2012).  Long-term mammography utilization 
has oftentimes been described as continuing with on-schedule screening past the first 
screening (Clark et al., 2003; Gierisch et al., 2010; Greene, Torio, & Klassen, 2005; 
Rakowski et al., 2006; Vernon et al., 2008).  Although assessing recent mammography is 
important, assessing mammography over extended periods of time provides a much better 
gauge to evaluate health improvement (Breen & Meissner, 2005; Clark et al., 2003; 
Kindig & Stoddart, 2003; Kindig, 2007; O'Neill et al., 2008). 
4.4.2 Key Mammography Utilization Predictors and Barriers 
Research has identified certain variables as important mammography predictors 
(factors that favorably influence an action occurring) and/or barriers (factors that 
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favorably inhibit an action occurring).  Despite repeated testing of many variables, there 
are conflicting results surrounding their statistical significance and association to 
mammography.  Even with the conflicting study findings, there are several key variables 
that have been identified as fundamental to monitoring disparities in cancer burden and 
screening differences—age (Duffy et al., 2010; Feldstein et al., 2011), race (American 
Cancer Society, 2016b; Amirikia et al., 2011; Smith et al., 2013; Wilson et al., 2009), 
socioeconomic status (i.e. income, health insurance, education, living conditions), and 
access to care (American Cancer Society, 2016b; Buki, Jamison, Anderson, & Cuadra, 
2007; Feldstein et al., 2011; Watson-Johnson et al., 2011; Young, Schwartz, & Booza, 
2011).  Barriers to mammography utilization and adherence in African American women 
include: cultural attitudes (Conway-Phillips & Millon-Underwood, 2009; Watson-
Johnson et al., 2011), healthcare access (O'Malley, Forrest, & Mandelblatt, 2002; 
Schueler et al., 2008) , socioeconomic status (Hiatt & Breen, 2008; Purc-Stephenson & 
Gorey, 2008; Welch, Miller, & James, 2008), cost , failure of health provider to 
recommend mammography, lack of insurance (Gierisch et al., 2009; Schueler et al., 
2008), cancer fear (Young et al., 2011), mammography misconception, and health 
provider trust (Conway-Phillips & Millon-Underwood, 2009; Hiatt et al., 2001; O'Malley 
et al., 2002; O'Malley, Sheppard, Schwartz, & Mandelblatt, 2004; Ooi et al., 2011). 
4.4.2.1 Age 
There are conflicting reports on whether or not age is a predictor of 
mammography utilization (Augustson, Vadaparampil, Paltoo, Kidd, & O’Malley, 2003; 
Nash, Chan, Horowitz, & Vlahov, 2007; Phillips, Kerlikowske, Baker, Chang, & Brown, 
1998; Russell, Champion, & Skinner, 2006).  A number of studies found that women 50-
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74 years of age are more adherent to mammography screening in comparison to women 
in their 40s (Calvocoressi et al., 2004; Nash et al., 2007; Rakowski et al., 2006).  Other 
studies have indicated that women in their 40s adhere to screening more often than 
women 50 years of age and older (Calvocoressi et al., 2004; Calvocoressi et al., 2008; 
Finney, Tumiel-Berhalter, Fox, & Jaen, 2006; Hiatt, Klabunde, Breen, Swan, & Ballard-
Barbash, 2002; Rawl et al., 2000).  As mammography behaviors differ among diverse-
age women, it is important to continuously explore age as a predictor in mammography 
utilization. 
4.4.2.2 Race/ Ethnicity 
Race/ethnicity has been examined extensively in past studies as a predictor 
variable (Breen et al., 2011; Calle, Flanders, Thun, & Martin, 1993; Carey et al., 2006; 
Chagpar, Polk, & McMasters, 2008; Gierisch et al., 2009; Jepson et al., 2000), with 
conflicting reports.  In a meta-analysis by Purc-Stephenson and Gorey of mammography 
adherence articles from 1990-2006, the authors found evidence suggesting that screening 
differences persist among ethnic women of color—African American and Hispanics were 
screened less than Whites (African American: OR.87, 95% CI 0.75; Hispanic: OR0.65, 
95% CI 0.50, 0.85) (2008).  However, when controlling for socioeconomic status, ethnic 
differences were no longer significant. Similarly in other studies, mammography did not 
differ by race (Calvocoressi et al., 2008; Gierisch et al., 2009).  
In Rakowski and colleague’s study of correlates of repeat mammography in 
women 45-75 years of age using 2003 Health Information National Trends Survey data, 
race was not statistically significantly associated with repeat mammography (Rakowski et 
al., 2006). Conversely, Lopez, Khoury, Dailey, Hall, and Chisholm found in their study 
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of characteristics of current, overdue, and never screeners in the south that race was a 
statistically significant mammography barrier for African Americans (2009). In studying 
the impact of age and race on mammography practices, Rawl, Champion, and Menon, did 
find significant interaction between age and race (2000), as did Wu, Hsieh, and West in 
their study Among Asian-American women (2008).  Since breast cancer may present 
differently in women of different ethnicities, it is paramount to explore mammography 
behavioral practice differences by race within the evolving structure of expanded 
interactions and technologies (Gelberg, Andersen, & Leake, 2000; Jatoi & Anderson, 
2010b; Phillips et al., 1998; Rawl et al., 2000). 
4.4.2.3 Breast Cancer Risk Assessment 
Recent mammography screening guideline changes by both the ACS and the 
USPSTF in 2015 promote the need for women to individually assess their breast cancer 
risk (Anderson, 2010; Oeffinger et al., 2015; Siu et al., 2016).  This approach better 
informs women and their health providers of the optimal screening commencement age 
and interval (Maas et al., 2016).  Although risked-based assessments are not widely used 
as of yet, in a study by Schapira et al. assessing practice-based systems to support breast 
and cervical cancer screening, 60.5% of providers routinely assessed breast cancer risk; 
yet only 21% used a breast cancer risk calculator (2016).  Several risk calculators are 
available online, such as the Breast Cancer Risk Assessment Tool/ Gail model or the 
Tyrer-Cuzick (IBIS) model (Amir et al., 2003; Amir, Freedman, Seruga, & Evans, 2010; 
Gail et al., 1989; Graubard, Freedman, & Gail, 2010).   
The Gail model calculates a woman's Gail risk score—her absolute risk of breast 
cancer over successive intervals of time, and is based on various factors including current 
 140 
age, race, age at first live birth, age at menarche, family history of breast cancer, genetic 
predisposition for breast cancer, and number of breast biopsies (Banegas, Leng, 
Graubard, & Morales, 2013; Euhus, Leitch, Huth, & Peters, 2002; Gail et al., 1989; Gail 
et al., 2007).  Women who know they have an elevated risk of breast cancer are more 
adherent to mammography (Anderson, 2010; Hiatt et al., 2002; Jepson et al., 2000; 
Rakowski et al., 2004).  Women with an elevated Gail risk score are potentially eligible 
for chemoprevention to lower their risk (Freedman et al., 2003).  Gail risk scores use a 
functional combination of risk factor variables to obtain a meaningful probability 
summary of individual absolute risks that a woman may get breast cancer over a set 
period of time (5 yr, 10 yr, 20 yr, or a lifetime) (Banegas et al., 2013; Freedman et al., 
2003; Gail et al., 1989; Gail et al., 2007; Maas et al., 2016; National Institute of Health, 
2011). 
4.4.2.4 Homelessness 
Those faced with homelessness have significant barriers to preventive services 
while also having increased prevalence of most cancer risk factors, which leads to lower 
cancer screening rates (Chau et al., 2002; Heyding, Cheung, Mocarski, Moineddin, & 
Hwang, 2005).  Homelessness can lead to less concern about preventive services and 
greatest concern on basic necessity challenges (e.g. food, shelter) (Austin, Andersen, & 
Gelberg, 2008; Gelberg et al., 2000; Moxley & Washington, 2016; Ritchey, La Gory, 
Fitzpatrick, & Mullis, 1990). 
4.4.2.5 Income 
There is some evidence of a relationship between high poverty and aggressive 
tumors, particularly in younger African American women (Andaya et al., 2012; Bao, Fox, 
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& Escarce, 2007; Chagpar et al., 2008).  Access to health care resources and greater 
utilization of those resources have been directly correlated to higher income (Adams et 
al., 2009; Anderson & Jakesz, 2008; Bao et al., 2007; Choi, 2011). 
4.4.3 Theoretical Model 
The Behavioral Model for Vulnerable Populations (BMVP) guided this study.  
The BMVP is an adaptation of the original Behavioral Model of Health Services Use 
(BM), designed to describe how families and individuals use health services (Aday & 
Andersen, 1974; Andersen, 1995; Evans & Stoddart, 1990). The BMVP was adapted 
from the BM to uniquely include and garner a better understanding of vulnerable 
population domains. The BMVP, though conspicuously different than the BM, contains 
three main elements:  population characteristics, health behaviors, and health outcomes 
(Gelberg et al., 2000).  Gelberg et al. (2000) originally tested the BMVP in a prospective 
study with people who were homeless, identifying predictors of health service utilization 
and physical health outcomes.  According to Gelberg et al., results of this vulnerable 
population study indicated the health status for the four health outcomes improved over 
time, and were predicted by a number of variables, most prominently having access to 
care. Gelberg et al. noted the major differences between the BM and the BMVP are the 
addition of vulnerable population domains (i.e., homelessness, criminal behavior, 
transportation, vulnerable population health conditions, etc.), and ability to consider the 
impact of utilization on health status outcomes.   
Population characteristics are individual determinants that predict personal health 
practices, and are divided into predisposing, enabling, and need factors (Andersen, 1995; 
Gelberg et al., 2000).  Predisposing factors describe how individuals use services and 
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include demographic factors (i.e. age, gender, and marital status, etc.), health beliefs, and 
social structure (i.e. living conditions, race, social networks, homelessness, etc.) (Gelberg 
et al., 2000).  Enabling factors impede or facilitate one’s ability to use health services, 
and include one’s personal and family resources (i.e. regular source of care, insurance, 
income, transportation, social support, etc.) (Gelberg et al., 2000).  Need factors include 
an individual’s self-perception and objective evaluation of their health, as well as a 
vulnerable population’s health condition (Gelberg et al., 2000).  According to Gelberg et 
al., health behavior variables include one’s personal health practices.   
The BMVP has guided studies examining correlates and predictors of adherence 
to cervical and breast cancer screening in women of color, to include African American 
women (Bazargan, Bazargan, Farooq, & Baker, 2004; Gonzalez et al., 2012; Owusu et 
al., 2005).  Additionally, the BMVP has guided studies exploring racial differences in 
vulnerable populations, identifying contributing factors to health behaviors (Austin et al., 
2008; Bazargan et al., 2004; Gelberg et al., 2000; Harcourt et al., 2013).  Using the 
BMVP, having a regular source of care, affordability, sticking to other preventive 
services, and race were shown to be principle correlates and/or predictors in cervical and 
breast cancer screening adherence (Bazargan et al., 2004; Gelberg et al., 2000; Gonzalez 
et al., 2012; Harcourt et al., 2013; Owusu et al., 2005).  Using the model, socioeconomic 
characteristics, access barriers, and women of color have also shown to be barriers to 
cervical and breast cancer screenings (Fernandez & Morales, 2007; Owusu et al., 2005). 
Although great strides have been made using the BMVP, research results suggests 
that comprehensive identification of factors is needed to better understand the complex 
role of race in health utilization and cancer screening (Austin et al., 2008; Bradley et al., 
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2002; Breen & Meissner, 2005; Harcourt et al., 2013; Owusu et al., 2005).  Due to the 
model’s sound applicability for utilization across ethnicities in vulnerable populations, 
and in evaluating predictors of cancer screening in women, it had reliable utilization in 
evaluating the relationships between the study variables.  A modified BMVP was used to 
guide this study (Figure 4.1). The modified BMVP emphasizes vulnerable population 
domains, with collective predictive effects of predisposing, enabling, and need factors on 
mammography utilization. 
 
 
 
 
4.5 Research Design and Methods 
The purpose of this study was to examine recent and long-term mammography 
utilization predictors for women 43-79 years of age to better understand differences 
Figure 4.1.  Behavioral Model for Vulnerable Populations with study variables, from “The 
Behavioral Model for Vulnerable Populations:  Application to Medical Care Use and 
Outcomes for Homeless People,” by L. Gelberg, R. Andersen, and B. Leake, 2000, Journal 
of Health Services Research, 34:6, p. 1278. 
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among and between age groups and races that may contribute to the breast cancer health 
disparity.  Four research questions were examined: (1) Are there differences in recent and 
long-term mammography utilization for African American women by age strata: 43-49, 
50-64, and 65-79? (2) Are the predisposing (age, race, marital status, Gail risk score, and 
homelessness), enabling (regular source of care, income, transportation, and health 
insurance) and need (perceived health status) variables associated with recent and long-
term mammography utilization? (3) Do the model variables associated with recent and 
long-term mammography utilization differ by race for women in the same age strata? and 
(4) Does Gail risk score on recent and long-term mammography utilization differ by 
race?  
This is the first study to test the 2010 NHIS Gail risk score, and homelessness in 
predicting mammography utilization using national-level data. Because this study 
specifically focuses on younger women aged 43-49 and African American women, 
African American women and women 43-49 years of age were used as reference groups 
for most of the analysis.  Because this study used secondary analysis of existing de-
identified public use data, the study was deemed exempt from human protections review.   
 This is a hypothesis-driven cross sectional analysis of the 2010 NHIS data. The 
NHIS is a nationwide multi-purpose health survey of civilian non-institutionalized 
households of the United States, conducted by the US Census Bureau (Ackermann & 
Cheal, 1994; Center for Disease Control and, 2011a, 2011b, 2012). The 2010 NHIS 
included a Cancer Control Supplement, which asks questions on cancer control, and is 
administered every five years (Center for Disease Control and, 2011a).  The 2010 NHIS 
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data was used because, at the time of the study, 2015 NHIS data had not been released 
and Gail risk were not calculated for the 2015 data.   
The 2010 NHIS oversampled both African Americans and Hispanics to better 
estimate health and disease in this population (Center for Disease Control and, 2011b).  
Information was gathered on socio-demographics, general health, mobility and function, 
health behaviors, health insurance, and health care utilization (2011b; Parsons et al., 
2014). Participants provided informed consent to participate in the survey. The NHIS 
data represents a statistically representative sample of the US population, which allows 
greater generalization of research study results (Centers for Disease Control and, 2012; 
Hiatt et al., 2002).  For the 2010 NHIS, there were 34,329 households interviewed 
(89,976 persons in 35,177 families), with an annual response rate of 90% (Center for 
Disease Control and, 2011a, 2011b).  The initial population of N=27,157 was used, as 
questions selected for this study were only asked of sample adults using Person-Level 
and Family-Level data. 
   All men and women who had reported a history of cancer were excluded from the 
NHIS adult population for the study sample. Figure 4.2 illustrates the sample selection 
steps. Women who refused to answer, who did not know if they ever had a mammogram, 
when their most recent mammogram occurred, or the number of mammograms they had 
in the past six years were excluded from the final sample. The final analytic sample 
consisted of N=6,334, which only included women ages 43-79, who were non-Hispanic 
African American, Non-Hispanic White, and Hispanic, with no history of breast cancer.  
Sample race/ ethnicity groups limited to the three included groups, due to the Office of 
Management and Budget requirements on race classifications and because the sample 
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size of the other minority groups was not homogenous; they included an extremely small 
proportion of the total U.S. population. Of this final sample, 1,141 were Non-Hispanic 
African American women, referred to as African American women throughout the study. 
 
 
4.5.1 Variables 
Table 4.1 shows the 10 independent study variables (predisposing, enabling and 
need), the two dependent variables, and the NHIS question(s) used to conceptualize and 
operationalize each variable. 
 
 
Figure 4.2. Derivation of Analytic Sample.  
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Table 4.1 Source and Definition of Independent and Dependent Variables 
 
 
Variable NHIS Question Study Operational Definition 
Predisposing 
   Age What is your age/ how old are you?        
RECODE into: Under 1 yr; 1 - 84 yrs; 85+ yrs
Groups:  43 - 49 yrs;  50 - 64 yrs;  65 - 79 yrs   
   Race* Do you consider your self Hispanic?  What 
race or races do you consider yourself to be? 
(chose one or more out of 16 choices).                
RECODE into:  Hispanic; non-Hispanic White; 
non-Hispanic Black; non-Hispanic Asian; non-
Hispanic All other races
Hispanic                                                                  
Non-Hispanic White                                             
Non-Hispanic Black/ African American           
*Race and Ethniticity used interchangably
   Marital Status Are you married, widowed, divorced, 
separated, never married, or living with a 
partner?
Married:  Living with a spouse or partner in 
household                                                               
Not-Married:  all other
   Gail Risk Score Calculated using answers to various questions:  
age; age when first child was born; total 
number of live births, ever had breast cancer, 
mother ever had breast cancer, number of 
sisters diagnosed with breast cancer; number 
of lumpectomies; age at first menarche; numer 
of first degree female relatives known to have 
breast cancer; ever had a hysterectomy; had 
non-cancerous breast lump removed; total 
number of biopsies; weight/ body mass index; 
and sociodemographic factors
A 5-year Gail risk score of equal to or greater than 
1.67% was targeted, as women with this score are 
considered high-risk and eligible for 
chemoprevention to lower their risk.  Women 
with a score less than 1.67% are not considered 
to have an elevated 5-year risk.
   Homelessness Have you ever spent more than 24 hours living 
on the streets, in a shelter, or in jail or prision?
Spent > 24 hours living on streets, in shelter, or in 
jail or prison: Yes/No
Enabling
   Regular Source of Care Is there a place that you usually go to when 
you are sick or need advice about your health?
Regular source of care:  Yes/No                        
   Income What is family income, family size, number of 
kids in household under 18 yrs? Ratio of family 
income to poverty threshold calculated using 
calendar year 2009 weighted federal poverty 
threshold. Five categories established.
Ratio of family income to poverty threshold (PT). 
Poverty threshold set annual expenditure amount 
below which a family is considered poor.  
Categories indicate income/ resources are a 
numerical value times (below or above) the 
poverty threshold.  $13,000 used for PT for family 
of two.                                                                           
< 1  - below poverty threshold                                  
1  - < 2  - between 1 & 1.99 times PT (poor)               
2  - < 3  - between 2 & 2.99 times PT                          
3  - < 4  - between 3 & 3.99 times PT                         
4 or more - 4 or more times PT (highest)
   Transportation Have you delayed getting health care in the 
past 12 mths because you did not have 
transportation?
Transporation delays:  Yes/No        
   Health Insurance Are you covered by any kind of health 
insureance or some kind of health plan? 
RECODE: Covered or Not Covered 
Had insurance: Covered                                        
Did not have insurance:  Not-Covered
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4.5.1.1 Predisposing Variables 
Women 43-79 years of age were included. The younger 40-42 year old women 
would not have had an opportunity to have more than one mammography, and therefore 
would not have met the long-term mammography utilization criteria. The 79 age limit 
was chosen to reflect the older age throughout the time women might continue 
mammography, as mammography declines are seen after age 74 (Breen, Feuer, Depuy, & 
Zapka, 1997; Buchbinder et al., 2016; Oeffinger et al., 2015; Rakowski et al., 2004; Siu 
et al., 2016).  For purposes of this study, race and ethnicity are used interchangeably.  
Following the Office of Management and Budget classification of federal data on race 
and ethnicity, and ensuring that the three ethnicities of were included, the study only 
included Non-Hispanic African American, Non-Hispanic White, and Hispanic (Register, 
1997; Williams & Jackson, 2000).   
The 5-year Gail risk scores for the 2010 data were calculated separately from 
information women provided to interviewers. Participants were not informed of their Gail 
Variable NHIS Question Study Operational Definition 
Need
   Perceived Health Status Would you say your health in general is 
excellent, very good, good, fair, or poor?
Excellent/very good/good  OR Fair/poor
Dependent Variables
   Recent Mammography Have you ever had a mammogram? If so, when 
was your most recent mammogram?
RECENT:  Had a mammogram 2yrs ago or less.                                                                         
NOT RECENT: Had a mammogram more than 2 
yrs ago.
   Long-Term Mammography Have you ever had a mammogram?  If so, how 
many mammograms have you had in the last 6 
years?  
Adherent to long-term mammography if had 3 or 
more mammograms in the past 6yrs.
Note.  Study variables identified using a modified Behavioral Model for Vulnerable 
Populations by L. Gelberg, R.M. Andersen, and B.D. Leake, 2000, Health Services 
Research Journal, 34:6, p. 1280. 
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risk score when responding to the survey questions (Banegas et al., 2013; Graubard et al., 
2010). A 5-year Gail risk score >= 1.67% was high risk, indicating a woman had an 
absolute risk of 1.67% or greater for having breast cancer in 5 years (Banegas et al., 
2013; Rakowski et al., 2004).  Even though age and race are used with other risk factors 
in computing the Gail risk score, simultaneously including these variables with the Gail 
risk in the analyses in this study as separate independent variables is not problematic 
because it will provide further adjustment for these variables.  Temporary homelessness 
was evaluated by assessing whether respondents had ever lived more than 24 hours in 
jail, prison, shelter, or in streets. 
4.5.1.2 Enabling and Need Variables 
The existence of a regular source of care was assessed by inquiring if women 
usually went to a certain place for healthcare when they were sick. To measure income, 
the federal poverty threshold was used (Center for Disease Control and, 2011b; 
Department of Health and Human, 2017).  Because of the historically high nonresponse 
rate for income (only 15-20% providing response), NHIS created five sets of imputed 
values for income using the multiple imputation method, which allows for the assessment 
of both variability of the imputation process along with the variability of the estimation in 
the standard errors and inferences.  For the 2010 data, $13,000 was used as the NHIS 
poverty threshold for a family of two (a least one member >= 65 years of age) (Center for 
Disease & Prevention, 2011). 
4.5.1.3 Dependent Variables/ Health Behavior 
Recent and long-term mammography utilization were evaluated based on the need 
to evaluate mammography trends and measure improvements as both a one-time behavior 
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and over time (Breen & Meissner, 2005; Hiatt et al., 2002; Rakowski et al., 2006; Russell 
et al., 2006). Operationalized definitions for the dependent variables reflected women as 
‘on schedule’ irrespective of their screening interval schedule used (annual or biennial). 
4.6 Analysis 
To avoid biased point estimates and standard errors due to the complex NHIS 
sample design, analysis was completed using SAS version 9.4, and SUDAAN version 
11.0.1. The study sample included 10 independent variables and two dependent variables 
(recent and long-term mammography utilization) shown in Table 1.  The 5-year Gail risk 
scores were previously calculated using questions from the 2010 NHIS data (Banegas et 
al., 2013). 
 Questions were used from the 2010 NHIS Person-Level and Family-Level data.  
Although the analytic sample size was 6,334, some participants were excluded from 
analysis if they had a missing value for any of the variables used in the statistical analysis 
modeling (except for income that is multiply imputed). Therefore, the sample size varied 
between 6,321 and 6,334, as outlined in Table 2.   
Frequency distributions were conducted on each variable to check for accuracy, 
missing data, and data consistency. The Taylor Linearization Method was used to 
compute standard errors that accounts for the complex survey design of the NHIS. 
Logistic regression was used to test for group differences (e.g., race/ethnicity) for specific 
outcome variables (e.g., recent mammography utilization) and to test for interactions 
between key independent variables and variables indicating group membership. Wald F 
test statistics that account for the NHIS sample weights and utilize the Taylor 
Linearization variance estimates were used for obtaining p-values of tests of hypotheses 
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for odds ratios (OR) and adjusted odds ratios (AOR) obtained from the logistic 
regressions. Two-sided p-values <0.05 that were not adjusted for multiple comparisons 
were used to determine statistical significance.  
For the income variable used in the analysis, all five sets of the imputed data for 
the income to poverty threshold were used. To quantify income variable results, multiples 
of the 2009 poverty threshold ($13,000 for a family of two) was used regardless of the 
woman’s family size (e.g. an income of 2 - <3 was 2.99 x $13,000). Unadjusted 
independent variables were evaluated using logistic regression. The resulting AORs for 
main effects are interpreted as the odds ratio holding all other independent variables 
constant. A comparison between the two models (unadjusted and adjusted) was done, 
assessing each variable’s impact on the dependent variables. 
4.7 Results 
Table 4.2 shows weighted percentages of the sample characteristics for the 10 
independent variables.  Ninety-five percent of Hispanics reported a 5-year Gail risk < 
1.67%, as compared to 69% of Whites and 79% of African Americans.  Sixteen percent 
of Hispanics reported no usual source of care, as compared to 7% of Whites and 8% of 
African Americans.  Twenty-six percent of Hispanics reported no health insurance, as 
compared to 9% of Whites and 15% of African American.  Thirty-nine percent of African 
Americans reported being married, compared to 67% of Whites and 61% of Hispanics. 
Forty-seven percent of Whites reported incomes of $51,870 or greater, as compared to 
23.1% of African American and 21% of Hispanics.  Seventy-three percent of women in 
the sample did not have an elevated 5-yr Gail risk score. 
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Table 4.2  
 
Sample  Characteristics 
  
(n = 6,334) 
      No. (%) 
AAa 
(n = 1,141) 
No. (%) 
White 
(n = 4,156) 
No. (%) 
Hispanic 
(n = 1,037) 
No. (%) 
Age Strata 
    43-49 yr 
    50-64 yr 
    65-79 yr 
 
1,523 (25.9) 
3,019 (49.3) 
1,792 (24.9) 
 
299 (28.7) 
551 (50.5) 
291 (20.7) 
 
885 (23.9) 
2,011 (49.8) 
1,260 (26.3) 
 
339 (36.1) 
457 (44.3) 
241 (19.6) 
Marital Status 
    Married 
    Not Married 
 
2,985 (63.2) 
3,339 (36.8) 
 
300 (38.9) 
838 (61.1) 
 
2,190 (67.3) 
1,960 (32.7) 
 
495 (60.7) 
541 (39.3) 
5-y Gail risk 
    >=1.67% 
    <1.67% 
 
1,668 (26.7) 
4,662 (73.3) 
 
257 (20.7) 
883 (79.3) 
 
1,352 (30.7) 
2,801 (69.3) 
 
59 (5.0) 
978 (95.0) 
Homelessness 
    Yes   
    No 
 
     213 (3.0) 
6,119 (97.0) 
 
58 (4.2) 
1,083 (95.8) 
 
137 (3.0) 
4,018 (97.0) 
 
18 (2.0) 
1,018 (98.0) 
Regular Source of Care 
    Yes 
    No 
 
5,787 (92.2) 
     547 (7.8) 
 
1,051 (92.3) 
90 (7.7) 
 
3,863 (93.5) 
293 (6.5) 
 
873 (83.6) 
164 (16.4) 
Incomeb 
    <1             ( < $13,000 ) 
    1 - < 2       ( < $25,870 ) 
    2 - < 3       ( < $38,870 ) 
    3 -  < 4      ( < $51,870 ) 
    4 or more  ( >= $51,870 ) 
 
   952 (10.4) 
1,300 (17.4) 
1,072 (16.2) 
   855 (14.6) 
2,155 (41.5) 
 
   279 (20.9) 
   304 (24.9) 
   197 (17.6) 
   136 (13.5) 
   225 (23.1) 
 
    395 ( 7.2) 
   703 (14.7) 
   699 (15.8) 
   608 (15.0) 
1,750 (47.4) 
 
    278 (21.5) 
    293 (27.8) 
    176 (17.0) 
    111 (12.8) 
    179 (20.9) 
Transportation Delay 
    Yes 
    No   
 
     210 (2.5) 
6,120 (97.5) 
 
       66 (5.5) 
1,075 (94.5) 
 
     100 (1.9) 
4,054 (98.1) 
 
        44 (3.6) 
    991 (96.4) 
Health Insurance 
    Yes 
    No 
 
5,497 (88.2) 
   824 (11.8) 
 
   976 (85.4) 
165 (14.6) 
 
3,750 (90.7) 
     395 (9.3) 
 
     771 (74.0) 
     264 (26.0) 
Perceived Health Status 
   Excellent/Very Good/Good    
   Fair/Poor 
 
5,060 (83.4) 
1,268 (16.6) 
 
790 (71.5) 
350 (28.5) 
 
3,503 (86.1) 
   648 (13.9) 
 
     767 (77.1) 
     270 (22.9) 
Note.  Study sample n = 6,321 – 6,334; six independent variables had missing responses or were not asked 
these questions; weighted percentages shown. Yr = Year. 
aAA = African American. bIncome categories indicate income and resource ratio of family income to 
poverty threshold (PT) set as an annual expenditure; Yr 2009 PT of $13,000 for a family of two used, 
below which, a family was considered poor.  
 
 
Tables 4.3 and 4.4 provide mammography utilization frequencies, by age strata 
and race for the sample along with unadjusted logistic regression results. The logistic 
regression results in Table 3 show women in the 50-64 and 65-79 age strata had greater 
odds of both recent and long-term mammography utilization than women in the 43-49 
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age strata. Table 4 show Non-Hispanic White women had greater odds of long-term 
mammography utilization than African American women, while Hispanic women had 
lower odds of long-term mammography than African American women.  
Table 4.3 
Recent and Long-Term Mammography Utilization by Age Strata 
Age Strata Recent 
YES 
p<0.01 
%            n            OR          95% CI 
Long-term 
YES 
p<0.01 
 %            n           OR       95% CI 
43-49 yr (n=1,523)* 66.0 991 1.00        - 54.8 802 1.00        - 
50-64 yr (n=3,019) 72.8 2,149 1.38 1.17-1.63 69.9 2,069 1.92 1.65-2.23 
65-79 yr (n=1,792) 70.3 1,246 1.22 1.03-1.44 68.0 1,194 1.76 1.47-2.10 
TOTAL N=6334              4,386              4,065 
Note.  (*) Represents reference group. Weighted percentages shown. Statistically significant in 
boldface. CI= 95 % Confidence interval. OR= Unadjusted odds ratio. Yr = Year. Recent: women who 
had a mammogram within the last two years; Wald F(2,299=7.52, p<0.01. Long-term: women who 
had three or more mammograms over the past six years; Wald F(2, 299)=38.04, p<0.01. Total 
includes analysis for both yes and no for mammography utilization.  
 
 
Table 4.4 
Sample Characteristics:  Recent and Long-term Mammography Utilization by Race/ Ethnicity 
Race Recent 
YES 
p=0.09 
  %           n            OR          95% CI 
Long-term 
YES 
p<0.01 
  %              n          OR          95% CI 
Hispanic   (n=1.037) 67.1 686 0.88 0.73-1.07 56.6 597 0.78 0.63-0.95 
White       (n=3,019) 71.0 2,911 1.06 0.90-1.24 67.2 2,760 1.23 1.04-1.45 
AAa *           (n=1,792) 69.8 789 1.00        - 62.6 780 1.00        - 
TOTAL    N=6,334                 4,386                 4,065 
Note. (*) Represent reference group. Weighted percentages shown. Statistically significant in 
boldface. OR= Unadjusted odds ratio. CI=95% Confidence interval. Recent: women who had a 
mammogram within the last two years; Wald F(2, 299)=2.40, p=0.09. Long-term:  women who had 
three or more mammograms over the past six years; Wald F(2, 299)=19.43, p<0.01. Total includes 
analysis for both yes and no for mammography utilization. 
aAA = African American.  
 
4.7.1 African American Mammography Utilization Rates by Age Strata 
To determine if there were differences in mammography utilization rates for 
African American women by age strata, logistic regression results and recent and long-
term mammography utilization rates by age strata for African American women were 
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examined (Table 4.5).  Women in the older two African American age strata had greater 
odds of long-term mammography than women in the 43-49 age strata. Weighted 
percentages indicate 69.1% had recent mammography utilization and 62.1% had long-
term mammography utilization. 
Table 4.5 
 
African American Logistic Regression and Mammography Utilization Rates by Age Strata  
Age Group 
 
Recent 
p=0.12 
OR/ (95% CI) 
Recent 
YES 
(% / n) 
Long-term 
p<0.01 
OR/ (95% CI) 
 
Long-term 
YES 
(% / n) 
43-49 yr (n=299)* 1.00 - 64.8 194 1.00 - 52.8 148 
50-64 yr (n=551) 1.51 1.00-2.27 73.5 400 1.80 1.24-2.62 66.8 369 
65-79 yr (n=291) 1.15 0.77-1.71 67.8 195 1.75 1.18-2.59 66.1 191 
TOTAL n=1,141                                    69.1      789                                62.1      708 
Note. (*) Represent reference group. OR = Unadjusted odds ratio. CI = Confidence Interval. 
Statistically significant in boldface.  Weighted percentages shown. Yr = Year. Recent: women who 
had a mammogram within the last two years; Wald F(2, 299)=2.13, p=0.12.  Long-term:  women 
who had three or more mammograms over the past six years; Long-Term: Wald F(2, 299)=5.64, 
p<0.01. Total includes analysis for both yes and no for mammography utilization.  
 
4.7.2 Comparison of Unadjusted and Adjusted Model Variables  
To address research questions 2-4 examining the relationships between all or key 
predictor variables on  mammography utilization, logistic regression using the adjusted 
and unadjusted model variables to determine their relationship in predicting recent and 
long-term mammography utilization for the entire sample was performed. Using all 
model variables, Table 4.6 provides the logistic regression results for both recent and 
long-term mammography utilization without age stratification. The overall adjusted 
models for mammography utilization were statistically significant.  For the unadjusted 
recent mammography models, p values were statistically significant for all variables 
except race/ethnicity.  Table 4.6 more comprehensively evaluates the model variables’ 
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effect on mammography. Experiencing homelessness (p=0.12) and transportation delays 
(p=46) did not contribute to recent mammography significantly in the adjusted model; 
however, homelessness did contribute significantly in the adjusted model for long-term 
mammography utilization.  Transportation delays (p=0.21) also did not contribute 
significantly to long-term mammography utilization in the adjusted model.  
Race/ethnicity (p=0.09) was the only variable that did not contribute significantly to 
recent mammography utilization in the unadjusted model.  All variables contributed 
significantly to long-mammography utilization in the unadjusted model. 
4.7.3 Between Group Differences for Recent Mammography 
 Between group differences for recent mammography were further outlined in 
Table 4.6. Women in the 50-64 age strata had greater odds of recent mammography 
utilization than women in the 43-49 age strata in both the adjusted and unadjusted models 
(Table 4.6) (AOR: 1.28, OR: 1.38, p<0.01). Women in the 65-79 age strata only had 
greater odds of recent mammography utilization than women in the 43-49 age strata in 
the unadjusted model (OR: 1.22, p<0.01).  Racial differences were found in the adjusted 
model only, with Non-Hispanic White women having lower odds of recent 
mammography utilization than African Americans (AOR: 0.71, p<0.01).  There were 
similar statistically significant results of greater odds of recent mammography utilization 
in both the adjusted and unadjusted models for the following variables:  married (AOR: 
1.22, OR: 1.63 p<0.01); elevated Gail risk (AOR: 1.62, OR: 1.72, p<0.01); having a 
regular source of care (AOR:  3.28, OR: 5.51, p<0.01); having health insurance (AOR: 
2.91, OR: 5.00, p<0.01), and having an excellent/very good/good perceived health status 
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(AOR: 1.30, OR: 1.67, p<0.01).  Homelessness (OR: 0.43, p<0.01) and transportation 
delays (OR: 0.58, p<0.01) were only statistically significant in the unadjusted model, 
revealing lower odds of recent mammography utilization.  Each category of the income 
variable was statistically significant for both the adjusted and unadjusted models, with all 
having lower odds of recent mammography utilization than women in the highest income 
category. 
4.7.4 Between Group Differences for Long-Term Mammography 
 Between group differences for long-term mammography are also provided in 
Table 4.6. Women in the 50-64 age strata (AOR: 1.84, OR: 1.92, p<0.01), and 65-79 age 
strata (AOR: 1.30, OR: 1.76, p<0.01) had greater odds of long-term mammography 
utilization than women in the 43-49 age strata. Racial differences were found among 
adjusted and unadjusted models for both Hispanic and Non-Hispanic White women. 
Hispanic women (OR: 0.78, p<0.01) had lower odds of long-term mammography 
utilization than African American women in the unadjusted model only. Non-Hispanic 
White women (AOR: 0.81, p=0.01) had lower odds of long-term mammography 
utilization than African American women in the adjusted model. Conversely, Non-
Hispanic White women (OR: 1.23, p<0.01) had greater odds of long-term mammography 
utilization than African American women in the unadjusted model.  There were similar 
statistically significant results of greater odds of long-term mammography utilization for 
both adjusted and unadjusted models for the following variables:  married (AOR: 1.23, 
OR: 1.61, p<0.01); elevated Gail risk score (AOR: 1.82, OR: 2.16, p<0.01); having a 
regular source of care (AOR: 3.16, OR: 5.29 p<0.01); having health insurance (AOR: 
2.60, OR: 4.92, p<0.01), and having an excellent/very good/good perceived health status 
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(AOR: 1.33, OR: 1.74, p<0.01). Women who experienced homelessness (AOR: 0.63, 
p=0.02, OR: 0.37, p<0.01) had lower odds of long-term mammography utilization in the
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Table 4.6 
 
Relationship of Unadjusted and Adjusted Model Variables on Mammography Utilization 
 
Independent Variables 
                      (n=6,296)+ 
 
 
Age Strata 
Recent 
Unadjusted                        Adjusted 
 
                                        
p value     OR (CI)        p value    AOR (CI) 
<0.01                             <0.01 
Long-Term 
        Unadjusted                              Adjusted 
 
                                                             
p value       OR (CI)         p value       AOR (CI) 
<0.01                                  <0.01 
   43 – 49yr *           1.00                                   1.00         1.00                                      1.00 
   50 – 64yr           1.38(1.17-1.63)           1.28(1.07-1.55)         1.84(1.56 - 2.19)            1.92(1.65-2.23) 
   65 – 79yr           1.22(1.03-1.44)        0.89(0.72-1.10)         1.30(1.04 - 1.62)            1.76(1.47-2.10) 
Race/Ethnicity 0.09                                <0.01   0.01                                   <0.01 
   Hispanic           0.88(0.73-1.07) 0 .     1.18(0.96-1.46)         1.00(0.80 - 1.25)           0.78(0.63-0.95) 
   White           1.06(0.90-1.24)      0.71(0.60- 0.85)         0.81(0.67 - 0.97)           1.23(1.04-1.45) 
   AAa*           1.00                                  1.00         1.00                                       1.00 
Marital Status <0.01                                0.01 <0.01                                   <0.01 
   Married          1.63(1.44-1.85)                                1.22(1.05 -1.41)         1.23(1.08 - 1.41)          1.61(1.44-1.81) 
   Not Married*          1.00                                  1.00         1.00                                       1.00 
5-yr Gail Risk <0.01                              <0.01 <0.01                                  <0.01 
   >=1.67%           1.72(1.49 - 1.99) 1.62(1.37-1.92)         1.82(1.54 - 2.15)             2.16(1.87-2.49) 
   < 1.67%*           1.00                                  1.00         1.00                                       1.00 
Homelessness <0.01                                 0.12   0.02                                   <0.01 
   Yes           0.43(0.31 - 0.60) 0.75(0.52-1.08)         0.63(0.44 - 0.91)              0.37(0.27-0.51) 
   No*           1.00                                  1.00         1.00                                       1.00 
Regular Source of Care <0.01                               <0.01 <0.01                                   <0.01 
   Yes           5.51(4.40 - 6.91)                3.28(2.54-4.24)         3.16(2.41 - 4.13)               5.29(4.17-6.71) 
   No*           1.00                                  1.00         1.00                                        1.00 
Income <0.01                               <0.01 <0.01                                   <0.01 
   less than 1           0.28(0.22 - 0.34) 0.44(0.34-0.57)         0.42(0.32 - 0.55) 0.25(0.21-0.31) 
   1- < 2           0.30(0.25 - 0.37) 0.46(0.37-0.58)         0.49(0.40 - 0.61) 0.33(0.27-0.39) 
   2- < 3           0.48(0.40 - 0.58) 0.62(0.50-0.76)         0.67(0.55 - 0.83) 0.54(0.45-0.65) 
   3- < 4           0.63(0.51 - 0.71) 0.72(0.58-0.90)         0.82(0.64 - 1.05) 0.73(0.57-0.93) 
   4 or greater*           1.00                                  1.00         1.00                                        1.00 
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Independent Variables 
                      (n=6,296)+ 
 
 
 
Recent 
Unadjusted                        Adjusted 
 
                                        
p value     OR (CI)            p value          AOR (CI) 
 
Long-Term 
        Unadjusted                              Adjusted 
 
                                                             
p value       OR (CI)           p value                 AOR (CI) 
 
Transportation Delay <0.01                                 0.46    0.21    <0.01 
   Yes           0.58(0.41 - 0.81) 0.87(0.60-1.26)         0.80(0.56 - 1.13) 0.50(0.36-0.69) 
   No*           1.00                                   1.00         1.00                                        1.00 
Health Insurance <0.01                               <0.01 <0.01                                    <0.01 
   Yes           5.00(4.16 - 6.03) 2.91(2.32-3.63)          2.60(2.06 - 3.28) 4.92(4.10-5.90) 
   No*           1.00                                  1.00          1.00                                       1.00 
Perceived Health Status <0.01                               <0.01 <0.01                                    <0.01 
   Excellent/Very Good/ Good           1.67(1.44 - 1.93) 1.30(1.10-1.54)          1.33(1.11 - 1.59) 1.74(1.50-2.02) 
   Fair/Poor*           1.00                                  1.00          1.00                                       1.00 
Note. (*) Represent reference group. Statistically significant in boldface. CI = 95% Confidence interval. Recent: women who had a mammogram within the 
last two years; Adjusted model: Wald F(15, 286)=34.01, p<0.01.  Long-term:  women who had three or more mammograms over the past six years; 
Adjusted model: Wald F(15, 286)=36.77, p<0.01.  (+) Denotes final sample size due to missing values.  
aAA = African American. 
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adjusted and unadjusted models. Only women in the lower three income categories 
(<$38,870) had statistically significant lower odds of long-term mammography 
utilization in the adjusted model.  Women in all four of the lower income categories 
(<$51,870) had statistically significant lower odds of long-term mammography 
utilization in the unadjusted model. 
4.7.5 Comparison of Model Variables by Race and Age 
In examining if there is a difference in Gail risk scores on mammography 
utilization by race, both variable interactions for recent mammography utilization were 
not statistically significant, neither between age strata and the 5-yr Gail risk score, Wald 
F(2, 299)=0.03, p=0.96; nor between age strata and race, Wald F(4, 297)=0.99, p=0.41.  
Similarly, both variable interactions for long-term mammography utilization were not 
statistically significant: between age strata and the 5-yr Gail risk score, Wald F(2, 
299)=1.92, p=0.15; nor between age strata and race, Wald F(4, 297)=0.57, p=0.69. 
Tables 4.7 (recent mammography) and 4.8 (long-term mammography) provide 
logistic regression results and comparison between the nine adjusted and unadjusted 
model variables stratified by age strata. There are similar differences seen between the 
adjusted and unadjusted models when stratified by age strata, as well as several different 
effects among the variables (between unadjusted and adjusted models) than what is seen 
when variables are not stratified by age. 
Having a regular source of care were statistically significant across all three age 
strata in both the adjusted and unadjusted models for recent and long-term mammography 
utilization: recent 43-49 yr, (AOR: 2.98; OR: 5.32), 50-64 yr, (AOR: 2.96; OR: 5.44), 65-
79 yr, (AOR: 7.82; OR: 8.71), and long-term: 43-49 yr, (AOR: 2.56; OR: 4.47), 50-64 yr, 
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(AOR: 3.00; OR: 5.30), 65-79 yr, (AOR: 8.27; OR: 9.18), p<0.01.  Inclusion in the lower 
two income categories (<$25,870) were statistically significant across all three age strata 
in both the adjusted and unadjusted models for recent and long-term mammography 
utilization: recent 43-49 yr, (AOR: 0.48, 0.45, p=0.01); (OR: 0.29, 0.29, p<0.01), 50-64 
yr, (AOR: 0.42, 0.49; OR: 0.26, 0.27), 65-79 yr, (AOR: 0.39, 0.42; OR: 0.29, 0.35), 
p<0.01, and long-term: 43-49 yr, (AOR: 0.40, 0.44; OR: 0.23, 0.29), 50-64 yr, (AOR: 
0.42, 0.53; OR: 0.24, 0.29), 65-79 yr (AOR: 0.42, 0.47; OR: 0.27, 0.36), p<0.01. Having 
health insurance was statistically significant across all three age strata in both the 
adjusted and unadjusted models for recent and long-term mammography utilization 
except for long-term mammography for the 65-79 age strata adjusted model: recent 43-49 
yr, (AOR: 2.60; OR: 4.76), 50-64 yr, (AOR: 3.26; OR: 5.78), p<0.01, 65-79 yr, (AOR: 
4.3, p=0.04); (OR: 7.76, p<0.01), and long-term: 43-49 yr, (AOR: 2.09; OR: 4.10), 50-64 
yr, (AOR: 3.08; OR: 5.60), p<0.01, 65-79 yr, (AOR: 3.16, p=0.10), (OR: 6.97, p<0.01).  
Perceived health status was only statistically significant in both the adjusted and 
unadjusted models for the 65-79 age strata (AOR: 1.46, p=0.02; OR: 1.79, p<0.01) for 
recent mammography, and the 50-64 age strata (AOR: 1.35, p=0.03; OR: 1.93, p<0.01) 
for long-term mammography. An elevated Gail risk score was statistically significant in 
both the adjusted and unadjusted models for all age strata for recent and long-term 
mammography utilization except for the 43-49 age strata: recent, 43-49 yr,  (AOR: 1.78, 
p=0.08); (OR: 2.16, p=0.01), 50-64 yr, AOR: 1.62; OR: 1.74), 65-79 yr, (AOR: 1.64; OR: 
1.74), p<0.01, and long-term: 43-49 yr, (AOR: 3.15; OR: 3.62), 50-64 yr, (AOR: 1.89; 
OR: 2.06), 65-79 yr, (AOR: 1.59; OR: 1.77), p<0.01. 
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4.7.6 Between Group Differences for Recent by Age Strata 
The overall logistic regression models for each age strata were statistically 
significant (Table 4.7).  For the adjusted and unadjusted age strata models, woman in all 
age strata with a regular source of care:  43-49 yr, (AOR: 2.98; OR: 5.32), 50-64 yr, 
(AOR: 2.96; OR: 5.44), 65-79 yr, (AOR: 7.82; OR: 8.71), p<0.01, and health insurance: 
43-49 yr, (AOR: 2.60; OR: 4.76), 50-64 yr, (AOR: 3.26; OR: 5.78), p<0.01, 65-79 yr, 
(AOR: 4.3, p=0.04); (OR: 7.76, p<0.01), had greater odds of recent mammography 
utilization.  As shown in Table 4.7 for the 43-49 age strata, being married (OR: 1.67 
p<0.01); having an elevated Gail risk score (OR: 2.16, p=0.01), experienced 
homelessness (OR: 0.49, p=0.01), and an excellent/ very good/ good perceived health 
status (OR: 1.57, p=0.01) contributed statistically significantly to the unadjusted model, 
but not to the adjusted model. Women who experienced homelessness had lower odds of 
recent mammography utilization in the unadjusted model for the 43-49 (OR: 0.49, 
p=0.01) and 50-64 (OR: 0.42, p<0.01) age strata.  Women in the lower three income 
categories had lower odds of recent mammography utilization across all three age strata 
for both adjusted and unadjusted models: 43-49 yr, (AOR: 0.48, 0.45, 0.58, p=0.01); 
(OR: 0.29, 0.29, 0.44, p<0.01), 50-64 yr, (AOR: 0.42, 0.49, 0.60; OR: 0.26, 0.27, 0.45), 
65-79 yr, (AOR: 0.39, 0.42, 0.62; OR: 0.29, 0.35, 0.57), p<0.01 . For women in the 50-64 
age strata, Non-Hispanic White women (AOR:  0.62, p<0.01) had lower odds of recent 
mammography utilization than African American women. Women who were married had 
greater odds of recent mammography utilization for women in the 50-64 (OR: 1.61, 
p<0.01) and 65-79 (AOR: 1.40, p=0.02, OR: 1.78, p<0.01) age strata. Women with an 
elevated Gail risk score had greater odds of recent mammography utilization for the 50-
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64 (AOR: 1.62, OR: 1.74, p<0.01) and 65-79 (AOR: 1.65, OR: 1.74, p<0.01) age strata. 
Women in the 50-64 age strata with transportation delays (OR: 0.57, p=0.02) had lower 
odds of recent mammography utilization. Women with an excellent/ very good/ good 
perceived health status in the 43-49 (OR: 1.57, p=0.01), 50-64 (OR: 1.75, p<0.01) and the 
65-79 (AOR: 1.46, p=0.02, OR: 1.79, p<0.01) age strata had greater odds of recent 
mammography utilization. 
4.7.7 Between Group Differences for Long-Term by Age Strata 
Non-Hispanic White women in the 50-64 age strata (AOR:  0.76, p=0.03) had 
lower odds of long-term mammography utilization than African American women (Table 
4.8). Women with an elevated Gail risk score: 43-49 yr, (AOR: 3.15; OR: 3.62), 50-64 yr, 
(AOR: 1.89; OR: 2.06), 65-79 yr, (AOR: 1.59; OR: 1.77), p<0.01, and a regular source of 
care: 43-49 yr, (AOR: 2.56; OR: 4.47), 50-64 yr, (AOR: 3.00; OR: 5.30), 65-79 yr, 
(AOR: 8.27; OR: 9.18), p<0.01, had greater odds of long-term mammography utilization 
in the adjusted and unadjusted models across all three age strata.  The Gail risk score was 
more predictive for women in their 40s (AOR: 3.15, OR: 3.62, p<0.01) than for women 
in the other two groups.  Incomes in the lower two categories: 43-49 yr, (AOR: 0.40, 
0.44; OR: 0.23, 0.29), 50-64 yr, (AOR: 0.42, 0.53; OR: 0.24, 0.29), 65-79 yr (AOR: 0.42, 
0.47; OR: 0.27, 0.36), p<0.01, had lower odds of long-term mammography across the 
three age strata.  Having health insurance had greater odds of long-term mammography 
utilization except in the adjusted model for women in the 65-79 (AOR: 3.16, p=0.10) age 
strata. Having an excellent/ very good/ good  perceived health status had greater odds of 
long-term mammography in both the adjusted and unadjusted models for the 50-64 age 
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strata (AOR: 1.35, p=0.03, OR: 1.93, p<0.01).  Women across all three age strata with 
transportation delays:  43-49 yr, (OR: 0.41, p=0.02), 50-64 yr, (OR: 0.55, p=0.01), 65-79
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Table 4.7 
  
Relationship of Unadjusted and Adjusted Model Variables on Recent Mammography Utilization by Age Strata 
Independent Variables 
 
 
43 – 49 yr (n=1,519) 
    Unadjusted                        Adjusted 
                          
                                      
p value    OR (CI)       p value    AOR (CI)         
50 – 64 yr (n=2,996) 
    Unadjusted                   Adjusted  
 
 
p value   OR (CI)     p value    AOR (CI)  
65 – 79 yr (n=1,781) 
    Unadjusted               Adjusted  
 
 
p value   OR (CI)  p value   AOR (CI)             
Race/Ethnicity 0.53                               0.03 0.19                           <0.01 0.70                       0.06 
   Hispanic          0.93(0.63- 1.37)         1.31(0.85-2.02)         0.80(0.59-1.08)        0.99(0.69-1.42)       1.12(0.72-1.75)      1.48(0.90-2.45) 
   White          1.10 (0.78-1.55)         0.78(0.53-1.16)         0.99(0.76-1.28)        0.62(0.46-0.83)       1.14(0.84-1.54)      0.87(0.62-1.21) 
   AAa*          1.00                            1.00         1.00                          1.00       1.00                        1.00 
Marital Status <0.01                            0.38 <0.01                          0.20 <0.01                      0.02 
   Married         1.67(1.29-2.15)           1.14(0.84-1.55)         1.61(1.33-1.95)        1.15(0.93-1.43)      1.78(1.41-2.25)       1.40(1.07-1.82) 
   Not Married*         1.00                             1.00         1.00                          1.00      1.00                         1.00 
5-yr Gail Risk 0.01                              0.08 <0.01                        <0.01 <0.01                    <0.01 
   >=1.67%         2.16(1.18-3.96)            1.78(0.94-3.36)        1.74(1.39-2.18)         1.62(1.27-2.06)      1.74(1.39-2.17)       1.65(1.30-2.09) 
   < 1.67%*        1.00                              1.00        1.00                           1.00      1.00                         1.00 
Homelessness 0.01                             0.44 <0.01                          0.25 0.05                         0.26 
   Yes        0.49(0.28-0.85)            0.79(0.44-1.43)        0.42(0.27-0.65)         0.75(0.46-1.22)      0.35(0.12-1.00)       0.55(0.19-1.57) 
   No*        1.00                              1.00        1.00                           1.00      1.00                         1.00 
Regular Source of Care <0.01                          <0.01 <0.01                        <0.01 <0.01                    <0.01 
   Yes        5.32(3.75-7.54)            2.98(1.94-4.57)       5.44(3.94-7.51)         2.96(2.05-4.30)     8.71(4.75-15.96)    7.82(4.12-14.82) 
   No*        1.00                              1.00       1.00                           1.00     1.00                        1.00 
Income  <0.01                             0.01 <0.01                        <0.01 <0.01                    <0.01 
   less than 1        0.29(0.19-0.42)            0.48(0.29-0.81)      0.26(0.19-0.36)          0.42(0.29-0.63)       0.29(0.19-0.45)      0.39(0.24-0.65) 
   1- < 2        0.29(0.20-0.43)            0.45(0.27-0.74)      0.27(0.20-0.36)          0.49(0.34-0.70)       0.35(0.24-0.52)      0.42(0.28-0.65) 
   2- < 3        0.44(0.30-0.66)            0.58(0.38-0.90)      0.45(0.34-0.59)          0.60(0.44-0.81)       0.57(0.38-0.85)      0.62(0.41-0.95) 
   3- < 4        0.67(0.43-1.04)            0.79(0.50-1.25)       0.59(0.43-0.81)          0.72(0.51-1.01)       0.63(0.40-1.01)      0.62(0.39-1.00) 
   4 or greater*        1.00                              1.00      1.00                            1.00       1.00                        1.00 
Transportation Delay 0.05                              0.43 0.02                            0.57 0.23                         0.99 
   Yes       0.48(0.23-1.01)             0.73(0.34-1.58)       0.57(0.36-0.91)         0.86(0.51-1.45)       0.68(0.37-1.28)      1.00(0.49-2.03) 
   No*       1.00                               1.00       1.00                           1.00       1.00                        1.00 
Health Insurance <0.01                         <0.01 <0.01                       <0.01 <0.01                      0.04 
   Yes      4.76(3.45-6.57)             2.60(1.72-3.93)       5.78(4.53-7.37)         3.26(2.47-4.30)       7.76(2.19-27.54)  4.30(1.12-16.51) 
   No*      1.00                               1.00       1.00                           1.00       1.00                        1.00 
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Independent Variables 
 
 
43 – 49 yr (n=1,519) 
    Unadjusted                        Adjusted 
                          
                                      
p value    OR (CI)       p value    AOR (CI)         
50 – 64 yr (n=2,996) 
    Unadjusted                   Adjusted  
 
 
p value   OR (CI)     p value    AOR (CI)  
65 – 79 yr (n=1,781) 
    Unadjusted               Adjusted  
 
 
p value   OR (CI)  p value   AOR (CI)             
Perceived Health Status 0.01                              0.32 <0.01                          0.12 <0.01                      0.02 
   Excellent/Very     
Good/Good 
    1.57(1.12-2.20)              1.23(0.82-1.83)       1.75(1.41-2.17)         1.24(0.94-1.64)        1.79(1.34-2.38)     1.46(1.06-1.99) 
   Fair/Poor*     1.00                                1.00       1.00                           1.00       1.00                        1.00 
Note. (*) Represent reference group. Statistically significant in boldface. CI = 95% Confidence Interval. Yr = year. AOR = Adjusted Odds Ratio.  OR = Odds 
Ratio. Recent: women who had a mammogram within the last two years; Adjusted models: (43-49 age strata) Wald F(13, 288)=10.86, p<0.01, (50-64 age strata) 
Wald F(13, 288)=23.43, p<0.01, and (65-79 age strata) Wald F(13, 288)=10.07, p<0.01.  
aAA = African American. 
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Table 4.8 
  
Relationship of Unadjusted and Adjusted Model Variables on Long-Term Mammography Utilization by Age Strata  
Independent  
Variables 
 
 
43 – 49 yr (n=1,519) 
  Unadjusted                        Adjusted 
 
                                                
p value   OR (CI)    p value    AOR (CI)                                      
50 – 64 yr (n=2,996) 
    Unadjusted                    Adjusted 
                       
                                               
p value OR (CI)    p value    AOR (CI)                              
65 – 79 yr (n=1,781) 
   Unadjusted                      Adjusted 
                        
                                                
p value OR (CI)      p value   AOR (CI)                          
Race/Ethnicity 0.02                           0.45 0.01                          0.03 0.03                            0.64 
   Hispanic       0.78(0.53-1.15)          0.99(0.65-1.51)       0.88(0.64-1.20)          1.07(0.76-1.51)        0.73(0.47-1.12)          0.86(0.53-1.41) 
   White       1.18(0.86-1.62)          0.84(0.59-1.20)       1.23(0.95-1.59)          0.76(0.59-0.99)        1.15(0.84-1.60)          0.85(0.60-1.20) 
   AAa*       1.00                            1.00       1.00                            1.00        1.00                            1.00 
Marital Status <0.01                         0.60 <0.01                          0.33 <0.01                        <0.01 
   Married      1.59(1.26-2.00)           1.08(0.82-1.41)      1.60(1.32-1.94)          1.12(0.90-1.40)        2.11(1.67-2.66)         1.66(1.28-2.16) 
   Not Married *      1.00                             1.00      1.00                             1.00        1.00                           1.00 
5-yr Gail Risk  <0.01                      <0.01 <0.01                        <0.01 <0.01                        <0.01 
   >=1.67%       3.62(2.01-6.50)           3.15(1.71-5.83)      2.06(1.65-2.58)           1.89(1.48-2.41)        1.77(1.39-2.25)         1.59(1.23-2.06) 
   < 1.67%*      1.00                             1.00      1.00                             1.00        1.00                           1.00 
Homelessness <0.01                        0.01 <0.01                          0.15 0.14                            0.60 
   Yes      0.30(0.17-0.54)           0.45(0.25-0.83)     0.42(0.27-0.64)            0.71(0.45-1.12)        0.46(0.16-1.31)          0.75(0.26-2.20)      
   No*      1.00                             1.00     1.00                              1.00        1.00                            1.00 
Regular Source of Care <0.01                      <0.01 <0.01                        <0.01 <0.01                         <0.01 
   Yes      4.47(2.98-6.69)           2.56(1.56-4.18)     5.30(3.87-7.26)            3.00(2.11-4.27)        9.18(4.84-17.42)      8.27(4.11-16.61) 
   No*      1.00                             1.00     1.00                              1.00        1.00                          1.00 
Income <0.01                      <0.01 <0.01                        <0.01 <0.01                         <0.01 
   less than 1      0.23(0.16-0.34)           0.40(0.25-0.64)      0.24(0.18-0.32)           0.42(0.29-0.60)        0.27(0.18-0.43)          0.42(0.25-0.70) 
   1- < 2      0.29(0.20-0.42)           0.44(0.28-0.68)      0.29(0.22-0.38)           0.53(0.39-0.72)        0.36(0.25-0.51)          0.47(0.31-0.70) 
   2- < 3      0.52(0.36-0.74)           0.67(0.45-1.00)      0.49(0.37-0.65)           0.66(0.48-0.90)        0.57(0.37-0.87)          0.64(0.40-1.00) 
   3- < 4      0.85(0.56-1.28)           1.00(0.67-1.51)      0.58(0.41-0.83)           0.71(0.49-1.02)        0.79(0.47-1.33)          0.80(0.47-1.35) 
   4 or greater*      1.00                             1.00      1.00                             1.00        1.00                            1.00 
Transportation Delay 0.02                          0.44 0.01                            0.72 0.01                              0.23 
   Yes       0.41(0.19-0.88)          0.73(0.33-1.61)       0.55(0.36-0.86)          0.91(0.55-1.51)       0.45(0.24-0.84)           0.65(0.32-1.32) 
   No*       1.00                            1.00       1.00                            1.00       1.00                             1.00 
Health Insurance <0.01                      <0.01 <0.01                        <0.01 <0.01                          0.10 
   Yes       4.10(2.95-5.70)          2.09(1.38-3.16)       5.60(4.38-7.15)          3.08(2.32-4.10)       6.97(1.94-25.04)       3.16(0.83-11.98) 
   No*       1.00                            1.00       1.00                            1.00       1.00                           1.00 
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Independent  
Variables 
 
 
43 – 49 yr (n=1,519) 
  Unadjusted                        Adjusted 
 
                                                
p value   OR (CI)    p value    AOR (CI)                                      
50 – 64 yr (n=2,996) 
    Unadjusted                    Adjusted 
                       
                                               
p value OR (CI)    p value    AOR (CI)                              
65 – 79 yr (n=1,781) 
   Unadjusted                      Adjusted 
                        
                                                
p value OR (CI)      p value   AOR (CI)                          
Perceived Health Status <0.01                         0.19 <0.01                          0.03 <0.01                           0.08 
   Excellent/Very     
Good/Good 
      1.87(1.35-2.60)         1.30(0.88-1.91)      1.93(1.55-2.39)           1.35(1.03-1.76)       1.76(1.35-2.30)          1.33(0.97-1.83) 
   Fair/Poor*       1.00                           1.00      1.00                             1.00       1.00                            1.00 
Note. (*) Represent reference group. Statistically significant in boldface. CI = 95% Confidence Interval. Yr = year. AOR = Adjusted Odds Ratio.  OR = Odds 
Ratio.  Long-term:  women who had three or more mammograms over the past six years; Adjusted models: (43-49 age strata) Wald F(13, 288)=10.08, p<0.01,  
(50-64 age strata) Wald F(13, 288)=24.77, p<0.01, and (65-79 age strata) Wald F(13, 288)=10.36, p<0.01. 
aAA = African American. 
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yr, (OR: 0.45, p=0.01), had lower odds of long-term mammography utilization in the 
unadjusted model.  Homelessness was only statistically significant for women in the 43-
49 (AOR: 0.45, p=0.01, OR: 0.30, p<0.01) and 50-64 (OR: 0.42, p<0.01) age strata. 
Being married was a statistically significant contributor in both the adjusted and 
unadjusted models only in the 65-79 age strata (AOR: 1.66, OR: 2.11, p<0.01). Being 
married was statistically significant in the unadjusted model for the 43-49 (OR:1.59, 
p<0.01) and 50-64 (OR: 1.60, p<0.01) age strata. Homelessness was a statistically 
significant contributor in the adjusted and unadjusted models for the 43-49 (AOR: 0.45, 
p=0.01, OR: 0.30, p<0.01) age strata, yet only contributed to the unadjusted model for the 
50-64 (OR: 0.42, p<0.01) age strata. 
4.7.8 Gail Risk Scores on Mammography by Race 
Interactions were tested between race and the 5-yr Gail risk score for both recent 
and long-term mammography utilization.  The interactions were not statistically 
significant for recent mammography, Wald F(2, 299)=1.76, p=0.18, nor for long-term 
mammography adherence, Wald F(2, 299)=0.58, p=0.56. 
4.8 Discussion 
The results of this study confirm previous mammography findings. The study 
results provided new information on mammography behaviors of Non-Hispanic White 
women and African American women in their 40s.  This was the first study to use 
calculated Gail risk scores from the 2010 NHIS data, as well as the first study to use the 
temporary homelessness variable in predicting mammography utilization using national-
level data.  
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 These study findings confirm that race/ethnicity, age, and socioeconomic 
(income) disparities still exist in mammography screening utilization (American Cancer 
Society, 2017; Centers for Disease & Prevention, 2012; Rakowski et al., 2004; White et 
al., 2017).  Fewer women in the 43-49 age strata utilized mammography, which may be 
attributed to prominent mammography guidelines not promoting mammography 
commencement at 40 due to the mammography controversy (Bjurstam et al., 2003; 
Nystrom et al., 1993; U. S. Preventive Services Task Force, 2009).  At the time of study 
data collection, mammography guidelines did not aggressively promote individualized 
risk assessment. Therefore, as expected overall among all ages, women in the older two 
age strata had greater odds of both recent and long-term mammography utilization than 
women in their 40s, which aligned with the preponderance of screening guidelines 
recommending regular mammography begin at age 50 (Nash et al., 2007; Rakowski et 
al., 2006; Siu et al., 2016; Smith et al., 2013).  Higher odds of both recent and long-term 
mammography for women in the 50-64 age strata prevailed throughout logistic regression 
testing of unadjusted and adjusted, which has been prevalent in previous studies (Centers 
for Disease Control and, 2012; Legler, Breen, Meissner, Malec, & Coyne, 2002; 
Rakowski et al., 2004).  In this study, women in the older two age strata participated most 
in mammography, and more heavily in continued long-term mammography; with the 
older 65-79 age strata having the higher odds of long-term mammography. This was an 
improvement over earlier studies using the NHIS data, which indicated women in the 
older group participated less in mammography (Hiatt et al., 2002; Legler et al., 2002; 
Swan, Breen, Coates, Rimer, & Lee, 2003).   
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 African American patterns of long-term mammography utilization aligned with 
general long-term mammography utilization for all three races together, with the two 
older age strata having greater odds of long-term mammography than African American 
women in their 40s.  This finding may be attributed to the cross-sectional nature of the 
study, and the mammography controversy with its associated ambiguity surrounding 
commencement for younger women. Since study findings indicate that fewer African 
American women in their 40s are continuing with long-term mammography, an 
evaluation of their individual risk along with an understanding of the timeframes between 
mammograms is warranted due to the aggressive cancer morphology of some breast 
cancer in this population. Should long-term mammography trends in this population 
continue to decline, a more widened breast cancer mortality disparity could be seen 
(Carey et al., 2006; Ooi et al., 2011; Rahman, Dignan, & Shelton, 2003; Rawl et al., 
2000; van Ravesteyn et al., 2012).  A potential positive improvement in mammography 
behaviors for African American in their 40s was seen, with participation in recent 
mammography utilization rates not statistically significantly different than the other 
races.   
A key finding of this study, which is consistent with more recent analyzed 2015 
NHIS  data, was mammography utilization behaviors of Non-Hispanic White women, in 
which adjusted results showed lower odds of recent and long-term mammography for this 
group as compared African American women (White et al., 2017).  Although previous 
studies using 2005 or earlier NHIS or other national-level data show a converse result, 
these updated results could indicate targeted efforts in the African American community 
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in mitigating screening disparities (Amirikia et al., 2011; Rakowski et al., 2004; 
Rakowski et al., 2006; Samson et al., 2016; Swan et al., 2003).    
Another key finding of this study was that Non-Hispanic White women in the 50-
64 age strata had lower odds of both recent and long-term mammography utilization as 
compared to African American women in the same age strata. This finding is different 
from previous national-level data studies showing Non-Hispanic White women in the 50-
64 age strata with the highest recent mammography rates among ethnicities included 
(Rakowski et al., 2006; Rao, Breen, & Graubard, 2016; Swan et al., 2003).  This finding 
is consistent with recent 2015 NHIS data analysis (White et al., 2017).  This could signal 
that women of color are better understanding their breast cancer risk.  
All independent variables contributed as predictors for recent mammography in 
the adjusted model except for homelessness and transportation, while only transportation 
did not contribute to the adjusted long-term model.  Although these results were 
consistent with the literature for mammography predictors, homelessness and 
transportation delay were statistically significant contributors in the unadjusted models 
(Hiatt et al., 2002; Rakowski et al., 2006; White et al., 2017).  The prevailing literature 
guided the selection of the variables, thus this study confirmed the validity of each as a 
predictor of mammography in the unadjusted model (Rakowski et al., 2004).  
Gail risk score was a predictor for all age strata in both adjusted models for recent 
and long-term mammography except for the recent 43-49 age strata.  Regular source of 
care and income were the only two predictors that contributed statistically significantly to 
both recent and long-term mammography utilization for all age strata, which is consistent 
with previous studies (Rakowski et al., 2004; Rakowski et al., 2006; Rao et al., 2016).  
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Women in the youngest age strata who had experienced homelessness had lower odds of 
long-term mammography in both unadjusted and adjusted models. These finding related 
to homelessness is consistent with the literature that suggests that women will delay 
preventive health needs to meet their basic necessity challenges (shelter, food, clothing, 
etc.) (Chau et al., 2002; Gelberg et al., 2000; Moxley & Washington, 2016).   
Women in the older age strata who reported excellent or good perceived health 
were more likely to report recent mammography. Women in the middle age strata who 
reported an excellent or good perceived health were more likely to report long-term 
mammography. This is born out in the literature that having an excellent or good 
perception of one’s health would lead to greater mammography participation (Rakowski 
et al., 2004; Rao, Graubard, Breen, & Gastwirth, 2004).  Marital status was only a 
mammography utilization predictor with the oldest age strata in the adjusted model, 
verifying the importance of partner support for this age strata, suggesting perhaps 
motivation for improved quality of life and preventive health services with the presence 
of a spouse (Allen, Stoddard, & Sorensen, 2008; Farmer, Reddick, D'Agostino, & 
Jackson, 2007; Mobley, Kuo, Clayton, & Evans, 2009).  
Lower income was negatively associated with less mammography utilization in 
this study.  Including financial resources as a sociodemographic predictor for 
mammography utilization has been associated throughout the literature (Rakowski et al., 
2004; Rakowski et al., 2006; Rao et al., 2016). This might signal that the youngest and 
oldest age strata might be aware of community resources to meet their mammography 
needs. For the oldest age strata, they do contend with lowered and fixed incomes, which 
might inform their decision to delay mammography (Jennings-Dozier & Lawrence, 2000; 
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Kolb, 2006; Rakowski et al., 2006). Having health insurance was less of a factor for long-
term mammography utilization for the oldest age strata.  Although this study data was 
obtained pre-Patient Protection and Affordable Care Act (ACA), health insurance may 
not have been a barrier for the older age strata due to Medicare coverage, a free health 
insurance for older Americans beginning at age 65.      
Although study participants did not know their Gail risk score, questions from the 
NHIS allowed Gail risk score calculations ex post facto, which provided a rare element to 
this study.  These study findings were able to show that there was no difference in 5-year 
Gail risk score across age strata and races.  Study findings also showed that an elevated 
5-year Gail was a recent mammography utilization predictor for the two older age strata, 
and a long-term mammography utilization predictor for all three age strata.  These 
findings support the importance of women knowing their individual breast cancer risk, 
informing their mammography utilization (Anderson, 2010; Antill et al., 2006; Pace & 
Keating, 2014). 
4.8.1 Strengths 
This hypothesis-driven secondary data analysis study offered several strengths.  
The large national dataset provided optimal power, extensive variables, and 
generalizability of study results.  The conceptual tenets of the BMVP were strengths of 
the study that allowed for evaluation of vulnerable population domains (Austin et al., 
2008; Babitsch, Gohl, & von Lengerke, 2012; Gelberg et al., 2000; Oser, Bunting, Pullen, 
& Stevens-Watkins, 2016).  The vast number of variables within the 2010 NHIS allowed 
the Gail risk score to be calculated.  Although study participants did not know their 
individual breast cancer risk and did not make mammography utilization decisions using 
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knowledge of their risk, utilization of the Gail risk score was both a strength and 
limitation of this study.  Had women known their Gail risk, it would have factored into 
their mammography decisions.  Another limitation of the Gail risk score in the NHIS is 
that it does not account for women with atypical ductal hyperplasia (ADH), which is only 
diagnosed with screening mammography. Since ADH is a risk factor for developing 
breast cancer, women in the study may have potentially had ADH but were not noted as 
such in this study (Howard-McNatt, 2017; Purcell & Norris, 1998).  
4.8.2 Limitations 
Limitations of this study included its secondary data analysis design, income 
variable complexities, and participant self-report.  Secondary data analysis has inherent 
design limitations, in that, the original data was not collected for the specific purpose of 
this study, as there are capture and collection limits of multi-purpose survey data.  
Therefore, design of a new study would allow for greater specific information on 
mammography utilization.  Even though secondary data presented inherent limitations, 
the data set was extremely well suited for my research questions through its specific 
design to study mammography.  Calculations for the income variable were a limitation, 
as multiples of the 2009 poverty threshold for a family of two ($13,000) was used 
irrespective of whether women were from a family of < or > three, which may have 
caused some inherent variance. Additionally, the five sets of the multiple income variable 
complicated regression analysis computations. Yet, without the imputed income, the data 
would have included 20% missing income data, significantly impacting analysis.  Self-
report data also has intrinsic limitation factors: recall problems, overestimation, and 
telescoping (Caplan, Mandelson, Anderson, & Health Maintenance, 2003; Cronin et al., 
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2009; King, Rimer, Trock, Balshem, & Engstrom, 1990; Paskett et al., 1996).  Despite 
the innate parameters surrounding self-report, it is still shown to be accurate and reliable 
(Mack, Pavao, Tabnak, Knutson, & Kimerling, 2009; Newell, Girgis, Sanson-Fisher, & 
Savolainen, 1999). Lastly, while this study data is not as recent, it does still offer valuable 
insight into mammography utilization dynamics that should be further explored.   
4.8.3 Research and Practice Implications 
This study findings show that greater mammography among younger African 
American women is not increasing the incidence of breast cancer seen in the literature.  It 
is not clear if younger African American women are aware of their breast cancer risk, 
breast cancer incidence, and treatment or mortality rates.  This study results show that 
there is no statistically significant difference in mammography utilization by age strata 
for African American women that differed in what is seen when Non-Hispanic White, 
African American, and Hispanic women were compared together.  Therefore African 
American women in the different age strata are using mammography similarly as women 
in other races and age strata.  
There are still unresolved questions that should be further explored.  Temporary 
and long-term homelessness should be further explored in the context closer to the 
expressed mammography behavior, to better determine its effect. Delays in transportation 
also should be further explored to determine its effect in an adjusted model.  Further 
research is needed to determine how much younger women should be participating in 
mammography after they have explored their risk with their provider.      
It is encouraging to see that mammography use among African American and 
Hispanics women increasing; however it is concerning that non-Hispanic White women 
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have lower mammography use than in previous iterations of the NHIS (Rakowski et al., 
2004; Rakowski et al., 2006; Rao et al., 2016; Swan et al., 2003).  Future research is 
needed to explore why Non-Hispanic White women have lowered mammography 
utilization. It is also recommended that future breast cancer and mammography disparity 
research focus in the following areas:  predictors inherent to vulnerable populations;  
individual breast cancer risk tools like the Gail; how risk tools can improve 
mammography utilization and breast cancer health disparities; race and mammography; 
mammography adherence using current recommended mammography guidelines; and 
continued utilization of individualized breast cancer risk tools that may include 
evaluation of women with ADH.  Continual testing of mammography predictors is 
needed as systems and national healthcare policies change, and translation of that 
knowledge into practice (Kearney & Murray, 2009; Warnecke et al., 2008). 
4.8.4 Conclusion   
Mammography screening has a vital place in the continuum of early breast cancer 
detection and in assisting in mitigating breast cancer health disparities.  For African 
American women, despite mammography’s increased utilization by the two older age 
strata, it is important for women in their 40s to know their risk and consult with their 
health provider concerning commencement, frequency, and adjunct detection modalities. 
As new dynamics and interactions present, it is important to continue studying their 
impact on mammography utilization, so that continued improvements, knowledge, and 
breast cancer health disparity mitigation strategies can be garnered. 
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